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THE BIOPHYSICAL, BIOCHEMICAL AND STRUCTURAL CHARACTERIZATION OF 
POLY(ADP-RIBOSE) POLYMERASE-1 (PARP-1) AND ITS COMPLEXES WITH  DNA-DAMAGE 
MODELS AND CHROMATIN SUBSTRATES 
 
Eukaryotic DNA is highly dynamic and must be compacted and organized with the help of 
cellular machines, proteins, into ‘heterochromatin’ state.  At its basic level, chromatin is comprised of 
spool-like structures of protein complexes termed histones, which bind and organize DNA into larger 
fibrous structures. Cellular processes like transcription and DNA-damage repair require that chromatin be 
at least partially stripped of its protein components, which in turn allows for complete accessibility by 
DNA-repair or transcription machinery. A number of protein factors contribute to chromatin structure 
regulation.  Poly(ADP-ribose) Polymerase-1 (PARP-1) is one of these proteins that exists in all 
eukaryotic organisms except for yeast. In its inactive form, it compacts chromatin, but performs its 
chromatin-opening function by covalently modifying itself and other nuclear proteins with long polymers 
of ADP-ribose in response to DNA damage. Thus, it also serves as a first responder to many types of 
DNA damage.  The highly anionic polymers serve to disrupt protein-DNA interactions and thus allow for 
the creation of a temporary euchromatin structure.   
Contained herein are investigations aimed at addressing key questions regarding key differences 
between the interactions of PARP-1 and chromatin and its DNA-damage substrates.  Our experiments 
show that human PARP-1 interacts with and is enzymatically activated to a similar level by a variety of 
different DNA substrates.  In terms of chromatin, it appears that PARP-1 fails to interact with 
nucleosomes that do not have linker DNA.  PARP-1 most effectively interacts with chromatin by 
simultaneously binding two DNA strands through contacts made by its two N-terminal Zn-finger 
domains.  Small-Angle X-ray (SAXS) and Neutron Scattering (SANS) and molecular dynamics (MD) 
 iii 
experiments were combined with biophysical and biochemical studies to better describe the structural 
effects of DNA binding on PARP-1.  The average solution structure of PARP-1 indicates that the enzyme 
is a monomeric, non-spherical, elongated molecule with a radius of gyration (Rg) of ~55Å.  The DNA-
bound form of PARP-1 is also monomeric and binding DNA causes the molecule to become more 
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 Many of the molecules that are essential for life exist as polymers.  Nucleic acids and proteins are 
examples of important biological polymers. It was not until the mid-twentieth century that the real 
structural understanding of these complex biological chemistries began to take shape at the atomic level 
anyway.  Advances in X-ray sources and X-ray diffraction available to researchers in the early 1950s, 
allowed Franklin and Gosling to obtain the fiber diffraction cross-section of DNA [1].  The resulting 
diffraction pattern lead to the description of the molecular structure of B-form DNA by Watson and Crick 
[2].  A short time after the structure of DNA was deduced, the structure of myoglobin, the first protein 
structure, was published [3].  A novel polymer consisting of repeating units of ADP-ribose was first 
described just a few years later during the early 1960s. It was not known at the time that the discovery of 
ADP-ribose polymers would prove to have importance in many critical cellular pathways.   
Extracts of chicken liver cell nuclei contained formations of what was initially thought to be poly-
adenylation (poly-A).  In that study it was shown that a nuclear enzyme was responsible for the synthesis 
of a large quantity of the “poly-A”.  It turned out that the synthetic reaction depended on both the 
presence of DNA and nicotinamide mononucleotide (NMN), rather than the presumptive substrate ATP 
[4].  The discovery of chains of poly-A that were synthesized in the absence of nucleotide triphosphates 
suggested a novel synthetic pathway.  Additionally, the polymer they described was unlike other nucleic 
acids in that it had resistance to RNase and DNase activities.  This suggested the existence of a third type 
of nucleic acid.  Further support for the existence of a new type of nucleic acid came from the fact that 
ADP-ribose polymers were often purified with DNA and RNA.  Later, it was reported that depending on 
the purification scheme used to purify the poly-A, the polymers of heterogeneous sizes would or would 
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not co-purify with nucleic acids, as reviewed by H. Hitz and P. Stone [5].  Shortly after the discovery of 
poly-A, several groups described the structure of the poly-A as a novel type of polymer consisting of 
repeating units of adenosine diphosphate-ribose, ADP-ribose [6-8].  The monomeric units are comprised 
of two ribose molecules and two phosphate moieties and the units can be thought of chemically as NAD+ 
molecules without a nicotinamide group (Figure 1.1).   
Chambon et al. were correct in describing the novel reaction requirements, and later the 
fundamental structural elements of the polymer, but were incorrect in naming the NMN molecule as the 
starting molecule or building block of the polymer.  The energy rich substrate for the previously 
unknown-enzyme catalyzed synthesis of chains of ADP-ribose is nicotinamide adenine dinucleotide 
(NAD+).  A careful analysis, using doubly labeled ATP, NMN and NAD+ compounds allowed for the 
elucidation of the proper starting material [7, 8].  In the communication by Nishizuka et. al. it was also 
shown that DNA had to be present in the reaction for polymer formation to occur [7].  Clearly, Chambon 
et al., were on the right track but their experimental design may have overlooked the presence of other 
enzymes specifically, NAD+ pyrophosphorylase.  NAD+ pyrophosphorylase was no doubt present in the 
nuclear enzyme preparations used in their experiments.  NAD+ pyrophosphorylase is known to combine 
radioactive NMN with ATP to form the radioactive NAD+.  Combining those results with insight from 
their own experiments, Nishizuki et al. were able to confirm the need for NAD+ to be present for the 
enzymatic formation of the polymers [7]. 
The discovery and early characterization of the poly-ADP-ribose lead some to speculate about the 
cellular purpose for such polymers.  Upon describing what was thought to be poly-A, Chambon et al.  
hypothesized that the polymer served as a form of storage or containment for energy rich molecules [4].  
Alternatively, NAD-derived chains of poly-ADP-ribose were proposed by Nishizuka et al. to be a 
formation of energetically costly NAD+ molecules bound in an irreversible manner and contained within 
cellular nuclei.  Intriguingly, the authors calculated the rate of NAD+ consumption, during the synthesis of 
poly-ADP-ribose, and that rate seemed to exceed the rates of NAD+ formation by the two known 









Figure 1.1.  Nicotinamide Adenine Dinucleotide (NAD+) and poly-ADP-ribose (PAR). A.) the 
chemical structure of NAD+.  The orange oval highlights the nicotinamide portion of the molecule, this 
group is a leaving group during the ADP-ribosylation reaction.  The black circle represents the acceptor 
group for the successive addition of more ADP-ribose moieties during the synthesis of linear PAR chains.  
L-site and B-sites represent favorable acceptor sites for linear and branched chain formation, respectively. 
B.) PAR formation depends on the initial ADP-ribosyl modification of surface exposed amino acids on 
target proteins, in this case the acceptor site is a glutamic acid side chain.  The polymers are 
heterogeneous in that they contain varying length and their complexity depends on the levels of 
branching.  PAR chains are highly charged since there are two negatively charged phosphate moieties 
between ribose sugar groups.  These highly anionic polymers are thought to compete with DNA for the 
binding of chromatin-associated proteins. C).  The Poly(ADP-ribose) cycle.  PARP-1 binds and 
condenses chromatin until DNA-damage induces its activation.  Modified PARP-1 and other chromatin 
associated proteins are then released from DNA.  Naked DNA is accessible by DNA-repair and 
transcription machinery.  Meanwhile the poly-ADP-ribose polymers are removed by Poly(ADP-ribose) 
Glycohydrolase (PARG).  After PAR removal, PARP-1 and other chromatin associated proteins can 





Within a decade of the discovery of the poly-ADP-ribose polymers, it was observed that the polymers 
were subject to degradation.  In fact, a whole new class of enzyme responsible for the poly-ADP-ribose 
catabolism was discovered in that context.  The enzyme exhibited a glyco-hydrolase activity and was 
aptly named Poly(ADP-ribose) Glycohydrolase (PARG) [9].   
Almost immediately after poly-ADP-ribose polymers were characterized, they were found 
covalently linked to nuclear proteins (Figure 1.1B).  The discovery of ADP-ribose linkages to nuclear 
proteins revealed a new purpose for the polymers as covalent protein modifications [10].  It was shown 
that poly-ADP-ribose was associated with chromatin and specifically enriched in histone fractions.  
Following the discovery of the poly-ADP-ribose histone link the topic has been and remains of great 
interest to the field of chromatin and DNA repair alike. Previously the identification of the particular 
histone targets or more specifically the amino acid residues that contained the covalent linkage were hard 
to decipher.  Recent advances in analytical analysis techniques like mass spectrometry have allowed for 
the precise mapping of the ADP-ribose modification sites on the histones [11].  According to peptide 
mapping experiments, the major modification sites appear not to be the surface exposed glutamic acids as 
previously suspected.  Rather, the target sites reside in the flexible tail regions of the histones.  
Chemically, the poly-ADP-ribose polymers are quite similar to nucleic acid.  Since a large 
concentration of the poly-ADP-ribose has been observed in the nucleus, it is reasonable to consider the 
possibility that poly-ADP-ribose might serve as an alternative substrate for DNA binding proteins.  Not 
surprisingly, the acidic polymers were indeed shown to serve as binding platforms for basic histone 
proteins [12].  Early studies on how histones interact with poly-ADP-ribose were quite revealing.  The 
histones could bind the ADP-ribose polymers with a very high affinity, which varied depending on the 
branched nature of the polymers.  The affinities were so strong that neither chaotropic salts nor strong 
acids had any effect in ablating the histone-ADP-ribose interaction.  Intriguingly, the interaction could be 
disrupted if DNA, the preferred histone substrate, was present [12].  Immediately following the discovery 
of non-covalent histone-ADP-ribose interaction, a new role for the poly-ADP-ribose was described.  It 
was hypothesized that DNA-damage induced the formation of poly-ADP-ribose polymers, which in turn 
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served as a temporary binding platform for histones while the DNA is repaired.  The interaction was 
shown to be temporary because the polymers were immediately degraded, presumably after the histones 
rebound DNA, by Poly (ADP-ribose) Glycohydrolase (PARG).  The emerging view from that study was 
that poly-ADP-ribose served as a histone shuttle for a brief period while the DNA damage that resulted in 
its formation was repaired [13].  In other words, poly-ADP-ribose was shown to be involved in a DNA-
damage induced cycle: DNA damage triggers the formation of the polymer, the polymer serves as a 
histone sink near the damage site, the DNA is repaired rapidly in the histone-less “naked” state and the 
ADP-ribose is then rapidly degraded allowing the histones to return to the newly repaired DNA substrate 
(Figure 1.1C).        
 
1.2 The Poly(ADP-ribose) Polymerase Superfamily 
 
Meanwhile, many other studies focused on the enzymatic source of the poly-ADP-ribose 
polymers, the polymerase itself.  The enzyme responsible for the synthesis of the ADP-ribose polymers 
was named Poly(ADP-ribose) Polymerase (PARP) and was occasionally referred to by an older name, 
Poly(ADPR) synthetase (used as far back as the nineteen seventies) [5].  According to the National Center 
for Biotechnology Information (NCBI), the enzyme is known by several aliases, the most frequently used 
ADP-Ribosyl Transferase (ADPRT).  For nearly 30 years the PARP enzyme was believed to be the sole 
source of ADP-ribose polymerization.  It wasn’t until 1995 that a plant homologue of mammalian PARP 
was discovered in the plant species Arabidopsis thaliana [14].  Later it was shown that two independent 
PARP proteins were present in A. thaliana [15].   
Cell lines derived in a mouse PARP-/- background retained the ability to synthesize poly-ADP-
ribose when treated with DNA-damaging agents [16].  A closer investigation of the PARP-/- cell lines lead 
directly to the discovery of a new mammalian enzyme with poly(ADP-ribose) polymerase activity, the 
enzyme was named PARP-2 [17].  Later it was shown that when both PARP-1 and PARP-2 are ablated, 
null mouse embryos do not live past gastrulation [18]. Accordingly, the amount of poly-ADP-ribose 
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produced in the PARP-1-/- cells was severely diminished. When the two enzymes were compared in vitro, 
it was shown that PARP-2 could only synthesize a fraction of the levels poly-(ADP-ribose produced by 
PARP-1 (~18-fold lower) [18].  In terms of cellular survival in the presence of DNA-damaging agents the 
lower enzymatic activity of PARP-2 seems to be sufficient to cover the PARP-1-/- phenotype.    
Preceding the description of PARP-2 was the discovery of another PARP-family member, 
Tankyrase [19].  Tankyrase has sequence homology with both the enzymatic region of PARP-1 and the 
ankyrin-repeat regions of the ankyrin class of proteins.  The localization of Tankyrase to telomeric DNA 
and its ability to synthesize polymers of ADP-ribose signified the importance of the polymers in 
regulating cellular processes other than DNA-damage repair. 
While PARP-2 and Tankyrase were being described a simultaneous search for other PARP-like gene 
products was underway.  Later, cDNA cloning techniques and homology comparisons helped define the 
existence of PARP-2 independently of Ame et al. [20].  The communication describing the cDNA cloning 
technique also described the existence of yet another PARP-family member, PARP-3.  The PARP-3 
protein was later described as being primarily localized at the centriole.  The enzymatic activity of PARP-
3 was shown to be DNA-dependent and the PARP-3 derived poly-ADP-ribose polymer is functionally 
involved in the negative regulation of cell cycle progression [21, 22]. 
In all, a total of 18 proteins have now been characterized as members of the PARP-family.  The 
requisite for membership is a shared homology with the enzymatic domain of PARP-1 (reviewed in [23, 
24]).  It is important to note that structural homology to the PARP-enzymatic domain does not necessarily 
mean that the protein is a functional polymerase. A recent comparison of the enzymatic properties of the 
PARP-family discussed the need to reclassify the family into 3 subgroups [25].  Although all PARP-
family members share homology with PARP-1, certain members lack critical amino acids within the 
enzymatic domain.  A fully functional polymerase would belong to group i.) a PARP-polymerase.  Key 
differences in the active site or the substrate recognition region of the enzymatic domain leads to 
differences in the chemistry and the overall polymerase activity, and such proteins would be classified  to 
the ii.) mono-ADP-Ribosyl Transferase (mART) group.  Finally, a complete lack of activity would define 
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a PARP-family member as belonging to group iii.) the functionally inactive enzyme category.  As a result 
of the study by Kleine et al., an effort has been made to rename the entire family based on the shared 
homology of the PARP-family with a more ancient class of proteins, the diphtheria toxin (a mART in its 
own right) [26].  The three classes of the PARP-family are diverse, and the roles that many of the 
members perform within the cell have yet to be elucidated.     
 
1.3 Poly (ADP-ribose) polymerase-1, a structural and functional description. 
  
As was discussed previously, the enzymatic product of PARP-1 protein have been intensely 
investigated over the past several decades.  In the late 1970’s, several studies focusing on the enzyme 
itself started to surface.  From those reports it was shown that the enzyme was on the order of 110-130 
kDa in size.  It was also shown that the PARP-1 protein primarily localized within the nuclei of several 
species of eukaryotes [27, 28].  The work of Yoshihara et al. provided for a thorough enzymatic analysis, 
which was greatly aided by the researcher’s ability to purify, to a high degree, the PARP-1 protein from 
bovine thymus preparations. The enzyme was shown to have a half-maximal enzyme rate (Km) of ~60µM 
for NAD+ (see Chapter 2 for comparisons of different allosteric activators, or DNA substrates).  For the 
first time researchers deciphered the DNA-to-enzyme ratio for effective catalytic activation [28].  It was 
shown that the enzyme required an equivalent mass concentration of DNA. In other words, effective 
enzymatic activation required the formation of a one-to-one complex of PARP-1 to DNA even in the 
absence of histones (then thought to be the major activators of the enzyme) [28].  Also from that study, it 
was shown that the enzyme requires a double-stranded, damaged-DNA substrate with a minimum length 
of 10 bp, and for effective activation a divalent metal, namely magnesium, must also be present.  Finally 
one of the major nuclear proteins thought to be necessary for enzymatic activation, the histone class of 
proteins, turned-out to be not required.  An added level of complication came from the experiments of the 
past decades, which showed that the PARP-1 enzyme was responsible for the formation of very 
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heterogeneous polymers (variation in degree of branching and in length).  Taken together, what was 
emerging was a description of a very complex enzyme.  
The complicated nature of the PARP-1 protein has remained a major challenge for researchers 
over the years.  The biochemists’ approach of minimizing the number of variables in a given problem no 
doubt guided some of the ensuing characterizations of the PARP-1 enzyme.  Thanks to the purification 
protocols of Yoshihara et al., large quantities of the pure enzyme were attainable [28].  Once purified 
protein was in hand, efforts to understand the structure-function relationship of PARP-1 could get 
underway.  A great deal of effort was spent on creating anti-PARP-1 antibodies to better define the types 
of interactions and/or the binding partners of PARP-1 [29-31].  Some researchers even thought to better 
define the specific regions of the PARP-1 protein that were critical for said interactions [30].  Limited 
proteolysis was used to generate monoclonal antibodies for specific PARP-1 fragments.  From limited 
proteolysis, it was shown that the protein was comprised of several functional domains [30, 31].  When 
proteolytically digested, the 113 kDa enzyme released three major fragments of roughly 22 kDa, 46 kDa 
and 56 kDa in size.  The 22 kDa fragment was identified as the automodification region [30].  Further 
characterization by DNA-cellulose chromatography revealed that the 46 kDa fragment was responsible 
for the DNA binding properties of the enzyme.  The other major fragment, the 56 kDa piece, contained 
the NAD+ binding activity [30].  Taken together, it appeared that the protein was comprised of three 
domains, the DNA-binding region, the automodification region and finally the catalytic component.  
As a result of a careful analysis of the enzyme’s dependence on metal ions, it was shown that 
PARP-1 required both magnesium and Zn(II) for enzymatic activity to be present [32].  It should be noted 
that the discoverers of the Zn(II) requirement cautioned against the assumption that the enzymatic 
consumption of NAD+ relied on Zn(II).  The elegant experiments of Menissier-de Murci et al., revealed 
that the enzyme required two Zn(II) atoms, not for enzymatic catalysis, but for DNA-binding 
functionality [33].   These researchers defined further the region of DNA binding to a cysteine rich stretch 
of amino acids in the N-terminal region of PARP-1.   The Zn(II) binding area of PARP-1 was described 
as a tandem repeat of what appeared to be a putative zinc-finger motif [33].  The Zn-finger domains were 
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further defined as comprising the N-terminal 24kDa of the protein.  Several years later, the Riken 
Structural Genomic and Proteomics group of Japan published the Nuclear Magnetic Resonance (NMR) 
solution structures of the PARP-1 Zn-finger domains, Zn1 and Zn2 [34].  The PARP-1 Zn-fingers are 
described as containing a rarely seen Zn-coordinating motif comprised of Cysteine-Histidine-Cysteine-
Cysteine pattern.  The rarity comes from the long stretch of amino acids that separate the critical zinc-
binding residues.  Interestingly, the DNA-repair protein, DNA-ligase IIIα, appears to share homology 
with the PARP-1 Zn-finger domains [35]. 
Further structural information has provided atomic-level information on how PARP-1 binds DNA 
[35, 36]. The sequence identity between the two Zn-fingers is not identical and according to recent 
publications, the Zn2 domain has a greater affinity for DNA [35, 36].  The crystallographic and solution 
structures of the PARP-1 Zn-fingers in complex with DNA describe a high-affinity interaction with 
multiple DNA-damage substrates (small oligonucleotide models of DNA damage).  The solution studies 
of Eustermann et al. on a Zn1-Zn2 protein fragment (amino acids 1-209), also known as the DNA-
binding domain (DBD), (a fragment similar to the one described by Menissier-de Murci et al.) described a 
dynamic interaction with DNA.  The NMR data of the Zn1-Zn2 protein-DNA complex may even indicate 
a specific binding orientation [35].  The recent structures describing how PARP-1 interacts with DNA are 
exceedingly valuable and contribute to the understanding of how the protein interacts with DNA damage.  
What remains to be elucidated is the interaction of the Zn-fingers, or the entire enzyme, with the non-
damaged DNA substrate PARP-1 is known to bind, chromatin.  
The domain mapping of PARP-1 by limited proteolysis revealed the major functional regions of 
the enzyme [30, 31].  However, the structural and biochemical work that defined the DBD revealed a 
major discrepancy between the apparent 46kDa DNA-binding proteolytic fragment and the 24kDa mass 
of the tandem Zn-fingers.  Later it was shown that during apoptosis, the PARP-1 protein is a major target 
for proteolytic cleavage upon treatment of cells with chemotherapeutics [37].  It was shown that cellular 
levels of poly(ADP-ribose) during apoptosis were significantly lower even in the presence of extensive 
DNA endonuclease activity.  The work by Kaufman et al. revealed that apoptosis related proteolytic 
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activity results in the cleavage of PARP into two fragments of roughly 25kDa and an 85kDa in size.  It 
was shown that the 25kDa fragment contained the DNA binding activity, the N-terminal Zn1 and Zn2 
domains, and the C-terminal catalytic domain was contained in the 85kDa fragment.  Interestingly, the C-
terminal cleavage product retained only basal levels of enzymatic activity because the enzyme could no 
longer be induced by DNA strand breaks.  Shortly after the apoptosis link was revealed, a novel caspase 
family member was described as the protease responsible for the PARP-1 cleavage [38].  The discovery 
of PARP-1 as a major target during the early stages of apoptosis revealed an important dichotomy in the 
apparent multiple roles of PARP-1.  For instance, PARP-1 was responsible for alerting the cell to DNA 
damage yet, its enzymatic activity must be silenced in the early stages of apoptosis.  If PARP-1 were not 
silenced, the cellular store of NAD+ would be depleted very rapidly by the enzyme. 
Recently, PARP-1 has been of renewed interest to many different structural biology research 
groups.  The Riken Genomics and Proteomics group of Japan were successful in large-scale recombinant 
expression of several different PARP-1 domains for NMR studies [34].  The researchers who published 
the first PARP-1 domain structures, the Zn1 and Zn2 domains, followed up those studies with an 
additional crystallographic structure.  The group also published the solution structures of a domain with 
homology to the C-terminus of the Breast Cancer type 1 susceptibility protein (BRCA-1) (pdb 2COK).  
The solution structures were published without any mention of biological function.  However, homology 
to this domain is quite common in DNA repair pathway members and it is known that the interactions 
between the pathway members X-Ray Cross-Complementing group 1 (XRCC-1), DNA-ligase III and 
PARP-1 are mediated through interactions between the BRCT-domains of those Base-Excision Repair 
(BER) members [39].  Currently, there are two independent structures of the BRCT domain of PARP-1 in 
the Protein Data Bank including a recent submission by Loeffler et al. [40].  The authors who published 
the second BRCT structure discuss an apparent lack of a true interaction with the BRCT domain of the 
XRCC-1 protein.   The authors suggest that the PARP-1 interaction with XRCC-1 might be dependent on 
the presence of covalently linked ADP-ribose moieties, as depicted in Figure 1B [40]. 
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Following the publication of the BRCT domain of PARP-1, the Riken group published the 
solution structures of a novel domain found on the C-terminal side of the BRCT domain, the WGR 
domain.  The domain was named for a conserved three amino acid motif of W, G and R.  The WGR 
domain has no known function but it is conserved in poly(A) polymerases [41].  The three most active 
members of the PARP-family, PARP-proteins 1-3, contain WGR domains immediately upstream of the 
C-terminal catalytic or enzymatic domain.  A study by Altmeyer et al. showed that the WGR domain was 
necessary for efficient activation of the enzyme.  From a chimera study, it was shown that even though 
the domains of all three proteins share a high sequence homology, the WGR domains could only 
effectively activate the protein to which they naturally belong [42]. 
Arguably the most important domain structure for PARP-1 was solved through X-ray 
crystallography in 1996 [43]. The structure was of the chicken C-terminal PARP-homology domain, also 
known as the enzymatic domain.  Shortly after the publication of the first catalytic domain structure, the 
same structural biologists published a number of other structures including; the human catalytic domain 
structure alone and in complex with several inhibitors and most importantly a structure of the catalytic 
domain in complex with an NAD+ analogue, carba-NAD+.   In the manuscript describing the crystal 
structure of the catalytic domain complexed with carba-NAD+, Ruf et al. claimed they were able to 
determine the mechanism for the poly-ADP-ribose reaction [44].    The enzyme-bound NAD+ analogue 
allowed the researchers to hypothesize which amino acids were responsible for NAD+ catalysis, poly-
ADP-ribose elongation, branching.  Additionally, the researchers defined the critical amino acid for the 
polymerase function of the enzyme to be glutamate 988.  An enzyme without the critical glutamic acid at 
position 988 would result in a reaction that catalyzes the transfer of a single ADP-ribose moiety [25].  
Additionally, the numerous crystal structures of the catalytic domain in complex with the different classes 
of inhibitors no doubt allowed for the development of pharmaceutically relevant small molecule inhibitor 
compounds [45].  Several PARP-inhibitors are now in clinical trials and they appear to be a promising 
new class of molecules in the treatment of cancer [46]. 
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One of the most recent discoveries in terms of PARP-1 structural domains was of a third Zn(II) 
binding domain.  A solution structure based on NMR spectra and a crystal structure of the domain were 
published nearly simultaneously [47, 48].  Both groups found that the Zn3-domain was of a novel fold in 
that its Zn-coordinating ability was not involved in DNA binding.  The crystal structure revealed what 
appeared to be a dimerization interface between two molecules in the crystal lattice [48].  However, no 
dimerization was detected in the solution structure [47]. Both groups were able to test the enzymatic 
function in a PARP-1 construct with a Zn3 deletion, or in the case of Langelier et al., a critical mutation 
[47, 48].  Collectively, the structural studies on the Zn3 domain indicate that the Zinc-ribbon structure is 
critical for mediating contacts with other PARP-1 domains, which in turn coordinate the DNA-binding 
event at the N-terminus with the activation of the enzymatic function at the C-terminus of the protein. 
Recently Langelier et al. solved the crystal structure of a near full-length PARP-1 complex with a 
DNA damage substrate [49].  From stability studies, the authors speculated that the catalytic domain 
becomes unstable when the other domains are bound to DNA.  The destabilized catalytic domain is 
thought to undergo major conformational dynamics.  With increased motion and internal stability 
changes, the NAD+ binding pocket was thought to undergo major changes that would directly influence 
the binding of NAD+ within the catalytic domain [49].  Additionally, when the other domains were bound 
to DNA, Langelier et al. inferred that they would be stabilized and would better serve as a modification 
target since only the catalytic domain was destabilized and in turn was more dynamically able to modify 
non-moving target amino acids.  The latest crystal structure and the stability studies are the closest anyone 
has come to date in determining the mechanism of PARP-1 activation.  Given the flexibility of PARP-1, a 
low-resolution solution study or modern electron microscopy techniques involving the full-length protein, 
both with and without DNA, might help to shed light on the DNA induced dynamics of the C-terminal 
catalytic domain. 
The modular nature of PARP-1 is highly reminiscent to other nuclear proteins which are either 
natively unfolded or contain regions of order interrupted by disordered stretches of amino acids (reviewed 






Figure 1.2.  The domain organization of Poly(ADP-ribose) Polymerease-1 (PARP-1). PARP-1 is a 
modular protein consisting of 6 folded structural domains that are connected by flexible linker domains.  
From left to right the protein is comprised of the DNA binding domain (DBD), which includes the Zinc 
fingers, Zn1 and Zn2 (residues 1-206).  The Zn3 domain is a novel protein fold that both coordinates zinc 
atom yet it is not involved in DNA binding rather, it is thought to mediate inter-domain interactions.  The 
BRCT domain shares homology with the BRCA-1 C-terminus and it is thought that BRCT serves 
multiple functions in PARP-1, among them include mediating interactions with other BRCT-domains of 
known binding partners and serving as the primary target for automodification by the C-terminal PARP-
Enzymatic or Catalytic domain.  Between the BRCT and the Catalytic domain resides a WGR domain, 
which is also thought to have a weak DNA binding function.  Below the domain map representation are 
the 3-dimensional structures taken from NMR and crystallographic studies (PDB codes 2DMJ, 









three-dimensional structure, roughly 10% of the protein is made up of flexible linker regions (Figure 1.2).  
The linkers contain highly charged and polar amino acids (rich in Lys, Ala, Glu, Pro, Arg, Ser and Gly 
residues).  These unfolded regions can be thought of as flexible loops that serve to link the independent 
roles of the multiple domains for optimal enzyme functionality.  PARP-1 may have evolved to be flexible 
in order to properly interact with its known multiple binding partners.  It is likely that the enzyme can take 
on multiple orientations and binding partners so that it can effectively participate in several nuclear 
pathways.  Even some of the strongest biological interactions known, like the interaction of an antibody 
with its epitope, have been shown to be stronger if the polypeptide for which the antibody recognizes is 
relatively disordered [52]. A recent comparison of chromatin associated proteins revealed a high degree 
of disorder amongst remodeler proteins [53].  Proteins that perform their functions in the context of large 
complexes may have evolved to have regions of disorder as a means to better interact with multiple 
substrates that might include DNA, histones and other chromatin modifiers.  Additionally, the flexibility 
of PARP-1 might be related to intra- and inter-domain interactions that must occur for optimal enzymatic 
function.  Besides the known ability of PARP-1 to automodify certain domains or regions of itself, there 
is some evidence that different domains of PARP-1 have the potential to interact with each other both in 
cis and trans [47, 49]. 
 There may be other reasons why PARP-1 has so many linkers and is such a flexible molecule, 
which may have to do with enzyme processivity.  In fact, several decades ago a thorough biophysical 
analysis was performed on highly purified bovine PARP-1.  In that study, Ohgushi et al. discussed the 
elongated nature of the polypeptide and reasoned that the enzyme must undergo a conformational change 
upon binding DNA [54].  The researchers hypothesized that DNA binding and catalytic activation were 
separate events, and that DNA binding occured prior to the induction of the enzymatic activity.  Later, a 
structural study demonstrated that the catalytic domain of PARP-1 had an altered conformation when an 
NAD+ analog, FR257517 (a competitive inhibitor), was co-crystalized within the enzymatic domain [55].  
The biologists who solved the inhibitor-bound PARP-1 structure reasoned that the relatively large 
conformational change in the catalytic domain was due to the movement of a single amino acid, Arginine 
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878, an amino acid in the region known as the adenine-ribose binding site.  Basically, the binding of the 
NAD-like molecule to a small region within the PARP-1 catalytic domain induces a large conformational 
change that could echos throughout the greater domain structure.  
 
1.4 PARP-1 in DNA damage repair 
 
 The flexibility and modular make up of PARP-1 allows it to undergo multiple conformations and 
bind many DNA and protein substrates.  In the absence of DNA damage, poly-ADP-ribose is barely 
detectable [56].  Upon induction of DNA damage, the poly-ADP-ribose polymer concentration increases 
by as much as 100 to 500-fold, 90% of which is synthesized by PARP-1 [56, 57].  If PARP-1 were 
overactivated within the cell, in a case where DNA damage levels were very high, the enzyme has been 
shown to deplete the cellular stores of NAD+.   In fact it has been shown that over activated PARP-1, if 
unchecked by caspases, would result in cellular death by necrosis due to severe NAD+ depletion [58].  In 
order for PARP-1 to exist without depleting the NAD+ stores of a cell, the enzyme is thought to be 
inactive in the absence of DNA damage.  Some years back it was shown that PARP-1 is very sensitive to 
the structure of nicked DNA [33, 59].  It is thought that PARP-1 exists in its inactive form, or 
enzymatically silent state, until it binds broken or free DNA ends to protect the genome for unchecked 
DNA damage sites [60].  Among the several DNA structures recognized by PARP-1, a nick represents 
one of the preferred binding substrates over that of a double stranded break DNA.  A study with a 139bp 
double-stranded DNA indicated that a centrally located nick results in a V-shaped structure [61].  From 
electron micrographs, it was shown that PARP-1 preferentially bound the apex of the V-shaped nicked 
DNA, over the double-strand DNA ends.  A recent structural study by Eustermann et al. showed that 
PARP1 had an increased in affinity for a gapped DNA over a nicked version of the same sequence, 
indicating to the authors that flexibility matters in terms of binding affinity [62].  The preference for 
single-strand over double-strand breaks (DSBs) helps explain why PARP-1 is so critically connected to 
the base-excision repair (BER) pathway, as well as to single-strand break repair (SSBR) [63, 64].   
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 It is known that the PARP-1 enzyme has an extremely high specific activity and that it primarily 
targets itself through automodification [28, 54, 65].  Automodification of PARP-1 serves as a signal to the 
DNA repair machinery that damage is present.  The ADP-ribose polymers that remain anchored to the 
PARP-1 protein are thought to bring the base-excision repair protein complex to vicinity of the site of 
DNA damage.   The BRCT-domain of PARP-1 has homology to similar domains present in many of the 
XRCC-1 BER and SSBR protein complexes [39, 63, 66-68].  It is thought that the BRCT-homology 
domains serve as key sites for protein interactions.  However, a careful biophysical study that investigated 
the BRCA-domain binding properties of a number of these related domains found that domain 
interactions may rely on their modification by ADP-ribose polymers [40].  Regardless of how the proteins 
interact, it is important to note that the critical event for recruiting the repair machinery is the formation of 
ADP-ribose polymers after the PARP-1 DNA-binding occurs.  The recognition and binding of damaged 
DNA by PARP-1 seems to be a critical factor in both the BER and SSBR repair pathways.  Subsequent 
recruitment of the XRCC-1 complex allows for the binding of PARP-1 by complex members, most likely 
DNA-ligase III and XRCC-1 proteins.  Once bound to XRCC-1, the enzymatic activity of PARP-1 
drastically diminishes, there-by conserving NAD+ [68].  Additionally, the PARP-1/XRCC-1/DNA Ligase 
III complex seems to be quite stable and may even serve to function in an alternative or redundant DSB 
repair pathway [66]. 
 The involvement of PARP-1 in several different DNA damaged repair pathways has lead some to 
regard the enzyme as “the guardian angel” of the genome [69].  For example, comparative analysis of 
PARP-1 and another important DNA repair complex, DNA dependent Protein Kinase (DNA-PK), 
indicates that PARP-1 has a notably higher affinity for several types of DNA damage [70].  The interplay 
between PARP-1 and DNA-PK was first addressed in a key genetic study in the 1990s [71].  Another 
group has shown that PARP-1 may cooperate with the heterodimer Ku70/Ku80 to increase the affinity of 
binding of the possible ternary PARP-1/Ku70/Ku80 complex to matrix attachment regions (MARs) of 
DNA flanking the coding region of immunoglobulin µ heavy chains [72].  The MAR regions are thought 
to have increased flexibility.  Although flexible DNA does not mimic a site of DNA damage per se, the 
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hypothesis is that increased flexibility in DNA increases PARP1’s ability to bind.  The binding of non-
damaged bent DNA like that of MARs, might serve to sequester PARP-1 so that it can participate in 
V(D)J recombination.  V(D)J recombination is critical for the maintenance of a functional immune 
system and represents large scale events that may appear to PARP-1 as DNA damage.  In, a study by 
Brown et. al., PARP-1 and specifically its ADP-ribose polymers, were critical for activating the DNA-
damage pathway if the DNA-PK catalytic subunit were absent, a situation that results in an immune-
deficient phenotype [73].  Brown et. al. reasoned that in severe combined immune deficient (scid) cells, 
PARP-1 is an obstacle to effective V(D)J recombination because it binds DNA ends too effectively.  
However, upon automodification, PAR-bound PARP-1 looses affinity for DNA and can be replaced by 
the DNA-PK complex, in turn allowing for effective DNA repair, but not effective V(D)J recombination 
[73].  
Another study investigated V(D)J recombination and found that, as might be expected, PARP1 
automodification was present at DNA ends.  The resulting poly-ADP-ribose was shown to be important 
during the PARP-mediated recruitment of DNA-PK.  Additionally, it was shown that PARP-1 is involved 
in deciding the type of DNA repair that will result once the DNA-PK is recruited [74].  Paddock et al. 
discussed important interplay between DNA-PK and PARP-1 in their recent study.  In that study, the 
authors demonstrated binding competition between PARP-1 and Ku70, a component of the DNA-PK 
complex, which controls the type of DNA repair the cell undergoes; high-fidelity or mutagenic repair 
[74].   Recently, the interaction between PARP-1 and DNA-PK was observed in single molecule electron 
microscopy studies [75].  The complex indicates that PARP-1 may help to alter DNA-PK conformations 
on DNA.  The evidence for this claim comes in the form of a small-angle x-ray scattering (SAXS) 
solution model of the DNA-PK molecule without PARP-1 present [76].  Comparing the electron 
micrograph derived model with the SAXS model results in two significantly different conformations of 
the DNA-PK complex.  Spagnolo et al. speculate that PARP-1 may influence the structure of the DNA-
PK molecule so that the enzyme complex can undergo auto-phosphorylation [75].   
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In the sense that PARP-1 binds and protects ends from recombination, PARP-1 may serve as an 
anti-recombinogenic factor [69]. According to Tong et al. this particular property of PARP-1 is important 
for preventing unwanted and deleterious chromosomal recombination events.  Additionally, PARP-1 null 
murine cells display increased levels of aneuploidy, chromosomal fragmentation, fusion and loss, some of 
which result from telemeric dis-regulation [77-79].  The decades of work linking PARP-1 to the DNA 
damage response has made it an obvious target for pharmaceutical inhibition [46, 80].  Recent studies 
have shown that PARP-1 inhibition may be especially effective in killing cells when combined with 
chemotherapeutics, which are deficient in performing DNA repair through the Homologous 
Recombination (HR) pathway; PARP inhibition seems to be especially promising as an anti-cancer agent 
in cells deficient in BRCA-1 and BRCA-2 proteins [81-83].  The mode of action that PARP-1 inhibitors 
have on HR-deficient cells seems to be a method to further sensitize cells to SSBs.   PARP-1 inhibition 
results in an increase in the number of DNA lesions that would normally be repaired through the PARP-1-
mediated SSBR or BER pathways.  In cells deficient in HR, like cells with BRCA-1 or BRCA-2 deletions 
or mutations, unrepaired single-strand breaks become unrepaired double-strand breaks that result in 
chromatid breaks and further aberrations.  The phenotype is thought to be so severe that the cells would 
cease to be viable if they were further assaulted through PARP inhibition [81].   
The involvement of PARP-1 in DNA repair seems to be ubiquitous.  PARP-1 has demonstrated 
roles in several types of DNA damage repair including single-strand break repair (SSBR), base excision 
repair (BER), non-homologous end joining (NHEJ) (through its interactions with DNA-PK), and is 
indirectly involved in homologous recombination (HR).  Many studies link the enzymatic activity of 
PARP-1 to its roles in DNA repair.  It is through its involvement in DNA repair that PARP-1 is thought to 
protect or “guard” the genome.  In fact, the work of Beneke, Burkle and colleagues has linked PARP-1 
function to longevity in mammals [84-90].  Their work has lead to the notion that the enzymatic activity 
of PARP-1 varies among species and that variation correlates positively with lifespan (species with higher 
PARP-1 specific activity maintain longer lifespans) [91].  Beneke and Burkle cite subtle differences in the 
primary structure of PARP-1 and these differences represent an evolutionary “control” [92].  In that work 
 19 
Human PARP-1 had a relative activity level roughly 2-fold above that of the Rat PARP-1.  Interestingly, 
certain single nucleotide polymorphisms (SNPs) within the enzyme’s active site have been documented 
within the human population [93, 94].  It is known that these SNPs result in increased cancer 
susceptibility [95, 96] and have been shown to have major enzymatic implications in vitro [93, 94].  
According to Beneke and Burkle, the major differences between species might depend less on the active 
site of the enzyme and more to sites of automodification, other post-translational modifications, and/or 
regions critical for optimal protein-protein interactions [92]. 
It is known that the DNA binding of PARP-1 is the crucial initiating step for the enzyme [33, 59].  
Additionally, several researchers have indicated specific domains of PARP-1 are responsible for 
mediating the protein-protein interactions between PARP-1 and the other members of the DNA repair 
pathways [39, 63, 66-68].  What is not clear from the research to date is how the domains of PARP-1 
interact in the presence or absence of DNA damage.  To better understand the fluid nature of the PARP-1 
interaction with other key DNA repair proteins, a clear understanding of how the protein behaves alone is 
required.  Several investigations have described the binding of different DNA structures by PARP-1.  
However, side-by-side comparisons of the different DNA-damage models (i.e. single-strand breaks 
(nicks), overhang and blunt-ended DNA damage models) have yet to be performed.  A better description 
of how PARP-1 binds different DNA structures is needed.  It is thought that PAR-bound PARP-1 loses its 
ability to bind DNA due to charge repulsion of the long polymers of ADP-ribose [92]. PARP-1 has been 
shown to bind DNA at its N-terminal DNA-binding domain, specifically its Zn1 and Zn2 domains [33, 
59].  Altmeyer et al. and Tao et al. independently showed that PARP-1 primarily automodifies itself in 
the central region of the protein, relatively far from the DNA binding domain [42, 97].  The relative 
impact of how the automodification on the central region of PARP-1 affects the DNA binding at the N-
terminus of the protein remains to be elucidated.  The major question that arises is how that relates to the 
flexible nature of the protein.  Could the flexible and independent Zn-fingers [35] retain their DNA 
binding ability in the presence of large negatively charged polymers located some distance downstream? 
In addition to determining thermodynamic differences between different DNA structures, a thorough 
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comparison of the enzymatic parameters of PARP-1 should be undertaken.  For instance is the enzymatic 
efficiency (kcat/KM) of PARP-1 somehow dependent on the structure of its allosteric activator, DNA? 
Addressing such questions might lead to improved cancer therapies in the future, since different 
chemotherapeutics lead to different types of DNA damage (see review [98]). PARP-1 was recently linked 
to a the DNA-damage response of platinum-based chemotherapeutics [99].  Since all PARP-family 
members share homology in the catalytic domain, competitive inhibitors that target that domain are likely 
to interfere with non-DNA damage related pathways.  The use of PARP inhibitors may be enhanced if 
combined with specific chemotherapeutics that are known to cause the type of damage PARP-1 
recognizes.  By eliminating some of the redundancy in DNA repair pathways, PARP inhibition might 
serve as a means to better sensitize and kill cancer cells. 
 
1.5 PARP-1 in Chromatin and Transcription 
 
 PARP-1 is one of the most abundant proteins within the nucleus.  It is estimated that between 105 
and 106 molecules of PARP-1 are present in the nucleus at any given time [100, 101].  It is no wonder that 
PARP-1 has been implicated in nearly every type of DNA damage repair.  With nearly a million 
molecules constantly scanning for DNA damage, one might expect sites of DNA damage to be discovered 
quite quickly.  Another effect of having so many enzymes present in the nucleus could be that PARP-1 
may inadvertently contaminate nuclear extracts and complicate other types of experiments.   In fact, 
during the early 1980s the research of Matsui et al. implicated a nuclear factor necessary for effective 
RNA Polymerase initiation [102].  The protein or factor implicated was named TFIIC but was later shown 
to be PARP-1 (reviewed in [103]).  The connection between PARP-1 and transcription by RNA 
Polymerase II became evident a short time later through the work of Hough and Smulson [104], where it 
was shown that PARP-1 was not a contaminant in the transcription experiment after all.  Hough and 
Smulson made that connection that poly-ADP-ribose strands were indeed involved in transcription [104]. 
The authors showed that ADP-ribosylation of the base unit of chromatin, the histones that comprise the 
 21 
nucleosome [105], resulted in chromatin that was more sensitive to nuclease activity.  The implication 
was that the enzymatic activity of PARP-1 was associated with histone modification, which resulted in a 
more open conformation of DNA, and an increase in RNA Polymerase II transcription [104].  However, 
that same study showed poly-ADP-ribose was not an absolute requirement for active transcription for all 
genes.  The role of PARP-1 in transcription remained unclear until the discovery of ADP-ribose bound 
histones. The experiments of Loetscher et al. implicated the product of PARP-1 in a signaling pathway 
[106].  The authors knew that cellular NAD+ levels were related to PARP-1 activity.  In their study, 
monolayers of hepatocytes were incubated with media containing increasing amounts of NAD+ and as a 
result, increased chromatin-associated poly-ADP-ribose was observed.  The authors inferred that cellular 
NAD+ levels represent a signal to chromatin by PARP-1.  In other words, PARP-1 is an important 
signaling molecule for chromatin and it serves to alert the cell of important environmental changes in the 
cellular surroundings [106].  Other studies have shown that complexities of the poly-ADP-ribose 
polymers, in terms of branching and linear length, are directly dependent on NAD+ concentrations within 
the reaction conditions [107, 108].  Also dependent on the concentrations of NAD+ used in the reaction, 
were the levels of poly-ADP-ribose histone modifications [107].  PARP-1 was shown to be the primary 
target for poly-ADP-ribose modification, and histones were shown to be far less frequent targets for trans-
ADP-ribosylation [107, 108]. 
  Regardless of the total level of modification present, PARP-1 was shown to be involved in the 
modification of histones preceding the efficient initiation of transcription [104].  A major factor that 
remained unclear at the time was how PARP-1 was able to associate with the more condensed chromatin 
structure prior to transcription initiation. In 2003 the work of Tulin and Spradling changed our 
understanding of how PARP-1 functions in transcription [109]. The authors elegantly described the 
chromatin structure pre- and post-transcription initiation using modern fluorescence microscopy 
techniques [109]. Furthermore, it was shown that PARP-1 was activated in a DNA damage-independent 
manner at the promoter region of the gene that codes for the Hsp70 chaperone protein.  The authors of 
that study were able to visualize what they termed “puffs” in their studies of drosophila salivary gland 
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polytene chromatin [109].  The “puffs” were described as short-lived localized PARP-1 activation events 
whereby PARP-1, histones and transcription factors were covalently modified with ADP-ribose polymers.  
The ADP-ribose polymers were quickly removed through the enzymatic response of Poly(ADP-ribose) 
Glycohydrolase (PARG).  After poly-ADP-ribose removal, the chromatin once again returned to the 
condensed appearance with a similar structure to that of the pre-induced polytene chromatin.  
Interestingly, PARP1 remained present at the chromatin “puffs” throughout the activation event.  This is 
contrary to the common belief that once PARP-1 is modified the negatively charged ADP-ribose 
polymers repel the like charged DNA [103, 110-112].  It is possible that PARP-1 retained some of its 
binding affinity to the open euchromatin and this could explain why the molecule was not excluded from 
the “puffed” regions by charge repulsion. An alternative explanation might be that the large polymers 
serve to sterically trap PARP-1 in the “puff” region by preventing it from diffusing away from the active 
transcription site.  In an effort to rule out other factors, that may be responsible for the “puffing”, the 
authors targeted the enzymatic properties of PARP-1.  Following the treatment of drosophila larvae with 
3-aminobenzamidine (3-AB), a PARP inhibitor, the “puff” phenomenon was no longer visible.  The lack 
of “puff” formation and the marked reduction in mRNA transcripts in the presence of PARP-specific 
inhibitors is highly suggestive that PARP-1 is critically linked to transcription, at least at Hsp70 
promoters in Drosophila.   
The elegant description of PARP-1 induced “puffing” in drosophila may help to clarify a separate 
issue of puffing-related phenomena seen prior to the publication by Tulin and Spradling [109].  
Cartwright and Elgin showed that after heat shock induction, the structure of chromatin, the continuous 
repeated spacing of mononucleosomes, is disrupted at HSP70 promoters [113].  Interestingly, the authors 
presumed that the spacing was due to major changes in chromatin structure.  PARP-1 activation and the 
subsequent modification of proximal histones may in fact underlie the cause of the changes in 
nucleosome spacing in the sense that modified histones would lose their ability to bind DNA effectively 
and this would result in the decondensation of chromatin.  A mechanism consistent with the experimental 
findings of Tulin and Spradling was described by Cartwright et al., where the expected increased 
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accessibility by the nuclease DNase I was possible due to the more open structure of the heterochromatin 
[113]. 
The importance of PARP-1 in transcription is still being investigated.  The implication that 
PARP-1 is associated with undamaged chromatin prior to transcription initiation is rather intriguing.  For 
instance, how is an enzyme, which recognizes sites of damage activated in the absence of said damage?  
Two separate groups shed light on this question [114, 115].  Both Kauppinen et al., and Cohen-Arman et 
al., discovered a mode by which the enzymatic activity of PARP-1 could be enhanced by other cellular 
enzymes [114, 115].  From studies of neuronal cell cultures the researchers made the connection that 
PARP-1 mediated cell death could be attenuated if key small molecule kinase inhibitors were added to 
cell cultures.  The kinase inhibitors were specific to the extracellular signal-regulating kinases 1 and 2 
(ERK1/2), which belong to the mitogen-activated protein kinase (MAPK) family [116].  It seems that the 
ERK1/2 kinases are responsible for increasing PARP-1 to a “maximal” level of enzymatic activity in 
neurons exposed to alkylating agents or in the response of oxidative stress.  Kauppinen et al., went further 
and identified the ERK2-PARP-1 relationship as involving a direct interaction between PARP-1 and the 
kinases. The authors of that study showed that PARP-1 could be directly phosphorylated on two amino 
acid residues (residues S372 and T373) [115].  Deletion mutants of the residues proved detrimental to the 
interaction and resulted in a decrease of PAR synthesis by PARP-1.  Additionally, constitutively “on” 
mutations, in the form of S372E and T373E, resulted in higher PARP-1 activity without ERK2 present.  
The critical phosphorylation targets for the ERK1/2 kinase family reside in the flexible linker region that 
joins the Zn3 and BRCT domains [115] (linker region is depicted in Figure 1.2).  Others have described 
the phosphorylation of PARP-1 in different contexts [117, 118].  However, the fact that other enzymes 
can influence the enzymatic properties of PARP-1 signifies the important roles PARP-1 plays in non-
DNA-damage signal transduction pathways.   PARP-1 is the protein usually associated with its role as a 
first-responder in terms of signaling DNA-damage, but increasingly the enzymatic functions of this 
dynamic protein can be implicated elsewhere.    The existence of pathways that are independent of DNA-
damage  may yet prove critical in understanding the roles of PARP-1 in transcription.  Could other post-
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transcriptional modifications of PARP-1 serve as prerequisites for transcription initiation at key gene 
promoters like HSP70 for instance? The answer to that question remains to be found.  However a recent 
study by Kotovo et al., discussed an indirect phosphorylation event that resulted in the activation of the 
drosophila homologue of PARP-1.  In that study the authors discovered a connection between the 
phosphorylation of H2Av, the homologue to the mammalian histone H2AX, and a resulting increase in 
PARP-1 activity [119].  The connection between PARP-1 activation and chromatin de-condensation or 
transcription initiation seems to reflect our expanding knowledge of the sensitivity of PARP-1 to 
changing environments both intra- and extracellularly.  PARP-1 plays an important role in relaying 
environmental changes, whether it becomes activated by binding DNA-damage or through signal 
transduction mediated pathways.  
 
The Role of PARP-1 in Chromatin Architecture 
 
As has been discussed, most cells have a large quantity of PARP-1 molecules within the nucleus.  
Additionally, PARP-1 binds all types of DNA damage models.  In the absence of DNA-damage or active 
transcription, how is such an important molecule kept occupied/sequestered until it is needed for the 
enzymatic signaling functions.  Does PARP-1 bind to undamaged DNA and if so, is it as enzymatically 
active?  Among the researchers who tried to address this persistent question was Gradwohl et. al. in the 
late 1980s [120].  In that work, the researchers carefully prepared plasmid DNA in several different forms 
that included; linearized, nicked, topoisomerase relaxed and closed and supercoiled.  Next, purified 
PARP-1 was incubated with the different forms of DNA and the relative enzymatic activity compared.  
Finally, the researchers used electron micrographs to determine the types of PARP-bound DNA structures 
that were present under those conditions [120].  Interestingly, PARP-1 seemed to preferentially bind the 
supercoiled plasmid DNA even though the enzyme was the least activated in that context.  The 
micrographs, snapshots help describe the types of DNA structures PARP-1 can binding, from those 
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images it a definite preference for binding to DNA crossovers.  In micrograph after micrograph, PARP-1 
was found at the center of the x-shaped DNA crossover junctions [120].   
Intriguingly, a similar pattern for the binding of superhelical crossovers was seen for the linker 
histone protein H1 [121, 122].  The H1 protein plays an important role in chromatin compaction and it 
most likely does this by binding the two duplex strands of DNA at the entry and exit points of the 
nucleosome.  In naked superhelical DNA, the crossovers appear to be the region in which H1 is optimally 
positioned.  The cross-over region represents a position in which H1 can simultaneously bind two strands 
of DNA [122].  Kim et al. showed that H1 and PARP-1 compete for binding at the dyad axis site of 
nucleosomal arrays [123].    From that work, the authors were able to determine a great deal of 
information on the H1-PARP-1 interplay on chromatin: 1) only one PARP-1 or H1 molecule binds per 
dyad axis (both bind 2 duplex strands of DNA monomerically); 2) in micrococcal nuclease (MNase) 
digestion of chromatin arrays both proteins protect a similar number of additional base pairs of DNA 
(~160bp and ~165bp for PARP-1 and H1, respectively); 3) like H1, incubating chromatin with PARP-1 
decreases RNA polymerase II (Pol II) dependent transcription.  Importantly, one major difference 
between PARP-1 and H1 was established.  The addition of NAD+ to the PARP-bound chromatin reverses 
the structural effects of PARP-1, but not of H1.  In other words, simply adding the enzyme’s catalytic 
substrate was enough to de-condense chromatin.  The de-condensation was shown to be a result of the 
automodification of PARP-1 and not the covalent addition of PAR moieties to the chromatin, no signs of 
histone modification were detected [123].  The findings presented in the work by Kim et al. suggest an 
example of a kind dichotomy in protein function [120].  For instance PARP-1 can bind and condense the 
structure of chromatin and in essence act as a transcription repressor, however, upon activation of its 
enzymatic domain the repressive activity is reversed to a degree that the role of PARP-1 is reminiscent of 
an enhancer of RNA transcription.    
The work of Kim et al. was a major contribution to the understanding of how PARP-1 imparts 
structural changes on chromatin.  What was not elucidated in those important studies was the mechanism 
by which PARP-1 binds chromatin.  For example, the H1 protein is thought to bind chromatin at the dyad 
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axis of nucleosomes yet, it is only a fraction of the size of PARP-1 (~20kDa and ~110lDa, respectively).  
Additionally, from MNase digestions of chromatin PARP-1, it was shown to protect less of the linker 
DNA between nucleosomes than the H1 [123].  Structurally, this is likely since the Zn1-Zn2 comprised 
DNA binding domain is relatively small (~20% of the protein). Since it is not contributing to the DNase1 
protection, where could the other ~80% of the protein’s bulk reside? Could the non-DNA binding region 
of PARP-1 be interacting with the DNA that wraps around the histone octamer?  If that were the case, the 
additional bulk of PARP-1 enzyme would serve as redundant protection to the ~150bp of DNA already 
protected by the histones themselves.  Alternatively the model might be that the additional non-DNA 
binding regions of PARP-1 would directly interact with the histones surfaces not occluded by the DNA 
gyres.  Support for the latter model came in the form of a 2007 manuscript by Pinnola et al. [110].  
Pinnola et al. showed that the binding of key regions of the histones themselves could influence the 
enzymatic activity of Drosophila PARP-1.  Those experiments proved that, at least for drosophila, 
PARP-1 could directly interact and be regulated by histones.  Others had shown previously that PARP-1 
could interact with histones but the mechanism for interaction was not clearly defined in those reports 
(reviewed in [103]).  
The structural complexity of PARP-1 with its DNA binding region, its automodification region 
and its catalytic domain, make describing specific interactions, with any measure of detail, very difficult.  
However, if one were to investigate a specific interaction by using truncation mutants of PARP-1, detail 
in describing that interaction might result.  Thanks to the creation of certain protein truncation constructs, 
Wacker et al. was able to add greater detail to the understanding of the PARP-nucleosome interaction 
[124].  The authors showed that the N-terminal DNA binding region of PARP-1 binds chromatin with 
similar affinity as full-length PARP-1.  However, without the NAD+ binding portion of the C-terminal 
catalytic domain present, the PARP-1 truncation constructs fail at condensing chromatin.  Interestingly, 
the C-terminus has never been implicated with any function other than enzymatic activity prior to the 
publication of that study [124].  The critical interactions with chromatin seem to specifically involve the 
binding of DNA by the N-terminal Zn-fingers.  Also described in the Wacker et al. study was a construct 
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that consisted of a full-length PARP-1 with critical Zn-finger mutations that could neither bind DNA nor 
condense chromatin.  These findings suggest that without proper interaction with DNA, the other regions 
of the protein, like the C-terminal catalytic domain, cannot properly interact with a nucleosome, or 
nucleosomes, and contribute to chromatin compaction.  One question that remains unanswered in terms of 
the PARP-chromatin interaction is; does Zn-finger binding to non-damaged DNA in the context of 
chromatin result in a conformational change similar to the change that is hypothesized for the enzyme in 
the context of DNA damage?  According to studies of non-damaged intact plasmid DNA, PARP-1 readily 
associates with intact circular DNA, but its relative enzymatic activity levels are far decreased when 
compared to the binding of plasmids that contain nicked regions [121].  Studies of the PARP-1 
interactions with intact plasmids suggest that the protein preferentially binds two duplexes of DNA 
simultaneously [121].  The crossover structures strongly resemble DNA at the entry and exit sites of the 
nucleosome.  Another question that remains is where exactly is PARP-1 binding to the nucleosome could 
it bind the DNA at the crossover, or at the entry-exit site?  According to Kim et al., the PARP-1 protein 
protects ~13 bps of linker DNA that protrudes from the nucleosome [123].  Is the protection due to the 
Zn-fingers binding that linker DNA or due to the non-DNA-binding regions of PARP-1 sterically 
blocking MNase from accessing that stretch of DNA?  In an effort to rectify the apparent differences in 
the NMR and crystallographic structures of Zn3, Langelier et al. found that mutating certain residues 
within the crystallographic “dimerization” interface of Zn3 reduced the ability of PARP-1 to condense 
chromatin [125].  It was from that study that the authors suggested a special case of PARP-1 dimerization 
as occurring in the context of chromatin but not necessary for its role as a DNA damage sensor.  Shortly 
after this model was proposed however, the same group of researchers altered the model slightly.  In that 
more recent publication by Lanelier et al. it was proposed that PARP-1 can more easily incorporate in the 
bent DNA, like the DNA located near the dyad axis of the nucleosome [36].  Taken together, there has 
been a lot of important information gathered regarding how PARP-1 can interact with chromatin yet 
many questions remain. 
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1.6 Specific Aims 
 
A great many researchers have dedicated the focus of their research toward advancing our 
understanding of the multiple roles and functions that PARP-1 plays within the cell.   We now have a 
better understanding of the key types of interactions that link PARP-1 to, chromatin dynamics, 
transcription, aging, and DNA damage repair. Additionally, several PARP-specific small molecule 
inhibitors are showing promise in clinically in the treatment of patients with breast cancer [126].  Since 
the small-molecule inhibitors are specific to the NAD+ binding region in the catalytic domain of PARP-1, 
their use could inhibit other non-PARP-1 related cellular functions as well, due to the sequence homology 
between PARP-family members occurs in the catalytic domain.  It is also not known whether there are 
any long-term side effects of PARP-family inhibition since such studies have yet to be completed.  One 
possible way to avoid unwanted PARP-1 inhibitor side effects might be to better define the specific 
differences between the diverse roles of PARP-1.  Dissecting the specific interactions needed for DNA 
damage repair and comparing them to the interactions needed for chromatin dynamics may result in an 
increased drug efficacy for patients who are undergoing treatment with PARP-inhibitors.  Increased 
appreciation for how PARP-1 functions in seemingly opposing cellular functions may lead to a different 
class of PARP-1 inhibitors entirely.   
It is my goal to contribute to more clearly defining how PARP-1 functions to bind in vitro models 
of known DNA-damage and chromatin substrates.  Below are the specific aims that have guided the 
research in this thesis in order to help answer some of the remaining questions related to the biochemistry 
of PARP-1.  The questions addressed here are 1.) How does PARP-1 recognize different types of DNA 
structures?  2.) Are there differences in the binding modes of PARP-1 to chromatin substrates as opposed 
to DNA-damage?  3.) Does DNA structure relate to differences in enzymatic activity levels?  4.) How 
does the catalytic domain become activated upon DNA binding?  I hypothesize that the type of DNA 
substrate, either DNA damage or nucleosomes, recognized by the N-terminus of PARP-1 serve to relay a 
message to the C-terminal catalytic domain and the resulting level of enzymatic activity is a function of 
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the distinct molecular conformational rearrangement that is specific to that binding substrate.  
Additionally, in order to describe the substrate binding at the N-terminus, an intact and fully functional 
enzyme should be the primary construct used in in vitro experiments since truncation mutants by 
definition can not provide a complete understanding. 
 
Specific Aim 1.)  Using biochemical and biophysical techniques including; eukaryotic cell culture, 
enzymatic activity assays, thermodynamic measurements of binding constants, biophysical studies of 
PARP-1 bound to its DNA-damage and chromatin substrates, determine relative affinities and enzymatic 
parameters for the two opposing types of nuclear substrates.  Using the above mentioned techniques, the 
evidence gathered will help to test the hypothesis that the N-terminal DBD can differentiate between 
substrates and upon binding, those differences may result in varying levels of enzymatic activity. Chapter 
2 of this thesis addresses the germane questions regarding the means by which PARP-1 binds and 
responds enzymatically to unrelated nuclear structures, DNA-damage and chromatin.  
 
Specific Aim 2.) Using biochemical, structural biology and biophysical techniques, elucidate the mode of 
binding of PARP-1 to double stranded DNA-damage models.  Low-resolution small-angle scattering 
(SAS) techniques including light scattering, small-angle x-ray and neutron scattering (SAXS and SANS) 
will be used to gather structural information for the average conformer of PARP-1 alone and PARP-DNA 
complexes in solution. The biophysical techniques combined with molecular Monte Carlo simulations, 
will be used to test the hypothesis that DNA substrate binding results in a conformational rearrangement 
throughout the enzyme.  Chapters 3, 4 and 5 are dedicated to the low-resolution scattering data collected 
on two PARP-1 proteins and their complexes with DNA.  Chapter 3 will address the DNA binding modes 
of several DNA-damage models to the N-terminal half of PARP-1.  Chapter 4 will address the efforts 
implored to determine solution structures of full-length PARP-1 and the above-mentioned N-terminal half 
of PARP-1 from small angle x-ray scattering (SAXS).  Chapter 5 will compare and contrast small-angle 
neutron scattering (SANS) and SAXS data collected on the full-length and N-terminal PARP-1 proteins 
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alone and in complex with DNA damage substrates.  Taken together, the small angle scattering data and 
computational methods used to model the solution states of the molecules will help describe the DNA-































 The current chapter is a now a published, peer reviewed article in the Journal of Biological 
Chemistry, which was accepted on July 31st, 2012.  The first three authors contributed equally to the 
publication of this work.  The expertise of Dr. Uma Muthurajan and her knowledge of nucleosome 
assembly allowed for the study of the highly defined chromatin substrates described here.  The work and 
dedication provided by Michael Kramer MS allowed for the quantitative analysis of thermodynamic 
binding constants and he helped to develop the HI-FI FRET assay needed to study the PARP-1 protein as 
well as other systems in the laboratory.  This author contributed by producing high-quality full-length 
human PARP-1. Without the full-length PARP-1 protein, the enzymatic properties and high-quality 




Poly (ADP-ribose) Polymerase 1 (PARP-1) is an abundant nuclear protein that binds chromatin 
and catalyzes the transfer of ADP-ribose groups to itself and to numerous target proteins upon interacting 
with damaged DNA. The molecular basis for the dual role of PARP-1 as a chromatin architectural protein 
and a first responder in DNA repair pathways remain unclear. Here we quantify the interactions of full 
length PARP-1, as well as its N-terminal half with different types of DNA damage and with defined 
nucleosome substrates. We find that full length PARP-1 prefers nucleosomes with two linker DNA 
extensions over any other substrate (including several free DNA models), and that the C-terminal half of 
PARP-1 is necessary for this selectivity. We also assess the ability of various substrates to activate PARP-
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1 activity, and find that the most important feature for activation is one free DNA end, rather than tight 
interaction with the activating nucleic acid.  Our data provides insight into the different modes of 




PARP-1 is a conserved multi-domain enzyme that is present in all eukaryotes except yeast. With 
an estimated abundance of ~106 molecules per cell, there is approximately one PARP-1 molecule per 20 
nucleosomes [127]. Historically, its role in DNA damage detection has received much attention. More 
recently, PARP-1 has been linked to the regulation of chromatin structure and transcription (reviewed in 
[128, 129]). In its enzymatically inactive form, PARP-1 binds chromatin and contributes to the formation 
of transcriptionally silent chromatin domains [130]. Recent data imply a role in promoting the formation 
of chromatin structures that are permissive to gene expression [131]. Upon sensing DNA damage, PARP-
1 catalyzes the cleavage of its substrate NAD+ into nicotinamide and ADP-ribose and polymerizes long 
ADP-ribose chains onto core histones, linker histone H1, and many other nuclear proteins (hetero-
modification) as well as onto itself (auto-modification), with itself as the vastly preferred substrate [132]. 
Mutational studies have revealed several automodification sites in PARP-1 (Figure 2.1) [97, 133]. Due to 
its well-described role in DNA damage repair, PARP-1 is an attractive drug target to augment cancer 
therapy [134, 135]. However, little quantitative information is available on the many interactions of 
unmodified and modified PARP-1. For example, it is not known how strongly PARP-1 interacts with 
nucleosomes compared to nucleosome-free DNA, and whether PARP-1 can recognize DNA damage in 
the context of chromatin. This limits our understanding of PARP-1 function in chromatin structure 
maintenance and DNA repair.   
PARP-1 contains three N-terminal zinc finger domains, a ‘BRCA1 C-terminus’ (BRCT) domain 
that is linked to the WGR (‘Tryptophan-Glycine-Arginine-rich’) domain and catalytic domain (CAT) 
through a flexible linker (Figure 2.1A). Structural information on all individual domains is available.  
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Figure 2.1: PARP‐1 constructs and substrates assayed in the present study. A. Full length PARP-1 
contains all six domains; N-parp encompasses Zinc fingers Zn1-Zn3 and the BRCT domain (1-486); C-
parp spans residues 487-1014 and includes the WGR and catalytic domain. Surface exposed native 
cysteine residues (positions 256 and 845; indicated by asterisks) were labeled with Alexa488. Underlined 
residues denote auto-PARylation sites [97]. B. DNA models used for PARP-1 binding and activity assays. 
30Blunt, 30Ext, and 30Nick are identical in sequence; 30AATT replaces four central base pairs with 
AATT.  30Link is identical in sequence to the linker in Nuc178.  All DNA models were labeled at the 5’ 
end with Cy5 or Atto647N. C. Nucleosome substrates were labeled with Atto647N at H4 E63C on the 
histone octamer [138]. All nucleosomal DNA is based on the ‘601’ positioning sequence [139]. The 
length of the linker DNA in each particle is indicated in base pairs. 
 
5’-ATC AGA TAG CAT CAA TTC GGC CGC TTA GGG – 3’
3’- TAG TCT ATC GTA GTT AAG CCG GCG AAT CCC – 5’
3’- TAG TCT ATC GTA GAC ACG CCG GCG AAT CCC – 5’
5’-ATC AGA TAG CAT CTG TGC GGC CGC TTA GGG – 3’







5’-ATC AGA TAG CAT CTG TGC GGC CGC TTA GGG – 3’
5’-ATC AGA TAG CAT CTG TGC GGC CGC TTA GGG – 3’
3’- TAG TCT ATC GTA GAC  ACG CCG GCG AAT CCC – 5’
5’ - ACG TAC ACC TAG GCT TAA GTA TAA TTA CTA – 3’
3’- TGC ATG TGG ATC CGA ATT CAT ATT AAT GAT – 5’
30Link
Clark et al.                                                    Figure 1 
Nuc147 Nuc207 Nuc178 Nuc165 
C.






















Zinc fingers 1 and 2 (Zn1 and Zn2) bind DNA with high affinity in a sequence-independent and structure-
dependent manner [35, 136], with the strongest interaction observed for Zn2. Zn3 does not bind DNA on 
its own but is essential for DNA dependent stimulation of PARP-1 activity [137].  It has been proposed 
that DNA binding by the zinc fingers triggers a conformational change in the full length protein, which 
then activates the catalytic domain [35]. The impressive structure of a near-full length PARP-1 – DNA 
complex [49] provides a detailed view of the domain arrangements upon DNA damage, and explains the 
propensity of PARP-1 for PARylating itself rather than target protein substrates. The crystallized PARP-1 
construct, which only lacks Zn2 and the BRCT domain, binds DNA as a monomer, consistent with earlier 
studies [35, 136] and displays extensive contacts between the DNA damage interface and the catalytic 
domain. Importantly, the interaction with a single DNA fragment is afforded by residues from Zn1, Zn3, 
and the WGR domain. This latter domain had previously not been implicated in DNA binding; and it was 
generally believed that amino acids 1-486 are solely responsible for the interaction with DNA [136, 140].     
In addition to recognizing DNA damage, PARP-1 also binds chromatin, and protects an additional ~ 10-
20 base pairs of nucleosomal DNA near the entry-exit sites, reminiscent of the pattern observed for H1-
nucleosome interaction [123]. Only a moderate contribution of the C-terminal domain of PARP-1 to the 
interaction with DNA or chromatin was reported [137, 141]. However, this domain is essential for 
chromatin compaction, independent of its catalytic activity [141].  
There are reports that PARP-1 activity is stimulated not only by free DNA but also by chromatin 
and isolated histones [110, 123, 141]. Consistent with the qualitative observation that PARP-1 also binds 
mixtures of histones in vitro, even in the absence of DNA, PARP-1 is reportedly activated by the N-
terminal tail of histone H4 [110]. However, readout of the binding affinities as well as of catalytic activity 
was indirect. Additionally, no systematic, quantitative comparisons of the degree of PARP-1 activation by 
the various allosteric activators have been made.  
To fill these significant gaps in our understanding of PARP-1 function, we measured the 
interactions of highly pure full length PARP-1, its N-terminal half (amino acids 1-486, N-parp), and its 
catalytic domain (amino acids 487-1014, C-parp) to defined DNA fragments, as well as to nucleosome 
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substrates with various extensions of linker DNA (Figure 2.1). We also quantified the ability of the 
various binding substrates to stimulate the enzymatic activity of PARP-1. Our data suggest fundamental 
differences in the mode of interaction between chromatin and free DNA, consistent with the two roles of 
PARP-1 as a chromatin architectural protein and a sensor of DNA damage. Furthermore, our data 
demonstrates that PARP-1 is capable of recognizing DNA double strand breaks in the context of a 




Expression, purification and fluorescent labeling of PARP-1 and N-parp 
 
N-parp was expressed, purified and labeled as described [142]. Full length human PARP-1 
V762A was expressed in Sf9 insect cells [93]. Cell pellets were thawed from -80°C and sonicated (3 x 5 s, 
output 6.5, duty cycle 65% on a Branson sonifier 450) on ice in lysis buffer (300 mM NaCl, 25 mM 
Tris/HCl, pH 8, 1 mM β-mercaptoethanol and 1 mM PMSF).  Cell lysates were then cleared by 
centrifugation (14,000 rpm for 30 minutes at 4°C) and the pellet was discarded.  DNA was removed by 
addition of 1.0 mg/ml salmon sperm protamine sulphate (Sigma-Aldrich) followed by centrifugation 
(14,000rpm for 30 minutes at 4°C). The supernatant was precipitated by a two-step ammonium sulphate 
treatment at 4°C while stirring overnight. In the first step, the supernatant was incubated with 30% 
ammonium sulphate (164 g/ 1000 ml), and centrifuged as above. In the second step the supernatant from 
30% ammonium sulphate was brought up to 70% ammonium sulphate saturation (249 g/ 1000 ml).  The 
precipitate was resuspended in Heparin chromatography buffer A (100 mM NaCl, 25 mM Tris/HCl, pH 8 
and 1.0 mM β-mercaptoethanol), loaded onto a HiTrap Heparin column (GE Healthcare) and eluted with 
a linear gradient (0-100% B) of Heparin chromatography buffer B (1.5 M NaCl, 25 mM Tris/HCl, pH 8 
and 1.0 mM β-mercaptoethanol). Further purification included size-exclusion chromatography and cation 
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exchange using a HiTrap SP column (GE Healthcare).  This homogeneous preparation of PARP-1 tested 
negatively for automodification by western-blot (data not shown).  
Purified full length PARP1 was fluorescently labeled at its native surface exposed (Cys256 and 
Cys842) cysteine residues. 10 mM Alexa-488 fluorophore (Invitrogen) in DMSO was added to PARP-1 
in 300 mM NaCl, 25 mM Tris pH 7.5 in equimolar amounts three times over three hours and allowed to 
mix overnight at 4°C; excess fluorophore was removed using a Hitrap Heparin HP column as described 
above. Labeled PARP-1 and N-parp run on a 4-12% gradient SDS-PAGE (Criterion XT) appeared as 
homogeneous bands (Figure 2A, B). A typical labeling efficiency of 10-25% was routinely obtained.  
 
Histone labeling  
Histone mutants H4 E63C and H2B T112C were labeled with Atto647N and refolded as described 
[138] (Figure 2.2A, B). A typical labeling efficiency of 10-25% was routinely obtained. 
 
DNA oligomers  
30 bp blunt-ended, nicked, and overhang DNA, all containing the template sequence 5’- ATC 
AGA TAG CAT CTG TGC GGC CGC TTA GGG -3’, either with or without a 5’-Cy5 or Atto647N 
fluorophore were ordered from Integrated DNA Technologies (IDT) (Figure 2.1B). Annealing was 
carried out by mixing equimolar amounts of template and reverse strand, heating at 95⁰ C for 2 minutes, 
followed by slow cooling to room temperature.  
All DNA used for nucleosome assembly contained the 601 positioning sequence with variable 
linker arms (Figure 2.1C) and were expressed and purified as described [143]. The 147 bp DNA 
represents the minimal nucleosomal DNA; Nuc165 had linker arms of 7 and 11 bp and Nuc207 exhibits 
linker lengths of 23 and 37 bp, respectively. We also generated an asymmetric linker arm by digesting the 




Chromatin Assembly and Characterization 
Labeled nucleosomes were assembled on DNA of varying lengths as described [143] using 
Atto647N labeled histone octamer (Figure 3A, B).  The nucleosome preparations typically had <1% free 
DNA present. 
 
HI-FI FRET Assay 
 
 We used the previously developed HI-FI FRET [142] for measuring affinities and stoichiometries 
for PARP-1 and N-parp labeled with donor dye Alexa 488 and titrated in substrates labeled with acceptor 
dye Atto647N. Buffer used for setting up the binding reactions included 25 mM Tris pH 7.5, 200 mM 
NaCl, 0.01 % (v/v) each of NP40 and CHAPS. FRET calculations and corrections were performed as 
described [142]. The data were plotted in Graphpad Prism and fitted using one site binding + background 
or one site-specific binding with Hill slope. The data were represented by plotting titrated species labeled 
with the acceptor on the X-axis and normalized FRET corrected values on the Y-axis. The Hill coefficient 
was held constant at 1 unless otherwise mentioned.  
 
Electrophoretic Mobility Shift Assay (EMSA) 
 
Labeled Nuc165 (1 µM) was titrated with increasing molar ratios of PARP-1 or N-parp labeled 
with Alexa488 in the binding buffer described above and incubated for 30 minutes at room temperature. 
Samples were subsequently run on a 22 cm x 20 cm native TBE gel and run in 0.5X TBE, at 4°C at 300V, 
10W for 120 minutes. The gel was scanned on a Typhoon Imager at wavelengths appropriate for 
measuring acceptor (633 excitation; 670 emission), donor (488 excitation; 520 emission) and FRET (488 
excitation; 670 emission). Gels were then stained with Ethidium Bromide to visualize the DNA.  
Unlabeled nucleosomes (1 µM) were incubated with increasing amounts of labeled or unlabeled 
PARP-1 constructs (PARP-1, N-parp and C-parp) in 25 mM or 50 mM Tris pH 7.5, 150 mM NaCl, 2 mM 
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Arginine, 0.01% CHAPS and NP40. The DNA/chromatin-PARP-1 samples were incubated at room 
temperature for 30 minutes, loaded on a pre-run 5% native TBE gel and run at 150 V for 60 minutes at 
4°C for 8 cm x 8 cm gels in 0.2X TBE. Gels were stained with Ethidium Bromide followed by Imperial 
stain for protein.  
 
Size Exclusion Chromatography/Multi-Angle Light Scattering (SEC-MALS) 
 
Nucleosomes (Nuc147, Nuc165 and Nuc207) and their complexes with PARP-1 were assembled in 50 
mM Tris pH 7.5, 150 or 300 mM NaCl, 2 mM Arginine and analyzed in SEC-MALS as described [144].  
 
PARP-1 Enzymatic Assay 
 
PARP-1 (constant at 1 µM) and ‘activators’ (DNA or nucleosomes; 1-2 µM) were mixed to a 
final volume of 30 µl in 50 mM Tris pH 8, 50 mM NaCl (100 mM NaCl for chromatin activators), 10 mM 
MgCl2 (or 1 mM MgCl2 for chromatin activators) and 1 mM DTT and allowed to incubate for 1 hour at 
30°C. 30 µl of the various NAD+ stocks (0-400 µM) were added to the above tubes.  Reactions were 
quenched after 30 seconds with either Laemmli buffer or ice cold 20% trichloroacetic acid (TCA). 
Reactions quenched with Laemmli buffer were analyzed on 8% SDS-PAGE and by western blot.  1-5% 
of reactions quenched with 20% TCA were loaded onto a Zeta-probe membrane (BioRad) using a 
BioRad® Dot Blot apparatus [93]. A PAR standard curve was also included in each blot to correlate the 
amount of PAR generated by automodification directly to a known amount of standard PAR. After 
loading the sample, the wells were washed once with 10% TCA followed by washing with 70% ethanol.  
The membrane was then dried on a gel dryer at 80° C for 1 hour, and blocked with 5% milk in 1x TBS 
overnight.  The blot was incubated in primary anti-PAR antibody (Abcam) for 1 hour followed by five 
washes with 1x TBS + 0.01% v/v Tween 20.  Secondary goat anti-mouse antibodies conjugated with 
Atto647 (Sigma) were incubated for 1 hour followed by five washes of 1x TBS containing 0.01% Tween 
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20. The blots were imaged on a Typhoon Imager using the Acceptor λ = 633 nm Excitation; 670 nm 
Emission. (GE Healthcare) and quantified using the array analysis program of ImageQuant.  Michaelis-




PARP-1 exhibits a slight preference for flexible DNA 
 
We have previously shown by agarose-gel mobility shift assays that a fragment of PARP-1 
encompassing the three Zinc fingers and the BRCT domain (N-parp; Figure 2.1A) binds tightly to 
various DNA damage models [136]. We wanted to investigate how full length PARP-1 compares to N-
parp, using a more rigorous solution-state assay that we recently developed in our lab [142, 145].  PARP-
1 and N-parp were purified to homogeneity and labeled with fluorophores as described [142] (Figure 2A, 
B). Electrophoretic mobility shifts were observed when a 30 base pair DNA fragment (30Blunt DNA) 
was titrated with either full length PARP-1 or N-parp, qualitatively confirming that both fluorescently 
labeled proteins form defined complexes with DNA (data not shown). Quantitative information on the 
interactions was obtained by monitoring binding reactions through Fluorescence Resonance Energy 
Transfer (FRET) in a plate assay (HI-FI FRET) [142]; representative data is shown in Figures 2.2C, D. 
Table 2.1 summarizes the affinities of the two PARP-1 constructs for the free DNA models listed in 
Figure 1B. Both full length and the N-terminal half of PARP-1 exhibit a slight preference for DNA 
containing an internal nick or an AATT insert. These features are thought to induce a curved or bent 
conformation into double stranded DNA [146].  
The dissociation constants of N-parp – DNA complexes, as determined by HI-FI FRET, compare 
well to the previously reported affinities for the various DNA damage models 30Blunt, 30Ext and 30Nick 
DNA [136]. The overall 3-5 fold tighter affinities of N-parp in the current study are likely due to 
differences in binding conditions (200 mM NaCl here versus 300 mM NaCl in previous studies). This is  
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Figure 2.2. The catalytic domain of PARP-1 contributes moderately to the interaction with DNA. A. 
Fluorescently labeled PARP-1 constructs and histones. All samples were run on a Criterion XT 4‐12% 
gradient SDS‐PAGE gel that was scanned on a Typhoon Imager at wavelengths appropriate for measuring 
donor (488 excitation; 520 emission) for the left panels in A depicting PARP-1 constructs, and  acceptor 
(633 excitation; 670 emission) for the right panel with labeled histones. Lanes 1, 4, 8: molecular weight 
marker; lane 2:  Alexa488 labeled PARP‐1 (at Cys256 and Cys845); lane 3: Alexa488 labeled N-parp (at 
Cys256); lane 5: H2A-H2B dimer (with Atto647N-labeled at H2B T112C); lane 6: (H3-H4)2 tetramer 
(labeled with Atto647N at H4E63C); lane 7: histone octamer (labeled with Atto647N at H4E36C). B. The 
same gel was visualized with Imperial stain. Lane 1: protein size marker; lane 2: unlabeled PARP‐1; lane 
3: labeled PARP‐1; lane 4: unlabeled N‐parp; lane 5: labeled N‐parp; lane 6: C‐parp; lane 7: unlabeled 
H2A-H2B; lane 8: labeled H2A-H2B; lane 9: unlabeled H3-H4; lane 10: labeled H3-H4; lane 11: 
unlabeled histone octamer, Lane 12: labeled histone octamer. C. N‐parp (labeled with Alexa488 at 























































































Table 2.1. Relative affinities of N‐parp, and PARP‐1 for various free DNA models and nucleosomes. 
Data were obtained using the HI-FI FRET assay [142]. Buffer for all binding reactions contained 25 mM 
Tris pH 7.5, 200 mM NaCl, 0.01% (v/v) each NP40 and CHAPS (with the exception of the values 
indicated by *). Standard deviations are reported for 2-5 independent experiments, except for the value 
indicated by **.   
* 250 mM NaCl instead of 200 mM NaCl. At 200 mM NaCl the affinity of PARP-1 for 30Nick was in the 
low nanomolar range (data not shown). 
**Errors are derived from one data set only   
                     N-parp  PARP-1  
 Binding 
substrate 
Kdapp (nM) R2       Kdapp (nM) R2 
 30Blunt 62.2 ± 10.2 0.97 31.7 ± 6.9 0.95 
 30Ext 111.5 ± 30.5 0.98 66.0 ± 11.0 0.89 
 30Nick 27.8 ± 5.6 0.95 23.4 ± 4.8* 0.98 
 30AATT 25.7 ± 0.9 0.92 8.5 ± 2.1 0.87 
 30Link 33.1 ± 1.5 0.98 24.0 ± 2.0 0.96 
 Nuc147 > 500 0.99 >500 0.98 
 Nuc165 57.8 ± 6.1 0.88 2.2 ± 1.5 0.86 
 Nuc207 48.8 ± 21.2 0.97 1.0 ± 0.2 0.90 












in keeping with the previously observed strong dependence of PARP-1-DNA interactions on ionic 
strength [142]. Compared to N-parp, full length PARP-1 exhibits 1.4-3 fold tighter affinity for all free 
DNA models (Table 2.1). This indicates that the C-terminal half of PARP-1 contributes moderately to the 
binding event, consistent with structural data demonstrating interactions between the WGR domain (not 
contained in N-parp) and DNA [49]. The C-terminal half of PARP-1 on its own is unable to interact 
measurably with DNA (data not shown). 
 
A single PARP-1 molecule interacts strongly with a nucleosome containing symmetric linker DNA  
 
We next wanted to test N-parp and PARP-1 affinities for defined mono-nucleosomes that vary in 
length and symmetry of their linker DNA (Figure 1C). Nuc147 is a mono-nucleosome that completely 
lacks DNA linker arms, while Nuc165 and Nuc207 contain two linker arms each. Nuc178 was designed 
to have only one exposed linker arm. The sequence of this 30 base pair extension is identical to that of 
30Link (Figure 2.1).  According to our analysis by native PAGE, all nucleosomes are uniquely 
positioned, and the percentage of free DNA in each of these nucleosome preparations was below 1% 
(Figure 2.3A, B). The addition of fluorophore to histones does not change the electrophoretic mobility of 
the reconstituted nucleosomes, indicating that they are structurally intact.  The interaction of N-parp and 
PARP-1 with Nuc165 was first tested by EMSA. When fluorescently labeled Nuc165 was titrated with 
either labeled PARP-1 or N-parp, distinct bands that exhibit both acceptor and donor fluorescence were 
observed (Figure 2.3C). These bands also displayed FRET (pink bands in bottom overlay panel), 
providing further proof of defined complex formation.    
We next quantified the interaction of N-parp and PARP-1 with the various nucleosome substrates 
in solution, using HI-FI FRET (Figure 2.4A).  Nuc165 as well as Nuc207 bind N-parp with 50-60 nM 
affinity, while no plateau was achieved with Nuc147 (Figure 2.4B), characteristic of very weak 
interaction. Because regions outside of N-parp are known not to interact with DNA on their own, we were 
surprised to see that full length PARP-1 binds nucleosomes with two DNA linker ends 25-50-fold tighter 
than N-parp (Figure 2.4C). In light of the moderate difference of the binding affinity of the two PARP-1 
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constructs for free DNA, this suggests a substantial contribution of the catalytic domain to the interaction 
with nucleosomes containing two DNA linker arms. This is despite the inability of the C-terminal domain 
of PARP-1 (C-parp) to bind mono-nucleosomes when tested by EMSA (Figure 2.4D). Like N-parp, full 
length PARP-1 binds Nuc147 only weakly (Figure 2.4C). Importantly, interaction of full length PARP-1 
with Nuc207 and Nuc165 is significantly tighter than to any of the free DNA substrates.   
To further test whether both DNA linker arms are required for a stable PARP-1 interaction, we 
generated a nucleosome with a single asymmetric ~30 bp extension of DNA linker (Nuc178; Figure 
2.1C). Both PARP-1 constructs bind this nucleosome substrate with significantly reduced affinity 
compared to Nuc165 or Nuc207 (Table 2.1). The data suggests that both linker arms are required for 
optimal PARP-1 binding. Binding of both PARP-1 constructs to Nuc178 is also 3-7-fold weaker than to 
the corresponding ‘free’ 30mer with identical sequence (30Link), indicating steric hindrance of PARP-1 
binding to Nuc178. Finally, full length PARP-1 binds these nucleosomes only 3-fold tighter than does N-
parp, in contrast with the 25-50- fold increase of affinity for nucleosomes with two linker ends. This 
suggests that the catalytic domain contributes to positioning PARP-1 in a way that allows engagement of 
both DNA linker arms, and thus does not contribute as much to the interaction with a nucleosome with 
only one linker arm.  
We next wanted to determine the stoichiometry of the various nucleosome-PARP-1 complexes. Nuc207, 
Nuc165, or Nuc147 were mixed with varying amounts of PARP-1 and analyzed by size exclusion 
chromatography coupled to multi-angle light scattering (SEC-MALS; Figure 2.5 and Table 2.2). For the 
complexes between Nuc207 or Nuc165 and PARP-1, the observed molecular weights matched the 
calculated value for a 1:1 complex even when excess PARP-1 was added. In this case, a second peak for 
free PARP-1 was observed.  A stoichiometry of 1:1 was also measured for N-parp-nucleosome complexes 
(data not shown). Consistent with the low binding affinity, Nuc147 and PARP-1 eluted as two separate 
peaks (Table 2.1), despite the residual interactions observed by native PAGE (Figure 2.4D).  
Together, our quantitative analysis of PARP-1 nucleosome binding and stoichiometry reveals a 
strong contribution of the WGR-CAT domain to the interaction with nucleosomes with two linker arms 
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Figure 2.3. PARP-1 interacts with nucleosomes. A. Fluorescently labeled nucleosome substrates: 
DNA fragments 207, 178, 165 and 147 base pairs in length, all containing the 601 positioning sequence, 
were assembled into nucleosomes with histone octamers labeled at H4E63C with Atto647N. 
Nucleosomes were run on 5% native PAGE and scanned on a Typhoon imager at an emission wavelength 
of 670 nm. Lanes 2, 4, 6 and 8 are nucleosomes assembled on 207, 178, 165 and 147 bp DNA, 
respectively. B. The same gel, stained with ethidium bromide. Lanes 1 and 2 are labeled and unlabeled 
Nuc207 respectively, lanes 3 and 4 are labeled and unlabeled Nuc178, lanes 5 and 6 are labeled and 
unlabeled Nuc165, lanes 7 and 8 are labeled and unlabeled Nuc147. Lanes 9-12 are 207, 178, 165 and 147 
bp DNA fragments, respectively. Note the absence of free DNA (<1%) in the nucleosome samples. C. 
Atto647N (acceptor)-labeled nucleosomes (Nuc165) were incubated with increasing amounts of 
Alexa488-labeled PARP-1 or N-parp, and analyzed by native PAGE. Gels were scanned on a Typhoon 
Imager at the indicated wavelengths. Overlay: Acceptor, Donor and FRET channels are overlaid. Lanes 1 
and 6: Nuc165; lanes 2-5: nucleosomes incubated with increasing molar ratios of PARP-1 (0.5, 1, 1.5 and 
2 fold excess). Lanes 7-10: nucleosomes incubated with increasing molar ratios of N-parp (0.5, 1, 1.5 and 
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Figure 2.4: Quantification of interactions between PARP-1 and nucleosomes. A. Hi-Fi FRET plate 
assay. A portion of a typical 384-well plate is shown for Nuc178 and N-parp (top panel) and full length 
PARP-1 (bottom panel). Increasing amounts of Nuc178 labeled with Atto647N at H4E63C was titrated 
with constant amount of either N-parp or PARP-1 labeled with Alexa488. The top two rows in each panel 
represent acceptor only (A only) controls. The first two wells in bottom two rows in each panel are donor 
only (D only) wells. FRET between the interacting partners is shown in the bottom two rows of each 
panel (pink/purple). The plate was scanned using a Typhoon imager as described for the gel in Figure 2. 
Data from experiments were normalized, and the resulting curves were fit as described [142]. Results 
from this plate are shown in Table 2.1. B. N-parp and C. PARP-1 interactions with the various mono-
nucleosome substrates. All values from this and similar experiments are summarized in Table 2.1. D. C‐
parp does not bind nucleosomes. Nucleosomes were incubated with C‐parp or PARP‐1 at increasing molar 
excess (as indicated) and loaded on a pre‐run 5% native TBE gel. Gels were stained with Ethidium 
bromide.  C-parp does not interact with Nuc147 (lanes 2 and 3) or Nuc165 (lanes 7 and 8), while PARP‐1 
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Figure 2.5: One PARP-1 molecule binds per nucleosome. Size exclusion chromatography – multi-
angle light scattering (SEC-MALS) profiles for Nuc207 and its complexes with PARP-1. Nuc207 forms a 
1:1 complex with PARP-1 even when excess PARP-1 is added to the reaction mix. The molecular 














































Table 2.2. Molecular mass analysis of nucleosomes and their complexes with PARP-1 as determined 
by SEC-MALS (Figure 5). 




Nuc207 2.45 x 105 2.36 x 105 
PARP-1 1.1 x 105 1.13 x 105 
Nuc207 + PARP-1 (1:1) 3.5 x 105 3.49 x 105 




Nuc165 2.17 x 105 2.10 x 105 
PARP-1 1.01 x 105 1.13 x 105 
Nuc165 + PARP-1 (1:1) 2.6 x 105 3.23 x 105 




Nuc147 2.02 x 105 1.99 x 105 
PARP-1 1.01 x 105 1.13 x 105 
Nuc147 + PARP-1 (1:1) 1.95 x 105 3.12 x 105 










(25-50 fold increased affinity), whereas the contribution of these domains to the interaction with free 
DNA is moderate at best (1.4-3-fold). Similarly, the affinity of full length PARP-1 for Nuc178 is only  
increased three-fold compared to N-parp. Since nucleosomes without linker DNA show no significant 
PARP-1 binding, we conclude that the contributions of the ‘nucleosome core’ itself are minimal. Thus, 
high-affinity binding of full length PARP-1 is provided by specific arrangement of two linker DNA arms 
that are only provided in the context of a nucleosome.   
 
PARP-1 is activated by DNA and nucleosomes  
 
In light of the tight interaction of PARP-1 with a variety of DNA and chromatin substrates, we 
wanted to know what triggers the catalytic activity of PARP-1, and whether there is a quantitative 
difference in the degree of activation by the different DNA and chromatin substrates.  To address these 
questions, we measured PARP-1 activity in the presence of various DNA and chromatin activators using 
the slot blot method [93]. A representative case of PARP-1 activation by 30Blunt DNA is shown in 
Figure 2.6. SDS-PAGE followed by western blot analysis with anti- poly-ADP ribose (PAR) antibody 
clearly demonstrates an up-shift in the PARP-1 band with increasing NAD+ concentrations, indicative of 
the addition of PAR chains to PARP-1 (Figure 2.6A). To quantify the amount of PAR generated in each 
reaction, samples were analyzed by a slot blot and probed with the same anti-PAR antibody used above 
(Figure 2.6B). The data was plotted in GraphPad Prism using Michaelis-Menten curve fitting (Figure 
6C). The enzymatic parameters for PARP-1, in the absence and presence of the various activators are 
summarized in Table 2.3. kcat in the absence of DNA reflect the low basal background activity of PARP-
1.  
PARP-1 is significantly activated over background levels by all linear DNA substrates, as evident by 
increases in Vmax; our values are in good agreement with those obtained using a similar approach [93]. 
Closed circular plasmid DNA causes residual enzyme turnover, presumably due to the unavoidable 
contamination with nicked or linear DNA in most plasmid preparations. While PARP-1 binds NAD+ even 
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in the absence of DNA (no significant changes in KM), kcat values range between 0.9-2 per second for all 
linear DNA fragments, but are near 0 in the absence of DNA (Table 2.3).  Nucleosomes with either one 
or two linker ends (Nuc178 and Nuc207) activate PARP-1 to a similar degree, despite the difference in  
binding affinity and presumably binding mode. Nuc147, which lacks free linker ends, has only reduced 
ability to stimulate PARP-1. Chromatin with at least one free DNA end activates PARP-1 to a higher 
degree than a linear DNA fragment with the same sequence (compare 30Link and Nuc178; Table 2.3).  
While Nuc147 is rather inefficient at activating PARP-1 at 100 mM NaCl, it becomes a better activator at 
50 mM NaCl, consistent with the idea that lower ionic strength promotes spontaneous “breathing” of the 
DNA ends [147, 148]. The degree of activation resembles that achieved by short free DNA segments 
under the same conditions, where Nuc178 is still superior to either substrate. No PARP-1 activation was 
observed in the presence of any of the histone sub-complexes in the absence of DNA (data not shown). 
Thus, under our conditions, there is no direct correlation between activation and binding affinity; 
however, the presence of a nucleosome in addition to a DNA double strand break appears to contribute to 
PARP-1 activation. 
 PARP-1 is a highly abundant nuclear protein with a multitude of biological functions  
(reviewedin [129]). PARP-1 contributes to the compaction of chromatin through direct interactions with 
nucleosomes, but also binds various forms of damaged DNA. While its interaction with free DNA has 
been reasonably well-studied (e.g. [35, 49, 136], much less is known about the interaction of PARP-1 
with chromatin. To fill this significant gap, we measured the affinity of PARP-1 for defined DNA and 
chromatin substrates, and quantified the degree of stimulation of its enzymatic activity by the various for 
high-affinity binding to nucleosomes; and iii) a requirement for at least one free DNA end on the 









Figure 2.6: PARP‐1 is activated by DNA. A. SDS-PAGE showing a shift in PARP-1 mobility as it 
undergoes auto-PARylation in the presence of 1 µM 30Blunt DNA and increasing concentrations (0, 10, 
20, 50, 100, 200 and 400 µM in lanes 3-9 respectively) of NAD+. The right-hand panel is a western blot 
of an identical gel probed with anti-PAR antibodies. Lane 1: protein size marker. Lane 2: no NAD+; 
Lanes 3-9 have increasing amounts of NAD+; lane 10: no DNA in the presence of 400 µM NAD+. B. A 
slot blot of the above reaction was probed with anti-PAR antibody and with secondary antibodies 
conjugated with Atto647, and visualized on a Typhoon scanner at 633 nm Excitation; 670 nm emission 
wavelength. C. The data were quantified using ImageQuant TL and analyzed in a Michaelis-Menten plot. 
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Table 2.3. Enzymatic parameters for PARP‐1 upon activation by DNA or nucleosomes. *Kd values 
are taken from Table 2.1.  
Reaction conditions : DNA[50]=50 mM Tris 8.0, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT 
DNA[100]=50 mM Tris 8.0, 100 mM NaCl, 10 mM MgCl2, 1 mM DTT 
Chromatin[50]=50 mM Tris 8.0, 50 mM NaCl, 1 mM MgCl2, 1 mM DTT 














        9.40 19.4 ± 30.8 0.02 0.09  
DNA [50] 
pGEM-3Z    188.0 62.0 ± 17.7 0.35 0.56 x 104  
30Blunt 32   541.1 27.1 ± 6.03 1.02 3.95 x 104  
30Ext 66   541.4 62.9 ± 9.9 1.01 4.31 x 104  
30Nick 23   311.0 33.0 ± 7.6 0.88 1.89 x 104  
30AATT 8.5   568.2 25.7 ± 6.4 1.06 6.55 x 104  
30Link 24 1070.6 33.9 ± 18.9 1.99 6.03 x 104  
Chromatin [50] 
Nuc147    642.4 23.1 ± 7.52 1.2   5.20 x 104  
Nuc178  1408.2 16.4 ± 4 2.65 16.15 x 104  
Chromatin [100] 
Nuc147 >500     82.3 37.4 ± 21.0 0.15 0.42 x 104  
Nuc207   1.0   786.4 23.6 ± 8.0 1.47 6.22 x 104  
Nuc178 85.0   709.8   7.6 ± 10.5 1.33 1.76 x 104  
DNA [100] 
30Blunt  148.1 20.6 ± 9.3 0.28 1.40 x 104  
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ligands. Together, our data demonstrate, i) a significant contribution of the WGR-CAT domains to the 
interaction of PARP-1 with nucleosomes, but not to free DNA; ii) a requirement for a pair of linker DNA  
DNA substrates with a propensity to bend. EM studies have shown that PARP-1 induces a bend into 
nicked or gapped DNA [61]. The recognition of the weakened base stacking and the increased flexibility 
at DNA lesion sites has been proposed as a first step in DNA damage recognition by many repair proteins 
[149]. Consistent with previous qualitative reports [123] and with the recent crystal structure of near full 
length PARP-1 in complex with a short DNA fragment [49], we find a modest contribution of the C-
terminal half of PARP-1 (presumably due to the interactions made by the WGR domain) to the interaction 
with each of the short DNA fragments tested.  
Full length PARP-1 binds very tightly to mono-nucleosomes that contain at least 10 base pairs of 
linker DNA extending on either side. This is consistent with the result that 160 base pairs of nucleosomal 
DNA are protected from MNase digestion in the presence of PARP-1 [123], but contradicts indirect 
evidence that linker DNA does not contribute to the interaction [110]. The strong contribution of the C-
terminal half of PARP-1 to the interaction with nucleosomes is striking because this region on its own 
does not measurably bind nucleosomes, and because full length PARP-1 interacts only very marginally 
with nucleosomes lacking DNA linkers (Nuc147). Since histones are also subject to a low degree of 
PARylation, this interaction might also entail substrate recognition by the catalytic domain. However, the 
interaction of PARP-1 with nucleosomal histones or histone tails is not sufficient for robust binding in the 
absence of linker DNA.   
PARP-1 likely engages both DNA linker ends, since the deletion of one of the two linker arms in 
a nucleosome (leaving one 30 base pair DNA linker, Nuc178) resulted in a significant reduction in 
binding, and in a much reduced contribution of WGR-CAT to the interaction. The model for the structure 
of full length PARP-1 in complex with a single DNA fragment proposed by Langelier and colleagues 
[49], suggests that Zn2 might be the domain responsible for interacting with the second DNA linker end 
(Figure 2.7). This domain binds linear DNA on its own, and with tighter affinity than Zn1, but is not 
needed for the enzymatic activation of PARP-1 [137]. The 25-50-fold increase in binding affinity for  
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Figure 2.7: Model for N-parp and PARP-1 interactions with DNA and nucleosomes. A. Interaction 
with free DNA, as shown in [49] (cartoon adapted from [150]).  B. Nucleosomes without linker do not 
interact with either PARP-1 construct. C. Nucleosomes with one asymmetric linker arm likely interact 
similarly with PARP-1 as they do with free DNA, with some steric inhibition from the nucleosome, as 
indicated by the weaker binding affinities. D. Interaction with nucleosomes with two linker arms: Both 
linker arms are engaged in PARP-1 binding, with Zn2 binding the second DNA linker. Regions from C-
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nucleosome substrates of full length PARP-1 compared to N-parp suggest that the engagement of the 
WGR domain (and perhaps the catalytic domain) is required for Zn2 to position itself optimally for 
interaction with the second linker arm (Figure 2.7). This effect is not observed on nucleosomes with just 
one linker arm, or on free DNA. Both N-parp and full length PARP-1 bind less tightly to these 
nucleosomes than they bind to 30Link DNA, which has the same sequence as the linker extension in 
Nuc178, suggesting steric interference to binding by the nucleosome core.  Some controversy exists over 
the stoichiometry of PARP-1 in solution [48, 97], and on free DNA [125, 136, 151]. Here we have shown 
that a single PARP-1 molecule binds per nucleosome, consistent with the idea that PARP-1 and linker 
histone H1 interact similarly with PARP-1 [123]. Using the same approach, we find that H1 binds 
Nuc207 with higher affinity than full length PARP-1 ([142]; and unpublished results).   
PARP-1 activity is reportedly induced by DNA damage, chromatin and even isolated histones 
[110, 123]. Using highly pure recombinant PARP-1 and well-defined DNA and nucleosome substrates, 
Our data demonstrates that PARP-1 is able to recognize DNA double strand breaks in the context of 
chromatin and is potently activated, consistent with its role as a first responder to DNA damage in 
eukaryotic cells. The high affinity of PARP-1 to nucleosomes and its activation by DNA and 
nucleosomes explains how PARP-1 regulates chromatin structure, transcription and DNA repair 
pathways. Additionally, the requirement of NAD+ for PARP-1 activation implies that other pathways 
utilizing NAD+ will further regulate PARP-1 activity in the various cellular processes [152].  However, to 
understand if and how PARP-1 redistributes from undamaged chromatin to sites of DNA damage, we  
have to quantify the interactions of PARP-1 with complex chromatin structures and chromatin 
components in the absence of DNA damage.  
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Inferential structure determination of multi-domain proteins from  




 The work published in this chapter was initiated by Thomas Hamelryck PhD of the 
Bioinformatics Centre in the Department of Biology at the University of Copenhagen, Denmark.  The 
vision of his group is to combine low-resolution SAXS data with high-resolution structures for proteins 
that have not been fully described atomistically.  The intent was to obtain Small Angle X-ray Scattering 
(SAXS) data from researchers who perform biochemical and structural biology research on complex 
biological systems that contain regions of flexibility or disorder for which structural descriptions may 
otherwise be unobtainable.  The experimental approach was mostly focused on in silico calculations that 
were meant to determine the three-dimensional structure of the average molecule in solution. In terms of 
contributions, this author contributed the SAXS data of the truncated N-terminal and full-length PARP-1 
proteins used for the novel computational analysis.  Additionally, as a means to better understand the 
results from the novel computational approach, this author worked closely with the lead author Kasper 
Stovgaard to perform the more readily accepted SAXS analysis routinely published in the literature.  This 
chapter is presented in essentially the same form as a submission to the Journal PLoS Computational 
Biology.  Although, the article was denied publication the referees noted that the approach showed 
promise but was not quite developed enough to portray full confidence in the findings.  Our collaborators 







Obtaining information on the structure of large, flexible proteins is notoriously difficult, yet of 
prime importance given their central role in medicine and biotechnology. Recently, the use of low 
resolution small-angle X-ray scattering (SAXS) data has made it possible to obtain structural information 
on proteins that consist of multiple domains connected by flexible linkers. Current methods require 
subjective choices, such as the size of the ensemble or how to reconcile the influence of the SAXS data 
with the requirements of viable protein geometry. Here, we present a novel method that is powered by a 
well-justified probabilistic model, which takes the limited information content of SAXS data into account 
to avoid over-fitting. The method produces ensembles that consist of structures that closely fit the data 
and a geometry that is controlled by probabilistic models of local protein structure. We show that even 
such “conservative” ensembles contain a surprisingly large conformational variability. The method 
provides useful results if the shape of the ensemble is fairly close to the shape of the bulk of the 
individual conformations in solution. We carefully validated the method using artificial data and 
previously published experimental data on the cellulase Cel5G and a truncated form of PARP-1, a DNA 
binding protein that consists of six domains and is a potential target in cancer therapy. Subsequently, the 
method was applied to novel, unpublished data on full-length PARP-1, illustrating that biologically 
meaningful results can be obtained from large, flexible macromolecular systems of significant biological 
relevance. 
Proteins are vital to the function of most cellular functions and are the principle target for drugs. 
While the three-dimensional structure of proteins is essential for their function, it remains tedious and 
costly to obtain high-resolution protein structures. In particular, high- resolution structure determination 
methods have limitations with regards to flexible, multi-domain proteins. This group of proteins is of 
special interest, as they are involved in critical functions such as regulation of gene expression and the 
cell cycle. Small-angle X-ray scattering (SAXS) is a method that provides easy access to low-resolution 
structural information, even for flexible, multi-domain proteins. Alone, it is insufficient for detailed 
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structural analysis. We present a method for inferential structure determination that combines SAXS data 
with a probabilistic model of protein structure. Our method provides an ensemble of structures that are all 
in agreement with the SAXS data. The method was successfully applied to two previously studied 
proteins with known high-resolution domains connected by flexible linkers. We applied the method to the 
challenging six domain protein PARP-1 using unpublished SAXS data, producing biologically relevant 




Despite advances in protein structure prediction, it is still not routinely possible to reliably fold 
proteins in silico [153]. However, easily obtainable low-resolution experimental data can provide valuable 
complementary constraints for structure prediction and determination. Small-angle X-ray scattering 
(SAXS) is a well-established low-resolution method for structure determination [154, 155]. Methods for 
high-throughput automated SAXS analysis of proteins have recently been developed [156, 157], 
potentially facilitating a large increase in available SAXS data.  SAXS curves are most commonly 
collected up to a maximum scattering vector of 0.3–0.6 Å−1 corresponding to a spatial maximum 
resolution of 10 to 35 Å. This makes SAXS a valuable constraint for investigating the flexibility of larger 
multi-domain proteins. Most eukaryotic proteins are indeed composed of multiple conserved domains 
connected by flexible linkers [158, 159]. Such proteins are of particular biological interest as they carry 
out vital functions in regulation of gene expression, cell growth, cell cycle, metabolic pathways, signal 
transduction, protein folding and transport [158]. Structural data on such proteins are few as they are 
notoriously difficult to study by high-resolution methods [154] and likely exist in multiple conformations. 
On the other hand, the atomic structures of the individual domains are often known. This work therefore 
focuses on obtaining information on relative domain orientations in multi-domain proteins for which only 
the structures of the individual domains are known. 
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Current methods for modeling flexible, multi-domain proteins can be divided into two groups, 
dependent on whether they fit single structures to the SAXS curve or employ ensembles of structures. The 
most widely used programs from the first group are the rigid body modeling tools in the ATSAS package 
[160], including SASREF and BUNCH. These tools are based on spherical harmonics algorithms and 
refine models against experimental SAXS curves using simulated annealing protocols. SAS-REF can be 
used to model the quaternary structure of protein complexes using random translations/rotations of the 
subunits in a grid search. BUNCH can model multi-domain proteins linked by flexible loops. The linkers 
are represented as interconnected chains, described by one scattering body per residue, and are sampled 
by random rotations about the axis connecting two such dummy residues. BUNCH can be used to fill in 
unknown linker fragments between domains of known structure; the resulting model reflects a single 
average conformation of the protein. Recently, methods utilizing ensembles of structures to fit the 
experimental SAXS data have been developed. Bernardo et al. [161] use a genetic algorithm to select a 
number of different conformers for flexible, multi-domain proteins to enable the average theoretical 
scattering curve to fit the experimental data. The structures in the initial pool – typically 10,000 – are 
randomly generated from Cα models. The resulting number of conformers in the ensemble and their 
diversity reflects the flexibility of the system. A related method uses molecular dynamics simulations to 
investigate the conformational space of the structure, followed by a selection of a minimal ensemble by a 
genetic algorithm [162]. 
We recently proposed a computationally efficient method for the calculation of SAXS profiles 
from protein structures [163]. The method is based on the Debye formula using a set of coarse-grained 
form factors, and proved successful in a decoy recognition experiment.   
 
Materials and Methods 
 
Protein expression and purification 
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Human Parp1-486 was cloned and expressed as described in [164].  Full-length human PARP-1 
was expressed in Sf9 in- sect cells according to [92]. Cell lysates were thawed from -80 C and sonicated 
(3 x 5 s, output 6.5, duty cycle 65%, Branson sonifer 450) on ice in ice-cold lysis buffer (300mM NaCl, 
25mM Tris/HCl, pH 8, 1mM β-mercaptoethanol and 1mM PMSF). Cell lysates were then cleared by 
centrifugation (14,000 rpm for 30 minutes at 4°C). DNA was removed by addition of 1.0 mg/ml salmon 
sperm protamine sulfate (Sigma-Aldrich) followed by centrifugation (14,000rpm for 30 minutes at 4°C). 
The supernatant was then precipitated by a two- step ammonium sulfate treatment. The first precipitation 
was from 0-30% (164g ammonium sulfate solid was added to 1000ml to give a 30% saturation) and the 
second step was from 30-70% (249g ammonium sulfate solid was added to 1000ml to give a 70% 
saturation). The ammonium sulfate precipitations were per- formed at 4°C while stirring overnight. The 
precipitated proteins were resuspended in heparin chromatography buffer A (100mM NaCl, 25mM 
Tris/HCl, pH 8 and 1mM β-mercaptoethanol) and loaded onto a HiTrap Heparin column (GE Healthcare) 
and eluted with a linear gradient of heparin chromatography buffer B (1.5M NaCl, 25mM Tris/HCl, pH 8 
and 1mM β-mercaptoethanol). Further purification included size-exclusion chromatography and cation 




Samples (2mg/ml) of either Parp1-486 or full-length PARP-1 in 50mM Tris/HCl, pH 8, 300mM 
NaCl and 1mM tris(carboxyethyl)phosphine (TCEP) were loaded onto an ÄKTA purifier HPLC system. 
A Superdex S200 (10/30) size-exclusion column (GE Healthcare) was used to characterize the proteins. 
The proteins were continuously run at a flow rate of 0.3ml/minute from the S200 column into an inline 
Dawn Heleos II (Wyatt Technologies) multi-angle light-scattering instrument, immediately followed by a 
REx refractive index detector (Wyatt Technologies). The proteins were further analyzed using a 
differential index of refraction (dn/dc) of 0.185. 
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Small Angle Scattering 
 
SAXS measurements were performed at two separate beam lines. Data for Parp1-486 as well as 
the full-length PARP-1 were collected at the Stanford Synchrotron Radiation Laboratory (SSRL) at the 
beam line 4-2. Samples were analyzed at room temperature using a Mar-CCD165 detector. The data 
images were normalized, the sample transmissions were corrected, if multiple images were found not to 
have time dependent changes in scattering, those images were combined prior to channel- by-channel 
buffer subtraction. Intensity curves for the Parp1-486 and full-length PARP-1 were both collected at 
concentrations ranging from 1-3 mg/ml. Scattering was independent of protein concentration indicating 
that inter-particle effects such as repulsion or aggregation were negligible (data not shown). Samples of 
full-length PARP-1 were also measured at Berkeley’s SIBYLS beam line (12.3.1) at the Advanced Light 
Source (ALS) using a Mar CCD area detector. The data images were circularly integrated, normalized 
and the buffer contribution subtracted. Intensity curves for 3.8, 1.9 mg/ml and 1.3 mg/ml concentrations 
showed no concentration dependent inter-particle effects (data not shown). 
Initial data processing was performed using the program PRIMUS [165] and the radius of 
gyration calculated using the Guinier approximation as implemented in the GNOM program [166]. The 
DAMMIN program [167] was used to generate the envelope models presented in Figures 3.5 and 3.7. 
Ten independent dummy-atom models were calculated from the scattering data for each PARP-1 
construct (in slow mode) and superimposed using SUPCOMB [168]. The resulting models were averaged 
and filtered using DAMAVER [169] and converted to volumetric maps using the program pdb2vol in the 
SITUS suite [170]. 
 
Input domain structures 
 
For the study with artificial data, the PDB file 1CCZ was used. The Cel5G domains were 
modeled used high-resolution structures 1AIW and 1EGZ for the cellulose binding and catalytic domains 
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respectively. For Parp1- 486 the following PDB files where used as input for the Zn1, Zn2, Zn3 and 
BRCT domains: 2DMJ, 2CS2, 2RIQ, 2COK. These were also used for the full-length PARP-1 modeling 
with the addition of 2CR9 for the WGR and 2RCW for the catalytic domain. 
 
Probabilistic model of the side chain scattering bodies 
 
The calculation of the SAXS likelihood requires coarse- grained structures; the side chains need 
only be represented by a single scattering body placed at their center- of-mass (CoM) [163]. If needed, 
full-atom side chains can later be added, for example using BASILISK [171] or IRECS [172]. The CoM 
position is calculated from all heavy atoms in the side chain; we excluded the β-carbon since its position 
is approximately fixed for a given a backbone conformation. 
We defined the position of the CoM by defining a local reference frame based on the residue’s 
backbone atoms (see Figure 3.9). The X-axis is defined by the N→C vector. The vector that defines the 
Y axis is perpendicular to this vector, and lies in the N − Cα − C plane. The Z-axis is defined by a vector 
that is perpendicular to both vectors, resulting in a right hand coordinate system. 
Bayesian networks are graphical models, where the nodes represent random variables and the 
edges encode their conditional independencies [173]. We formulated the probabilistic model of the CoM 
as a simple Bayesian network, consisting of a single hidden node, and four observed nodes that concern 
the variables of interest used in sampling (Figure 10). The model is named COMPAS, which loosely 
stands for “center of mass placement of side chain centers”. In the next two paragraphs, we describe the 
four observed nodes in COMPAS. 
Side chain conformations have a strong correlation with the conformation of the backbone [171]. 
In order to capture this relation, we included the two main degrees of freedom in the protein backbone, 
namely the φ and ψ angles, into the model. In order to model these angles we used the cosine variant of 
bivariate von Mises distribution, [174] which has successfully been applied in this context before [175]. 
This pair of angles is thus modeled by one bivariate von Mises node. 
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The amino acid type is represented by a discrete distribution that can adopt 18 states, corresponding to all 
amino acids except proline and glycine. The direction of the CoM was modeled using the 5-parameter 
Fisher-Bingham distribution [176, 177], which is a distribution over unit vectors. Analyzing the training 
data revealed that the placement of the CoM atom is limited to a small number of distinct distances for 
each amino acid. Therefore, the CoM distance from the Cα atom is described by a discrete distribution of 
three states. Each state corresponds to a certain distance, which also depends on the amino acid type and 
the hidden node can adopt 120 states. The distance parameters are included in Table S3.15. 
COMPAS is used in the following way. First, the amino acid type and the values of the φ and ψ 
angles values are specified using the corresponding nodes. Then, a value is sampled for the hidden node, 
conditional upon this information. Finally, a unit vector and distance are sampled conditional upon the 
sampled hidden node value. The unit vector and distance uniquely specify the position of the CoM. 
The COMPAS model was trained on angles derived from 1703 high-resolution crystal structures that 
were culled from the Protein Databank using the Pisces server [178]. All structures selected have been 
solved to a resolution of at least 1.6 Å, an R-value of 0.25 or better and a pairwise sequence similarity of 
25% or less. Subsequently, the structures were processed using the REDUCE software [179], correcting 
common misconfigurations such as flipped histidine rings. From this initial set around 10% randomly 
selected structures (171 structures with 31,229 observations) were retained as a test and validation set. 
The remaining 1532 structure or 277,975 observations were used to train the model. The COMPAS model 
was implemented and trained using our freely available Mocapy++ toolkit [180]. The parameters in the 




Starting from the initial structures, MCMC sampling is performed using our molecular modeling 
software PHAISTOS [182]. We applied a generalized ensemble with a weighting according to the inverse 
cumulative density of states [183], called the 1/k-ensemble, to obtain exhaustive sampling in the high 
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probability regions.  A non- uniform, adaptive binning of the energy space was used to ensure efficient 
sampling for both smaller and larger proteins. Samples were dumped every 5000 iterations, typically 
resulting in thousands of random samples. The minimum energy structures were saved for further analysis 
as well. Only the linker regions were changed during sampling; the domains themselves were kept fixed. 
Various moves were investigated for this sampling. The best results, in terms of number of 
sampling iterations needed to reach the lowest energy structures, were achieved with a combination of 
two kinds of moves. So-called “pivot” moves, which are using the TorusDBN prior [175] and updating 1-
5 pairs of dihedral angles at a time, and the more contained “local pivot” moves, also including the 
TorusDBN prior, and restricted to change one dihedral angle at a time with a smaller variation. For the 
side chain CoM, a new position was sampled according to the COMPAS model given the amino acid 
label and the backbone conformation at this residue. For the refinement run, all the heavy atoms of the 
side chains were inserted, and the dihedral angles were sampled using the probabilistic model BASILISK 
[171]. 
Based on a diverse validation set of proteins [163], we expect the sampled energy to reach 





with Q the number of q-bins, Iq and Iq* the input and theoretically calculated scattering intensities and +q 
the estimated experimental error. Multi-threaded runs were applied for PARP-1 simulations due to the 
size of these constructs. For the latter, we ran three independent Markov chains, which share the entropy 







Following the Bayesian calculus, the posterior probability used to drive the sampling was defined 
 
 
where X is the protein structure under investigation with backbone dihedral angles ! ", # " and amino acid 
sequence A; I is the experimental scattering curve; I* is the theoretical scattering curve calculated from X; 
N(,) is the Gaussian distribution; and the product runs over all q- bins. We used an estimated standard 
deviation for the experimental error +q [11]. The sampling was primarily investigating low energy 
structures and in effect  
P(X|D,A) ! P1/k(E)!(" #,$ # | A)          (3) 
where 
 
denotes the energy and P1/k(E) ! w1/k(E)g(E) is the marginal distribution over the energy implied by the 
1/k- weights, w1/k(E), and the density of states, g(E). 
Apart from the SAXS energy, a simple steric hindrance term was also included in order to 
prevent clashes be- tween atoms in the structure. This term assign an infinite energy to structures with 
separations of less than 1 Å between hydrogen atoms and 1.5 Å for all other pairs of atoms. Otherwise 
this term is zero. 
For the ensemble analysis we selected the conservative ensemble as the samples within the lowest energy 
bin in the adaptive binning scheme, thus having no distinguishable difference in goodness of fit to the 
SAXS data. 
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As an additional validation, the scattering profiles for the centroid structures, computed by our 
coarse-grained model, were compared to the ones produced by the programs CRYSOL [184] and FoXS 
[185]. 
Both methods use full atomic details in the calculation of the theoretical scattering curve. 
CRYSOL applies a spherical harmonics algorithm for these calculations while FoXS uses the Debye 
formula for all atoms. The three different methods were in good agreement and all within the 
experimental uncertainty of the input curve. Examples for Parp1-486 and Parp1-1014 are included in 
Figures S3.16 and S3.17. 
 
Clustering and centroid selection 
 
Calculating all pairwise distances for a large set of samples of structures in RMSD space is 
cumbersome and time consuming. We therefore used a clustering method where the structures are 
represented using Gauss integral tuned (GIT) vectors developed by Røgen and coworkers [186]. Here the 
protein topology is described by a 31 dimensional vector rather than atomic positions, which allows for a 
fast evaluation of the Euclidean distance between two such vectors. These GIT distances have been 
shown to correspond well with the RMSD measure [186]. Using the GIT clustering approach, the result 
of a typical MCMC sampling, in the order of tens of thousands of samples, can be clustered within 
seconds. The k-means algorithm [187] was used in the clustering step with k fixed at ten clusters. The 
GIT vectors do not represent large proteins sufficiently well, so this clustering approach was applied only 
for the 1CCZ and Cel5G proteins. 
The PARP-1 structure was modeled as fixed domains connected by long flexible linkers, which 
results in samples with a high geometrical variability. For Parp1-1014 the scattering profiles was 
collected with a resolution up to q = 0.3 Å−1, meaning information primarily on molecular mass, radius 
of gyration, volume and a partial description of the geometrical shape. Given our prior information, the 
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tertiary structure of the domains and the primary sequence of the linkers, more than a single structure can 
fit the experimental SAXS data. 
To appreciate the geometrical distribution of the individual domains, the structures were mapped 
to a feature vector containing the individual distances between the residues sterically placed at the 
extremes of the component domains: 
• Parp1-486: residues 59, 96, 166, 206, 244, 285, 408, 450 
• Parp1-1014: residues 43, 80, 150, 190, 228, 342, 441, 466, 563, 580, 668, 722 
Collecting these vectors for each sample, a feature matrix was constructed and a PCA describing the roto-
translations of the domain pairs was carried out. The first three PCA dimensions account for 88% percent 
of the variability for Parp1-486 and 86% for Parp1-1014. 
A distance matrix between the structures was also computed using these PCA components. The employed 
distance measures were the Euclidean distance, the Pearson’s correlation, the Spearman’s rank and the 
Kendall’s tau measure. For the distance matrices, a k-medoids algorithm [188] returned the cluster 
centroid structures used in the Results section. All the distance measures above agree on the cluster 




Overview of the methodology 
 
For NMR data the use of Bayesian inference for protein structure determination from 
experimental data was introduced by Rieping et al. [189]. This approach avoids arbitrary, ad hoc choices 
concerning the structure determination procedure [190] and is therefore both theoretically and practically 
attractive. We use a similar approach, thus formulating an alternative to methods that combine physical 
energies with pseudo-energies that then bring in the experimental data [191-193].  
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Following the Bayesian probability calculus, we formulate a posterior distribution P(X|D,A) in 
the following way: 
P (X|D, A) ∝ P (D|X, A)π(X|A)  (1) 
where X is a protein conformation, D is the experimental data and A is the amino acid sequence. The 
likelihood P (D|X, A) brings in the information from the experimental data. For the likelihood we assume 
a Gaussian model, which is based on our previously developed coarse-grained Debye method [11]. The 
prior distribution π(X|A) brings in prior knowledge on protein structure. As the prior distribution 
addressing the main chain, we use TorusDBN, our previously developed probabilistic model of local 
protein structure [175]. We complement TorusDBN with COMPAS, a probabilistic model of coarse-
grained side chain positions introduced here (see the Methods section). Both models are used as 
generative models to sample plausible protein structures consisting of the main chain in atomic detail, and 
the centers of mass of the side chains. The latter are necessary for the application of the coarse grained 
Debye method [11]. The posterior P(X|D,A) is the probability of a structure X given the experimental 
data D and the protein sequence A.  
 Structures are sampled from the posterior distribution using a Markov chain Monte Carlo 
(MCMC) approach. Starting from randomly sampled linker regions and following domain orientations, 
the corresponding scattering curve is calculated. This curve is evaluated with respect to the experimental 
data through the likelihood. In each step of the MCMC algorithm, a new structure is proposed using the 
prior, π(X|A), and accepted/rejected based on the likelihood function, P (D|X, A). To overcome the 
deficiencies of the standard Metropolis-Hastings algorithm, the simulation was done using 1/k 
generalized ensemble weights [194]. In effect, samples are drawn from the modified distribution: 
P∗(X | D,A) ∝ P1/k(E)π(X|A) 
where E = − log P (D|X, A) denotes the “energy” and P1/k(E) ∝ w1/k(E)g(E) is the marginal distribution 
over the energy implied by the 1/k-weights, w1/k(E), and the density of states, g(E). Effectively, this 
approach ensures that the SAXS curves of the sampled structures are predominantly close to the 
experimental data, while maintaining a good local structure.  
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Our coarse-grained method does not account for the so-called hydration layer, which is a layer 
with a slightly higher density than the bulk water that surrounds a protein in solution. However, this effect 
is considered to be small at a resolution below 0.3 Å−1 compared to the experimental uncertainties of the 
SAXS data [191]. 
Our method was applied to three different flexible, multi-domain proteins, as described below. In 
all cases, the high-resolution structure of each domain in the form of Protein Data Bank (PDB) files [195] 
and the amino acid sequence of the entire protein were used as input. A random, clash-free conformation 
of each linker region was sampled using TorusDBN, and used to attach the domains to each other. The 
resulting structure was then utilized as the starting point for the MCMC sampling. After convergence, the 
resulting structures are clustered, ranked according to the density of the clusters and the cluster centroids 




As a first test, our method was applied to a system with a known high-resolution structure, 
namely the two CD2-binding domains of CD58 (PDB code 1CCZ). Artificial SAXS data was generated 
from the native structure up to a scattering vector of 0.5 Å−1 using the program CRYSOL [184] (see 
Methods). The scattering vector is defined as q = 4π sin θ/λ, where λ is the wavelength and θ is half the 
scattering angle. The resolution limit was chosen as a current typical experimental high-resolution limit. 
Choosing a protein with a known high-resolution structure allows for the evaluation of the sampled 
structures in terms of their root-mean-square deviation (RMSD) from the native structure. For this 
evaluation, two parts of the structure where designated as fixed domains, while the central linker was 
assumed to be flexible. The two fixed parts comprise residues 1 to 95, and 100 to 171. 
Starting from a random conformation for the linker, MCMC sampling was carried out for 50 
million iterations to ensure that convergence had been reached. The resulting samples were divided into 
ten clusters using k- means clustering (see Methods). The correlation of the RMSD versus the energy of 
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the samples shows that the lowest energy samples are all below 2 Å RMSD to the native structure 
(Figure S3.1). The cluster centroids and their calculated scattering curves are in good agreement with the 
SAXS data (Figure S3.2). 
The resulting centroids are illustrated in Figure 3.1; centroids one to four are all very similar to 
the native structure (Table 3.1). In conclusion, the results from the experiment with artificial data confirm 
that the method works satisfactory in this case. We now turn to a more demanding application. 
Cel5G 
The cold-adapted cellulase Cel5G (EC 3.2.1.4) from the Antarctic bacterium Pseudoalteromonas 
haloplanktis consists of a catalytic module connected to a carbohydrate binding domain by an unusually 
long and flexible linker region. The importance of the linker region structure for the catalytic efficiency at 
low and moderate temperatures has been demonstrated by mutational studies followed by structural 
analysis using SAXS by Sonan and co-workers [196]. For the selected mutant, the three disulfide bridges 
in the linker were all disrupted, resulting in a reduction of the linker from 109 to 41 residues. 
We modeled the structure of this Cel5G mutant using experimental SAXS data [196] as well as 
the sequence of the linker along with the known high-resolution structures of the catalytic module (293 
residues) and carbohydrate-binding domain (60 residues) (see Methods). The experimental scattering 
curve was provided for a scattering vector q in the range of [0.022, 0.439] Å−1 and was discretized in bins 
of 0.015 Å−1 width for evaluations using the coarse grained Debye method. 
MCMC sampling was carried out for twenty million iterations, clustering the resulting samples. 
The clusters were ranked according to their cluster density, which approximately coincides with the 
cluster centroid χ2 values as defined in the Methods section (Figure S3.3). This is expected when the 
sampling is performed using the 1/k-weights, which favor structures with a high likelihood. Subsequently, 
the centroid structures were refined using the probabilistic model BASILISK [171] (see Methods), which 
allows filling in the atomic details of the side chains. This significantly improved the fit to the 
experimental data (Table 3.2 and Figure S3.4), without affecting the domain distances and orientations; 
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the rearrangements were limited to internal changes in the linker region and movements of the side chains 
in this region. 
The structures of the five best centroids are shown superimposed in Figure 3.2. Despite 
significant differences between the linkers of these structures – the RMSD is up to 4.6 Å between entire 
structures – they show orientations and domain-domain separations similar to the previously published 
model [196] obtained using the same data set with the program GASBOR [197]. For all centroids, the 
linkers are similar in their overall shape. The first residues of the linker region (residues 294– 298) are 
extended, while the central part of the linker (residues 295–329) is more compact, possibly including 
some turn/helical elements, and generally displaying more variation. Lastly, residues 330 to 335 are more 
extended and show more variation than the first part.  Figure 3.3 shows a histogram of the inter-domain 
distances for the sampled structures; the inter-domain distance is defined as the Euclidean distance 
between the center-of-mass for the two domains (catalytic module and carbohydrate binding domain). We 
observe a quite narrow domain distribution with a peak around 77–80 Å.  A similar MCMC run using the 
same input structures but without the SAXS constraint is shown for comparison.  Here, the distribution of 
inter-domain distances is broad, approximately ranging from 33 to 118 Å. 
A histogram for the radius of gyration (Rg) calculated for each sampled structure is shown in 
Figure 3.3. Again, including the SAXS information leads to a narrow Rg distribution (between 32 and 36 
Å) compared to an unrestrained simulation (between 22 and 47 Å). The lowest energy and first centroid 
structures have Rgs equal to 32.4 and 32.5 Å, respectively.  This is in good agreement with the expected 
Rg calculated from the experimental data using the Guinier approximation, which is equal to 32.8±0.9 Å. 
The average SAXS curve of the conservative ensemble for Cel5G, here represented by the over 6000 
samples in the first energy bin (see Methods), is practically identical to the lowest χ2 curve in the 
sampling (Figure S3.5). For Cel5G, the best centroid structures agree with previously published bead 
models, additionally providing information on the conformations of the linker. These conformations are 




Figure 3.1. 1CCZ centroid structures. Top: Best five centroid structures (c1 to c5) of 1CCZ compared 
to the native structure (green). The centroids are color-coded from dark blue (c1) through light blue (c5). 
Bottom: Next five centroid structures (c6 to c10) of 1CCZ compared to native structure (green). The 
centroids are color-coded from dark orange (c6) through light orange (c10). All centroids are 




Table 3.1. 1CCZ cluster centroids with corresponding energies and the RMSD to the native structure. 
The energy is defined as the negative logarithm of the likelihood. 
Centroid # 1 2 3 4 5 6 7 8 9 10 
Energy 566.9 567.3 566.9 567.5 573.8 578.8 574.7 577.8 585.6 593.0 






Poly(ADP-ribose) polymerase-1 (PARP-1) is a member of a large family of enzymes that share 
homology to the C-terminal catalytic domain [198]. This family of proteins is best known for their roles 
in DNA repair, chromatin and transcriptional regulation of a number of genes. PARP-1 is highly 
conserved in eukaryotic cells and is often responsible for the synthesis of poly(ADP- ribose) (PAR) [92]. 
The enzymatic activity of PARP-1 is enhanced 10-100 fold in response to DNA damage, while tightly 
regulated in the absence of genomic stress. 
PARP-1 consists of six domains of which the first two, Zn1 and Zn2, are zinc-fingers involved in DNA 
binding [164]. The third domain Zn3 is a zinc-ribbon domain that is required for DNA-stimulated 
activation of PARP-1, but not directly involved in DNA binding [199]. The Zn3 domain is immediately 
followed by a breast cancer 1 protein (BRCA1) C-terminus (BRCT) homology domain, which is thought 
to function as a protein–protein interaction module. The last two C-terminal domains are the WGR 
domain, named after the most conserved central motif, and the catalytic domain. 
We analyzed two different structures: a construct that was truncated after the BRCT domain 
(Parp1-486) [164] and the full-length protein (Parp1-1014). High-resolution structures are available for all 
six individual domains and were used in the modeling (see Methods). 
For the Parp1-486 construct, MCMC sampling was performed for twenty million iterations, up to 
convergence. The predicted scattering curves for the lowest energy structure and the best five cluster 
centroids were in good agreement with the experimental data (Figure 3.4); the corresponding χ2 values 
are in the range 0.95–0.97. 
The distributions of the calculated radius of gyration Rg and maximum dimensions Dmax for the 
Parp1-486 samples are quite narrow (Figure S6). The mean values are somewhat smaller than those 
calculated from the data itself by GNOM [166]. However, the best centroid structure is also in best 









Figure 3.2. GASBOR model of Cel5G (grey) with overlay of domain crystal structures from Sonan et al. 
[23] (top) and superimposed centroid structures for our top 5 clusters in blue (center). The grey arrow 









Table 3.2. The χ2-value, radius of gyration, Rg and inter-domain distance, D-D, for the refined Cel5G 
centroid structures. 
Centroid χ2 Rg [Å] D-D [Å] 
1 0.31 32.5 76.3 
2 0.31 32.5 76.3 
3 0.29 32.3 75.7 
4 0.31 32.8 77.2 
5 0.32 32.8 77.2 
6 0.32 32.9 77.5 
7 0.31 33.2 78.6 
8 0.31 33.3 78.3 
9 0.31 33.8 80.5 






















Figure 3.3. Cel5G inter-domain distance (top) and radius of gyration (bottom) for the sampled structures 








The structures of the centroids from the five clusters were investigated further. The curves and 
corresponding χ2 values for these centroids are shown in Figure 3.4. The structure of the best centroid is 
S-shaped and elongated, in agreement with the DAMMIN model previously published for this data set 
[164] (see Figure 3.5). 
The conservative ensemble indicates that very diverse structures are allowed by the experimental 
data. On the other hand, the average curve for the entire ensemble corresponds well to both the input data  
and the minimum χ2 curve (Figure S3.5). Our results indicate that Parp1-486 is quite flexible in solution, 
but also has a preferred domain arrangement. In addition, the best centroid structure corresponds well to a 




No SAXS data has previously been published for the full-length PARP-1, but is presented here (see 
Methods). We found that Parp1-1014 behaves as a monodisperse monomer in solution similar to what 
was found for the truncated Parp1-486 [164] (Figure S3.7). Additionally, both proteins were free of 
concentration and scattering dependent inter-particle effects. SEC-MALS measurements show that the 
proteins have experimental molecular weights very close to the corresponding theoretical values. For  
Parp1-1014 the experimental weight was 111 KDa versus a theoretical weight of 113 KDa; the 
corresponding values for Parp1-486 were 57KDa and 56KDa, respectively. Although both constructs 
contain the BRCT domain, neither protein dimerizes under the conditions of the studies discussed here. 
For the Parp1-1014 modeling, sampling proved computationally challenging due to the sheer size and 
number of linkers involved. It was for this reason there was slightly worse sampling statistics than for the 
previously discussed proteins. Nonetheless, structures in very good agreement with the experimental input 
were sampled with χ2 values in the range 0.35– 1.29 for the top five centroids (Figure 3.6). The Rg and 
maximum dimension distributions are also in reasonable agreement with the experimental expectations 
(Figure S3.8). The clustering method used for the other proteins is not suitable for structures of the size  
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Figure 3.4. Experimental scattering curve for Parp1-486 with error bars and theoretical curves for the top 











Figure 3.5. Comparison of the Parp1-486 top centroid structure (c1) in blue and an averaged DAMMIN 
model in grey, using the same input data (see Chapter 4 for comparison). The orientation is indicated by 






Table 3.3. χ2, Rg and Dmax values for Parp1-486 centroid structures. 
Centroid χ2 Rg [Å] Dmax [Å] 
1 0.95 40.5 155 
2 0.96 38.9 136 
3 0.97 39.0 123 
4 0.97 39.8 145 
5 0.95 38.6 112 
6 0.98 39.2 115 
7 1.14 39.2 121 
8 8.23 56.9 133 
9 0.98 38.4 166 
10 1.17 38.0 113 











of PARP-1. We therefore employed a PCA based clustering (see Methods), where cluster density does not 
correlate with χ2 values (Table 3.4). Based on the χ2 values, we consider the fourth centroid to be the 
most reliable of these structures, followed by the second and third centroid. Obtaining a complete 
structural alignment is difficult due to the protein size and the number and flexibility of the linkers. The 
centroid structures and their pair-distance distributions are illustrated in the supporting material (Figures 
S3.9–S3.11). 
 The fourth centroid is compared to an averaged DAMMIN model made using the same 
experimental data in Figure 3.7. Also in this case, the structural alignment is not straightforward, 
particularly since the DAMMIN model is almost ellipsoid and thus provides little information on the 
position of the domains. 
The structure of the fourth centroid displays proximity of the Zn1, Zn2, Zn3 and WGR domains whereas 
the BRCT and PARP Catalytic (CD) domains are both isolated. The arrangement is different in the 
second centroid: the Zn1, Zn2 and the enzymatic domains are close together, as are the Zn3 and WGR 
domains. In the third centroid, the Zn1 and Zn2 domains are in contact but distant from the Zn3, WGR 
and CD domains. Again the BRCT domain is isolated, which is a common feature of the best three 
centroids. They also all agree on a tight connection between the Zn1 and Zn2 domains and between the 
Zn3 and WGR domains. 
 The curve for the average ensemble from structures in the lowest energy MCMC bin is 
close to the best χ2 curve for the full-length PARP-1 (Figure S3.5). In order to analyze the main 
variability in the conservative ensemble, we conducted a structural principal component analysis (PCA) 
of these conformations. In this approach the eigenvectors for the covariance matrix of the ensemble 
structures are sorted by eigenvalues to determine the most important eigenmodes. The eigenmodes can 
then be visualized as structural displacements to describe the most significant variations. This is 
illustrated for the first three eigenmodes of Parp1-1014 in Movies S12–S14. The results show that the 





Figure 3.6. Experimental scattering curve for full-length PARP-1 and theoretical curves for the top 5 




Table 3.4. χ2, Rg and Dmax values for Parp1-1014 centroid structures. 
Centroid χ2 Rg [Å] Dmax [Å] 
1 0.85 50 161 
2 0.61 51 164 
3 0.78 49 155 
4 0.35 52 168 
5 1.29 49 152 




between the Zn3 and catalytic domains from around 15 to 25 Å. A smaller, hinge-like variation of the 
BRCT domain is also observed. 
 Next, we compare the domain orientation in Parp1- 1014 and Parp1-486 for the shared 
domains. As superposition of diverse samples is problematic for large, flexible structures, we decided to 
analyze each pair of connected domains separately. Each domain and its neighbor in sequence with its 
connecting linker is shown for Parp1-486 and Parp1-1014 in Figure 3.8. 
Figure 3.8 shows that the full-length construct appears to be more rigid than the Parp1-486 
construct, especially for the short linker between the Zn1 and Zn2 domains where the Parp1-486 is highly 
flexible. Also, Parp1-1014 seems to have a few distinct, preferred orientations of the linker between the 
Zn3 and BRCT domains, whereas the Parp1-486 linker shows no such preference. One possible factor in 
the flexibility and elongation of Parp1-486 compared to full-length PARP-1, is that our Parp1-486 models 
lack a salt-bridge between Zn3 and the linker be- tween Zn1 and Zn2. This salt-bridge is present in our 




We have introduced a method for modeling flexible, multi-domain proteins. The local structure of 
the linkers is under the control of a probabilistic model of protein structure. Combined with a fast, yet 
accurate evaluation of the theoretical scattering curves of these samples this enables tens of millions of 
realistic structures to be generated in an MCMC run. Using experimental SAXS data as a constraint while 
sampling protein structures from a correct distribution of dihedral backbone angles and side- chain 
centers, we have shown that it is possible to reconstruct a two-domain protein with a short flexible linker 
to a precision below 2 Å RMSD from generated SAXS data. For a two-domain cellulase with a medium 
sized flexible linker our method obtains more diverse structures, which combined correspond well with a 
published model from the GASBOR program using the same input data. Additionally, our method 






Figure 3.8. Variation in the linker regions. Relative domain positions for the top centroid structures of 
Parp1-1014 (top) and Parp1-486 (bottom) for domains Zn1-Zn2 (left), domains Zn2-Zn3 (center) and 
domains Zn3-BRCT (right). The first domain in each pair is superimposed for all centroids and is shown 
in grey while the second domains are colored in red (c1), cyan (c2), yellow (c3), green (c4) and magenta 
(c5). The approximate maximum dimension of each domain pair is outlined in grey. Figure prepared 














Figure 3.9. Center-of-mass placement. Center-of-mass vector for a tryptophan residue is shown as a red 
arrow. The axes in the local reference frame are shown in blue and the center-of-mass (CoM) used for the 
side chain scattering body position is marked as a red sphere. 
 
 
Figure 3.10. The COMPAS Bayesian Network model. The backbone angle is described by a bivariate 
von Mises distribution (on the torus) [13], the center of mass angular position with a 5 parameter Fisher-
Bingham distribution (on the sphere) [44], the amino acid type with discrete node with 18 states, and the 
center of mass distance from the Cα with a discrete distribution with three states. The hidden node, shown 
in white, can adopt 120 states. The observed nodes are displayed in grey. 
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and length of the linker region. Calculated values for the radius of gyration and maximum dimension 
concur with the expectations from the experimental data. The resulting S-shaped, elongated models of a 
truncated construct of the PARP-1 protein are likewise similar to a previously published DAMMIN 
model for the same data set. Both PARP-1 constructs proved quite flexible with different domain 
arrangements between the best centroids from our sampling. This result indicates that PARP-1 is a rather 
flexible protein, possibly continuously undergoing conformational changes in solution. 
Currently our method is limited by the requirement that the global shape of the ensemble needs to 
be close to the shape of the individual structures. Input data from a flexible protein with several discrete 
conformations in solution will not be representable by our conservative ensemble and results in an  
MCMC run that stays in the high-energy regions with poor convergence. This limitation could be 
overcome by allowing multiple curve fitting in a dynamic ensemble scheme as used for instance in the 
Ensemble Optimization Method [9]. Nonetheless, our method potentially generates ensembles that can be 
regarded as representing a true ensemble in solution. To verify the ensemble aspect, we calculated an 
average curve from all theoretical scattering curves in the ensemble of all samples in the lowest energy 
MCMC bin (supporting Figure S3.5). In all four test cases, the average ensemble curve is effectively as 
good as the minimum energy curves sampled. In order to visualize the main variability in the ensemble, 
we conducted a structural PCA of the ensemble conformations for Parp1-1014 (Movies S12–S14). We 
observed a remarkable variety of structures in our conservative ensembles. 
Since our method produces detailed conformations rather than bead or envelope models, the 
position and orientation of individual domains of the protein can be analyzed. This is of particular interest 
for eukaryotic multi-domain proteins where domain interactions and flexibility are vital for the function. 
One example is the observation that the BRCT domain in full-length PARP-1 is consistently found to be 
isolated and highly exposed compared to the flanking domains. The BRCT domain may not serve as a 
dimerization platform for the Parp1-1014 protein, since it exists as a monomer in solution, but its 
exposure may hold relevance in terms of a binding platform for known interaction partners like XRCC1 
[200] or DNA ligase III-alpha [39]. 
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Furthermore, the generalized ensemble MCMC sampling (see Methods) leads to a thorough 
investigation of the conformational space of the protein constrained by the SAXS data. This allows us to 
investigate the structural variability permitted by the data and the prior distribution through the variation 
in the obtained ensemble. 
In conclusion, our method provides a novel solution with a firm theoretical underpinning to the 
inference of domain orientation in multi-domain proteins. The method is available as part of our 
PHAISTOS molecular modeling package [182] and can be obtained freely from Sourceforge1 under the 
GNU Library General Public License. 
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Figure S3.1. Correlation of energy (log-likelihood) and RMSD to the native struc- ture for the 1CCZ 
samples. Maximum q in the input data was 0.5 Å−1. The cluster centroids are depicted as triangles with 
the top 3 centroids in green and the remaining in red. 
 
Table S3.1. Modeling the distances for the CoM position. In the COMPAS probabilistic model of the 
CoM conformational space, we modeled the distance to the Cα atom as a three-state discrete probability 













Figure S3.2. Generated SAXS curve for 1CCZ versus back-calculated scattering curves for the top 
centroids and minimum energy structure sampled (c1 to c10 and min_energy, see box in the upper right 
corner). Corresponding χ2 values are included in parentheses. Error bars show the estimated experimental 
σ’s (see Methods). 
 
Figure S3.3. Theoretical scattering curves for the centroid structures compared the experimental input 
curve for Cel5G (Cel5G_mut and c1 to c10, see box in the upper right corner). The curve calculated for 







Figure S3.4. Theoretical scattering curves for the top centroid and minimum energy structures for Cel5G 
compared the experimental input curve after a full-atom refinement run (c1_refined to c10_refined and 
min_e_refined, see box in the upper right corner). 
 
 
Figure S3.5. Minimum energy and the average scattering curves for the lowest energy bin ensemble with 
corresponding χ2 values. From top to bottom: 1CCZ (735 samples), Parp1-1014 (3266 samples), Parp1-









Figure S3.6. Distribution of the estimated maximum dimension (top) and radius of gyration (bottom) for 












Figure S3.7. Laboratory studies of the enzyme Poly(ADP-ribose) Polymerase-1 (PARP-1). (A) The 
domain organization map of the full-length PARP-1 con- sists of six structurally independent domains all 
of which have been investigated as individuals in either NMR or crystallographic studies. The first four 
domains make up the Parp1-486 construct. (B) An image of a 12% SDS-PAGE gel con- taining samples 
of the full-length PARP-1 and the Parp1-486 proteins prior to SAXS experimentation. (C) Size-exclusion 
coupled multiangle light scattering elution profiles of the full-length PARP-1 and the Parp1-486 proteins. 
The static-light scattering derived average molecular weights are illustrated by red and blue dotted lines 




















Figure S3.9: Full-length PARP-1 centroids 4 (left) and 2 (right) in two orientations. Domain colors are: 
Zn1 blue, Zn2 green, Zn3 yellow, BRCT red, WGR purple and PARP Catalytic domain cyan. 
 
 
Figure S3.10: Full-length PARP-1 centroids 3 (left) and 1 (right) in two orientations. Domain colors are: 
Zn1 blue, Zn2 green, Zn3 yellow, BRCT red, WGR purple and PARP Catalytic domain cyan. 
 
 
Figure S3.11: Pair-distance distribution functions. Estimates of the pair-distance distribution functions 





Figure S3.12: Theoretical scattering curves for the Parp1-486 c1 centroid using our coarse-grained model 
and the full-atom resolution CRYSOL and FoXS meth- ods. Experimental input curve is shown for 
comparison in black and χ2 values between the experimental and back-calculated curves are included (see 
legend, upper right corner). 
 
 
Figure S3.13: Theoretical scattering curves for the Parp1-1014 c4 centroid using our coarse-grained 
model and the full-atom resolution CRYSOL and FoXS methods. Experimental input curve is shown for 
comparison in black and χ2 values between the experimental and back-calculated curves are included in 









 This chapter is a peer reviewed journal article and it was accepted for publication in the Journal 
of Molecular Biology in 2010.  Wayne Lilyestrom PhD designed and implemented the experimental 
direction of the research.  I contributed my expertise in protein expression and high-quality protein 
purification.  Additionally, I performed some of the biophysical analyses such as size-exclusion 
chromatography-coupled multi-angle light scattering and was in attendance for several of the late night 
SAXS data collection sessions at two synchrotron light sources.  This chapter of the thesis served as a 
means to train me in the many structural biology and biochemical techniques that would later serve me 
during my own research on the full-length PARP-1 and its complexes with chromatin and DNA substrates 




The enzyme Poly (ADP-Ribose) polymerase-1 (PARP-1) is a global monitor of chromatin 
structure and DNA damage repair.  PARP-1 binds to nucleosomes and poly (ADP-ribosylates) histones 
and several chromatin-associated factors to expose specific DNA sequences to the cellular machinery 
involved in gene transcription and/or DNA damage repair. While these processes are critical to genomic 
stability, the molecular mechanisms of how DNA damage induces PARP-1 activation are poorly 
understood. We have used biochemical and thermodynamic measurements in conjunction with small 
angle X-ray scattering to determine the stoichiometry, affinity and overall structure of a human PARP-1 
construct containing the entire DNA binding region, the zinc-ribbon domain and automodification 
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domains (residues 1-486).   The interaction of this PARP-1 protein construct was evaluated with three 
different DNA damage models (DNA constructs containing a nick, a blunt end or a 3’-extension).  Our 
data indicates that PARP-1 binds each DNA damage model as a monomer, with similar affinity, and in all 
cases results in robust activation of the catalytic domain.  Using SAXS, we determined that the N-
terminal half of PARP-1 behaves as an extended and flexible arrangement of individually folded domains 
in the absence of DNA.  Upon binding DNA, PARP-1 undergoes a conformational change in the area 
surrounding the zinc-ribbon domain. These data support a model in which upon binding DNA, PARP-1 




The enzyme Poly (ADP-Ribose) polymerase-1 (PARP-1) is a global monitor of chromatin 
structure and DNA damage.  PARP-1 is a member of the large family of enzymes, which are defined by 
the PARP signature sequence, a 50-amino acid sequence within each member’s enzymatic domain [23].  
Several of the PARP proteins catalyze the cleavage of NAD+ into nicotinamide and ADP-ribose, using the 
latter to synthesize branched molecules of poly(ADP-ribose), a substrate that is covalently attached to a 
variety of nuclear proteins.  In eukaryotes, members of the PARP family are best noted for their roles in 
DNA repair, chromatin remodeling and transcriptional regulation of a variety of genes [23].   
PARP-1 is a highly conserved enzyme present in higher eukaryotes and Archaea[201] and is 
responsible for synthesis of the majority of poly(ADP-ribose) (PAR) within eukaryotic cells.  Although 
typically highly expressed at the protein level (200,000-1 million copies per cell [103]), PARP-1 
enzymatic activity is tightly regulated in the absence of genomic stress [202-205]. Under normal 
conditions, PARP-1 is found associated with histones, DNA and other chromatin associated factors [109, 
206].  In response to DNA damage, PARP-1 enzymatic activity is stimulated 10-500 fold.   This results in 
the poly ADP-ribosylation (PAR) of many target proteins including itself, core histones, linker histone H1 
and transcription factors.  The negative charge associated with PAR renders the target proteins unable to 
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associate with DNA and allows exposure to the cellular DNA repair machinery [109].  Interestingly, the 
PAR moiety itself is bound and hydrolyzed by many other enzymes including macro domain proteins and 
glycohydrolases [3,7,13,31]. 
While these processes are critical to genomic stability, the molecular mechanisms of how DNA 
damage induces PARP-1 activation are poorly understood. Due to the specificity of PARP-1 for non-B-
DNA[207], we hypothesize that the location and orientation of PARP-1 when it is bound to damaged 
DNA is critical for subsequent activation of the PARP-1 enzymatic domain. 
Human PARP-1 is a modular protein organized into at least 6 domains [47] (Figure 4.1).  Its 
affinity for damaged DNA is regulated by two unique zinc-finger motifs (CX2CX28-30HX2C) (residues 1- 
209; referred to as zf-PARP), which are sufficient to target the entire protein to damaged DNA [140, 208].  
Recently, comparative analysis has defined the zf-PARP fold as an exceptional zinc-finger domain 
composed of a hydrophobic core with three conserved beta-sheets and two terminal alpha helices16.  All 
zf-PARP family members contain two variable loop regions bridging β2-β3 and α1-α2 that may play a 
role in determining DNA structure specificity [207].  Proteins with the zf-PARP fold are evolutionary 
conserved in the eukaryotic lineage and are associated with many nuclear enzymes outside of the PARP 
protein family.  None of the zf-PARP fingers are known to have sequence specificity, but instead seem to 
recognize many different DNA structures such as stem-loops, cruciforms, nicked DNA and 3’-extensions.  
The two PARP-1 zf-PARP domains are known to recognize DNA nicks, overhangs, blunt ends and other 
forms of damage [208-211].  Thus zf-PARP differ both structurally and in their DNA binding specificity 
from the abundant and well-studied family of sequence specific C2H2 zinc fingers [207].  However, little 
is known about the interactions of zf-PARP fingers with DNA [207]. 
Two recent publications have defined a third zinc domain in human PARP-1 [47, 48].  This zinc 
ribbon domain resides between residues 233-273 of the protein.  Although the zinc ribbon domain does 
not bind DNA on its own, it is necessary for DNA stimulated activation of the full-length enzyme[47].   
This has lead to speculation that this domain modulates the N-terminal to C-terminal communication 
(possibly through a conformational change) that leads to DNA dependent activation of PARP-1 [47, 48].  
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Nevertheless, in the absence of multidomain PARP-1 structures, no direct evidence of a DNA dependent 
conformational change has been noted.  Moreover, information on length requirements, affinity, 
stoichiometry and mode of interaction of the DNA sensing region in this abundant enzyme with various 
DNA damage models is lacking.  Here, we characterize a highly purified fragment of human PARP-1 
encompassing the entire DNA binding region, the zinc ribbon domain as well as the auto-modification 
domain (BRCT), with defined DNA damage models.  The BRCT domain of PARP-1 is conserved with 
the BRCA-1 C-terminal region and is thought to function as a protein-protein interaction module. The 
structure and function all known human PARP-1 domains are reviewed in1.  The PARP-1 construct used 
in this manuscript was designed based on known domain structures Zn1, Zn2, Zn3 and BRCT (residues 1-
486, from now on referred to as hparp486) (pdb IDs: 2dmj, 2cs2, 2jvn, 2cok) (Figure 1A).  We find that 
hparp486 is a monodisperse monomer in solution on its own as well as in complex with blunt ended, 
nicked, or 3’-overhang DNA.  Control experiments indicate that full length PARP-1 is activated to 
similarly high levels by the different DNA damage model substrates.  Small angle X-ray scattering was 
used to determine the overall shape of hparp486 on its own and in complex with these DNA fragments.  
Distance distribution functions and ab initio particle reconstructions created from the SAXS data suggest 
a conformational change occurs in the zinc ribbon domain of the extended polypeptide chain upon DNA 
binding.   
 
Materials and Methods 
 
Cloning, expression and purification of hparp486:  
DNA encoding the first 486 residues of human PARP-1 (codon optimized for E. coli) was cloned 
into the pET28a vector system (Novagen).  hparp486 was expressed (via IPTG induction) in E. coli BL21 
(DE3) (Novagen) for 6 hours at 25°C.  Following cell lysis, the protein was bound to a Nickel-NTA fast 
flow column (Qiagen) and washed with 3 volumes of resuspension buffer prior to being eluted with 300 
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mM imidazole.  hparp486 was further purified by S200 size exclusion and Hitrap SP cation exchange 
columns (GE Healthcare). 
 
Cloning, expression and purification of Hparp209:   
The DNA sequence encoding the first 209 residues of human PARP-1 (codon optimized for 
insect cells) were cloned into pAB-GST (AB-Vector) baculovirus transfer vectors and co-transfected with 
linearized Pro-fold C1 (AB-Vector) baculovirus DNA.  The transfected virus was expanded and plaque 
assays were used to determine the isolates that best expressed hparp209.  The resulting infectious viruses 
express hparp209 under the control of the very-late Polyhedron promoter.   One liter of SF9 insect cells 
were grown to a density of 1x106 cells/ml in Ex-cell 420 serum free media (Sigma-Aldritch) and infected 
with an MOI of 3:1 for 72 hours at 28° C.  At this point cell pellets were spun down and frozen at -20°C 
until further use.  Upon thawing, the cell pellets were resuspended in lysis buffer (25 mM Tris HCl, 200 
mM NaCl) and sonicated for 2 minutes.  The suspension was spun at 10,000 g for 20 minutes and the 
supernatant was incubated with 10 mls of a Glutathione resin slurry (Qiagen) for 1 hour before washing 
with 50 mls of lysis buffer.  The GST moiety was removed by incubating the protein with 100 units of 
PreScission Protease (GE Healthcare) overnight while rocking at 4°C.  The protein was purified to 
homogeneity by HPLC chromatography over a Heparin HP ion exchange column. The protein bound at 
pH 7.0, 100mM NaCl and was eluted at pH 7.0 300mM NaCl (GE Healthcare).  Size exclusion 
chromatography (S200; GE Healthcare) was used as a final purification step.  The resulting protein 
preparation yields approximately 2.5 mg of hparp209 per liter of culture and the protein was stable for 
several weeks at a concentration of 1mg/ml when kept at 4°C.     
 
Light Scattering Measurements:   
 
2mg/ml samples of either hparp486, DNA or the hparp486-DNA complex in 75 mM Tris/HCl pH 
8.0, 300 mM NaCl and 1 mM TCEP were loaded onto an ÄKTA purifier HPLC system.  Samples were 
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characterized over a SHODEX-803 size exclusion column at a flow rate of 0.5 mls/minute prior to 
flowing into an online Dawn Heleos II (Wyatt Technologies) multiangle light scattering instrument 
followed by a REx refractive index detector (Wyatt Technologies).  A differential index of diffraction 
(dn/dc) value of 0.185, 0.170, 0.180 were used to determine the concentration of hparp486, DNA and the 
hparp486-DNA complex respectively.  
 
Analytical ultracentrifugation:  
 
Samples were dialyzed extensively against 25 mMTris pH 8.0, 200 mM NaCl and 1 mM TCEP 
prior to sedimentation.  All experiments were performed in a Beckman XL-I using the absorbance optical 
system and a 4-hole, AN60-Ti rotor.  Sedimentation velocity (SV) was performed in a 1.2 cm, 2-sector 
EPON centerpiece, while sedimentation equilibrium (EQ) was performed in a 1.2 cm, 6-sector 
centerpiece.  For SV, 400 µl samples of hparp486 were sedimented at 50,000 rpm for 4 hours at 20°C, 
with a radial step size of 0.002cm in the continuous scanning mode.  For EQ, 100 µl, samples were spun 
to equilibrium at 17,000, 24,000, 30,000 and 35,000 RPM.   
 
DNA oligomer preparations: 
 
  The oligomer sequences for the 30Ext primer were 5’-
ATCAGATAGCATCTGTGCGGCCGCTTAGGGTTAGGG-3’ for the overhang strand and  5’-
CCCTAAGCGGCCGCACAGATGCTATCTGAT-3’ for the shorter strand.  Other DNA constructs were 
generated by adding or deleting nucleotides from the 3’ region for the sequences shown above. Oregon 
Green labeled 3’- and 5’- labeled and unlabeled sequences were ordered from IDT DNA.  Various 3’ 
overhangs, nicked and blunt ended double stranded DNAs were created by annealing equimolar amounts 
of oligomer.  To anneal DNAs, the oligomer were mixed in an Eppendorf tube that was inserted in a 1 
liter boiling water bath for 5 minutes, then allowed to cool to room temperature over night.   
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Mobility shift assays:  
 
Protein-DNA complexes were assayed for homogeneity and stoichiometry by analyzing their 
mobility on 0.8-1.2% native agarose gels stained with Coomassie blue and ethidium bromide to visualize 
protein and DNA respectively.  Low EEO agarose was obtained from Fisher.  Gels were run in 25mM 
Tris pH. 8.0, 20 mM Glycine, at 60 volts for 60 minutes at 4°C.  
 
Thermodynamic Measurements:  
 
Affinity measurements of human parp486-DNA complexes were carried out in the Perkin Elmer 
Victor 3V plate reader.  Corning 384 well non-binding polystyrene plates were used to minimize 
nonspecific binding of the protein complex to the chamber surfaces.  In these experiments, human 
parp486 and DNA were resuspended into 75 mM Tris pH 8.0, 300 mM NaCl and 1 mM TCEP.  2 nM 
Oregon Green labeled DNA, 0.005-6µM PARP was added to each sample.  The fluorophores were 
excited at 488 nm and the quenching of fluorescence at 530 nanometers was monitored.  Triplicate 
samples were averaged and plotted with Kaleidagraph.  
Equation 1:   
Data were fit to Equation 1, derived from reaction scheme 1 (see text) to the normalized fraction 
quenched (F.C.) which was observed as a function of P, where Pt is the total concentration of protein 
titrated, NH is the Hill coefficient, and Kd is the apparent dissociation constant. The NH was assumed to 
be one unless the data dictated otherwise. 
 
Small Angle X-ray Scattering:  
 
Norm.F.C. = F.C max Pt
NH






SAXS data for human parp486, DNA constructs and their complexes were measured at the 
SIBYLS beamline (12.3.1) at the ALS using a Mar CCD area detector (165 mm diameter) at room 
temperature.  The intensity curves were measured at concentrations of human parp486 at 9mg/ml, 
6mg/ml, and 3mg/ml; DNA samples at 6mg/ml and 3mg/ml; and human parp486-DNA complex samples 
equal to 6mg/ml and 3mg/ml. Data images were subjected to circular integration, normalization, and 
subtraction of sample and buffer image files. The Rg for each particle was approximated using PRIMUS 
(Kovnarev et al., 2003) to evaluate the Guinier equation and GNOM (Svergun, 1992) to evaluate the P(r) 
function. The value of the maximum diameter of the particle, Dmax, was determined empirically by 
examining the quality of the fit to the experimental data for a range of Dmax values.  
Ab initio particle reconstructions were built by the program DAMMIN [212]. For each final 
model, thirty independent DAMMIN reconstructions were aligned and averaged with the programs 
DAMAVER and SUPCOMB to reduce the likelihood that the models represent local minima [213, 214].    
The most typical averaged model was filtered to an appropriate volume with the program DAMFILT.   
In an independent approach, a model of human parp486 in solution was generated by rigid-body 
refinement from the high-resolution structures of the individual domains, obtained from the Protein Data 
Bank. The program SASREF [215] uses simulated annealing to find an optimal configuration of the 
domains by simultaneous fitting of the SAXS data to a model consisting of the coordinate files from Zn1, 
Zn2, Zn3 and BRCT domains (PDB entries 2dmj, 2cs2, 2jvn, 2cok, respectively). The coordinate files 




hparp486 is an elongated monomeric particle in solution 
An N-terminally 6X His-tagged fusion construct of hparp486 was expressed in E. coli and 
purified to homogeneity.  Purified hparp486 elutes in a single peak from a SHODEX-803 gel filtration 
column and SDS-page analysis reveals that the protein is ~95% pure (Figure 4.1B).  Static light  
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Figure 4.1. hparp486 is a monomer in the absence of DNA. A)  hparp486 was designed to include the 
entire DNA binding region of the human PARP-1 protein. The first 486 residues encompass the three N-
terminal Zn domains and the BRCT domain.  The illustration indicates the C-terminal residue of each 
domain.  B) Top: Size exclusion chromatography and inline static light scattering of hparp486.  hparp486 
elutes in a single peak from a KW803 size exclusion column.  The static light scattering average 
molecular weight (~57kDa) for the central portion of the peak is illustrated by the black dotted line within 
the peak. Bottom: SDS-PAGE analysis of fractions from SEC purified hparp486.  C) The sedimentation 
velocity profile of purified are presented as G(s) plots of the integral of S20,w against boundary fraction 
(%). van Holde - Weischet analysis was used to determine the f/f0 value of 1.8.  D) Sedimentation 
equilibrium ultracentrifugation resolved that over 95% of the purified protein was monomeric at a 







scattering measurements determined that the purified protein is a monomer with a molar mass of ~57 kDa 
at concentrations exceeding 2 mg/ml (Figure 4.1B).  Sedimentation velocity experiments determined that 
hparp486 sediments as a single species of elongated character with an anhydrous frictional ratio (f/f0) = 
1.8 (Figure 4.1C).  Further sedimentation equilibrium experiments demonstrate that hparp486 has a 
molecular mass of 55 – 60 kDa (Figure 4.1D).  These results are in excellent agreement with the 
calculated mass of a hparp486 monomer, 56.480kDa. Small angle X-ray scattering (SAXS) is an effective 
method for determining the low-resolution (>10Å) structures of proteins, nucleic acids and their 
complexes in solution at reasonably low concentrations.  After an overall SAXS envelope is determined, 
hybrid methods can be applied to fit domains of known structure within the SAXS envelope [216].  
SAXS data were collected on hparp486 at 3, 6 and 9 mg/ml and the scattering curves were overlaid to 
determine any concentration-dependent effects. To determine the relative amount of folded domains and 
any aggregation within the hparp486 sample, the data were plotted in a Kratky plot and analyzed by 
Guinier approximation respectively (Supplemental Figure 4.1).  From this preliminary analysis we 
determined that the data were deemed of sufficient quality to use the scattering profiles up to 
qmax=0.205Å-1 (where q is the scattering vector).  For hparp486, the radius of gyration varies with 
increasing concentration in the range Rg ~46-48Å (Table 4.1).  Further analysis of the hparp486 
scattering data determined that the particles in solution do follow Porod’s law, reviewed in [214].  Thus 
their volume can be calculated from their scattering profile.  We established that hparp486 occupies 
~103,770 Å3 and has a molecular weight of ~54 kDa (Supplemental Figure 4.1).  This is in good 
agreement with values that were determined for hparp486 by AUC (~60 kDa) and classical light 
scattering at lower concentrations (~57kDa; figure 4.1).  Thus, hparp486 exists as a monodisperse 
monomer over a wide range of concentrations  (3-9mg/ml). 
Additional information can be extracted from well-behaved SAXS data.  The GNOM program 
[217] calculates pair distance distribution functions (denoted as P(r)) from scattering data using an 




Figure 4.2.  The low resolution structure of hparp486 reveals a molecule with conformational 
flexibility. A) Superposed experimental and modeled distance distribution functions of hparp486.  In 
blue, the SAXS distance distribution function P(r) for hparp486 is an asymmetric curve with two discrete 
maxima, representing two ordered regions connected by a flexible linker.  The relatively shallow decent 
towards a maximum size of 150Å is reflective of an elongated, flexible molecule.  Illustrated in violet, is 
the P(r) function resulting from the SASREF tertiary model shown in (B).  B) Superposed particle 
reconstructions and tertiary structure models of hparp486.  The DAMMIN particle reconstruction (grey) 
represents the filtered average of 30 models individually computed from a SAXS scattering curve and fits 
the SAXS scattering curve with a χ2 of 1.10. The SASREF tertiary structure model was computed by 
global rigid body modeling of the known domain structures of Zn1 (PDB id 2dmj, blue), Zn2 (PDB id 
2cs2, green), Zn3 (PDB id 2jvn orange) and BRCT (PDB id  2cok, red) with steric restraints against the 
solution scattering data; this model has a χ2 of 1.21.    In the orientation shown, the two models have a 
correlation coefficient of 0.56, while a 180˚ rotation of the polypeptide resulting in a switch in position of 
Zn1 and BRCT domains has a correlation coefficient of 0.54. The SASREF model illustrates the extended 














Table 4.1.  Overall dimensions hparp486, DNA and hparp486-DNA complexes.  Molar masses were 
obtained by SEC-MALS, radii of gyration (Rg) and maximum dimension (Dmax) were obtained from 
SAXS.   The calculated molar masses of each molecule and a 1:1 complex of hparp486-DNA are in the 
second column. The SEC-MALS determined mass listed in the third column.  The radius of gyration (Rg) 
for each molecule at the lowest concentration tested (3 mg/ml) while the highest concentration (9 mg/ml 
for hparp486 and 6 mg/ml for all other samples) are listed in the fourth and fifth columns respectively.  
The last column contains the maximum dimension for each molecule as determined by SAXS. Variation 






SAXS Rg (Å) 
[3mg/ml] 
SAXS Rg (Å) 
[6 or 9 mg/ml] 
SAXS 
Dmax(Å) 
hparp486 56.0 54.4±0.1% 46.3 48.3 150 
Hparp209 23.0 22.5±3% 29.0 29.5 115 
30Nick 18.4 22.8±5% 26.9 28.6 90 
30Blunt 18.4 22.0±2% 28.2 28.5 88 
30Ext 20.2 21.2±0.1% 30.2 29.8 100 
hparp486-
30Nick 
74.4 83.5±6% 63.5 64.2 195 
hparp486-
30Blunt 
74.4 70.0±6% 76.5 78.7 240 
hparp486-
30Ext 
76.3 71.3±1% 63.5 63.0 195 
Hparp209-
30Blunt 






(Figure 4.2A).  This is characteristic of two distances appearing with a higher probability, and indicates a 
macromolecule composed of at least two ordered domains connected by a flexible linker.  Additionally, 
the P(r) function shows a shallow descent between 125 and 150Å, which is the signature of an elongated, 
flexible particle. 
Two models of hparp486 were independently calculated with the programs DAMMIN and 
SASREF [212, 215].  The DAMMIN program was used to calculate 30 ab initio models that fit the SAXS 
scattering profile of hparp486 with a χ2=1.0-1.1. A superposition of 5 randomly chosen models is shown  
in supplemental figure 4.2.  The filtered, averaged envelope of the 27 most similar models has a 
maximum dimension (Dmax) of ~148Å and forms an overall S-shaped structure (Figure 4.2B).  Most 
residues (432 of 486, or 90%) within the N-terminal half of PARP-1 are represented in one of four 
domains previously deposited in the Protein Data Bank (PDB IDs: 2dmj, 2cs2, 2jvn, 2cok).  The SASREF 
program performs tertiary structure modeling by reconstructing all or parts of the SAXS model from 
domains of known structure. The PARP-1 domains were trimmed of extended linkers and subjected to N-
C terminus distance restrictions that limited overlapping regions and minimized steric restraints during 
the modeling process.  The domain definitions and optimized restrictions are summarized in the Materials 
and Methods section.  The SASREF model has a Dmax of ~140Å and fits the hparp486 P(r) function with a 
χ2=1.21 (Figure 4.2A).  The DAMMIN and SASREF models superpose well (Figure 4.2B), and it is 
clear that they both represent an overall S-shaped elongated molecule.    
 
The hparp486 interacts with damaged DNA as a monomer 
 
Previous biochemical studies have monitored the interaction of truncated PARP-1 constructs with 
55 base pair DNA fragments[210, 211].  We initially assayed the association of hparp486 to a 53 base 




Figure 4.3.  hparp486 binds as a monomer to damaged DNA.  A) EtBr and Coomassie stained 1% 
agarose gel EMSA assay of hparp486-DNA complexes.  1µM DNA was added to each lane.  In this 
assay, all DNA constructs contain a 6-nucleotide 3’ extension, but vary in the length of the double 
stranded region (21-30 base pairs).  hparp486 forms homogenous complexes as the DNA approaches 27-
30 base pairs in length.  B) A schematic representation of the three DNA damage models tested and the 
location of the fluorophores (green asterisk) used in this publication.  Varying the fluorophore position 
(either in position A or B) allowed us to test the effect of its position on hparp486 association. The arrow 
and red region highlight the area of the single stranded break in the 30Nick DNA, while the orange area 
highlights the 6 nucleotide 3’ extension in 30Ext.  C) EMSA of hparp486 association with 2µM 
fluorescently labeled 30Blunt, 30Nick and 30Ext DNA. hparp486 efficiently shifts the mobility of over 
90% of each DNA at a 1:1 ratio, eliminating the possibility of cooperative dimerization under these 
conditions.  D) Cumulative molar mass of DNA, hparp486 and hparp486-DNA complexes as determined 
by SEC-MALS.   2:1 molar ratios of hparp486:DNA were incubated for 30 minutes prior to subjecting 
the mixtures to SEC-MALS.  The distribution of masses present in the major peaks eluting from the 
column for DNA, hparp486 or each hparp486-DNA complex is plotted as a fraction of cumulative 
molecular weight.  hparp486 does not stably dimerize on any DNA fragment.  Supplemental Figure 4 
contains the elution profiles for each solution.    
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form either 1:1 or 2:1 complexes with this DNA at hparp486:DNA ratios between 0.5:1 and 2:1 
(Supplemental Figure 4.3).  Therefore, we first set out to determine the base pair length requirements 
needed to promote stable binding in order to investigate whether hparp486 binds DNA as a monomer or 
dimer.  We used an agarose gel-based mobility shift assay in which we visualize the homogeneity of 
various hparp486-DNA complexes.  Shown in Figure 4.3A is the effect of double-stranded DNA length 
on the homogeneity of complexes formed between hparp486 and DNA containing 6-nucleotide 3’-
overhangs.  As the double-stranded DNA length approached 27-30 base pairs, the complex migrates as a 
sharp single band when visualized by both EtBr and coomassie stains as opposed to a weaker, more 
diffuse shifting pattern observed with shorter DNA.  We concluded from the mobility-shift assay that a 30  
base pair double helical region is sufficient to stably bind hparp486 when a 6-base 3’-overhang is present.  
In order to determine how hparp486 interacted with other forms of DNA damage, we continued the 
remainder of our experiments to compare DNA of the same base pair length, but with varying ends (blunt 
ends, and nicked DNA). 
To determine the stoichiometry of the various hparp486-DNA complexes, we used 2 µM 
fluorescently labeled DNA in an EMSA to quantify the ratio at which all DNA formed a complex with 
hparp486.  DNA molecules with a single label at either location A or B were designed for the purpose of 
testing the stoichiometry and affinity of hparp486 association (Figure 3B).  We determined by EMSA 
that when using 30 base pair DNA, hparp486 forms homogeneous 1:1 complexes irrespective of nicks, 
extensions or blunt ends (30Ext, 30Nick, and 30Blunt; Figure 3C).  The addition of hparp486 past a 1:1 
protein to DNA molar ratio resulted in the retention of both protein and DNA within the wells irrespective 
of the length of time the gel was run.  This may represent either aggregation or a low affinity, possibly 
anti-cooperative dimerization of hparp486 on these DNA fragments.  To overcome the limitation of the 
mobility shift assay, we confirmed the stoichiometry of hparp486 on DNA in solution by Size Exclusion 
Chromatography in conjunction with Multi Angle Light Scattering (SEC-MALS).  A 2:1 mixture of 













Table 4.2.  SASREF domain definitions and distance restrictions. The solution structures for 
the human PARP-1 domains Zn1, Zn2, Zn3 and BRCT (PDB entries 2dmj, 2cs2, 2jvn, 2cok, 
respectively) were truncated of N- and C-terminal flexible regions prior to tertiary model 
reconstruction by the program SASREF.  The residues included and C-terminal distance 
restrictions used in the tertiary model are listed for each domain.  
  
Domain Modeled Residues C-term distance restriction 
Zn1 1-193 20Å 
Zn2 103-207 7Å 
Zn3 225-359 30Å 












molecular weight for macromolecules within each peak eluting from the SEC column was calculated from 
the MALS data.  hparp486 has a molar mass of ~56 kDa while each DNA is ~20 kDa, thus 1:1 complexes 
should be ~76 kDa, while a 2:1 complex would be ~133 kDa. SEC-MALS determined the molar masses 
for the hparp486 in complex with 30Ext, 30Blunt and 30Nick were 71.3, 74.4 and 84.5 kDa respectively; 
no evidence for a 2:1 complex was detected (Table 4.1).  In line with this result, the cumulative weight 
fraction and molar mass vs. volume profiles determined from the SEC-MALS experiments both illustrate 
the presence of a significant amount of free hparp486 in solution (Figure 4.3D, Supplemental Figure 
4.4).   
We next determined the affinity of hparp486 for the 30 base pair DNA damage models by 
monitoring the quenching of the fluorescence of labeled DNA molecules in solution. Using Equation 1 
(materials and methods) we fit the single-step scheme   (scheme 1, P= hparp486, 
D=DNA K1=Kd) to the experimental data obtained for each protein-DNA complex.  We determined that 
under uniform conditions, hparp486 associates with 30Ext ≈ 30Nick (Kd of ~100nM) > 30Blunt (Kd of 
~300nM), when they all contain the same 30bp ‘DNA core’ (Figure 4.4A, Table 4.3).  To minimize the 
possibility of the fluorophore interfering with protein – DNA interactions, we repeated the experiment 
with 30Ext with the fluorophore at multiple locations without a significant change in affinity (Table 4.3).  
However, when the 30Nick DNA was labeled at position A, interacting with hparp486 did not result in 
sufficient quenching of fluorescence (8%) to determine the Kd (Table 4.3).  Thus hparp486 does not 
change the environment of the fluorophore at the blunt end when it associates with the region surrounding 
the nick.  We determined that hparp486 associates with each DNA with a Hill coefficient of 0.92-0.99, 
reflecting the lack of a cooperative association between the protein and any of these DNA damage models 
(Table 4.3, Supplemental Figure 4.5), and further supporting the notion that hparp486 binds as a 
monomer.   
hPARP-1 is activated by DNA containing nicks, 3’-extensions and blunt ends  
The hPARP-1 enzyme is stimulated 10-500 fold upon binding damaged DNA [218].  We used a 
P + D
K1⎯ →⎯← ⎯⎯ PD
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Figure 4.4.  hparp486 has similar affinities for different forms of DNA damage; full-length human 
PARP-1 is efficiently activated by DNA containing blunt ends, nicks or a 3’-extension.  A) The 
affinity of hparp486 for fluorescently labeled 30 base pair DNA: 30Blunt (red), 30Nick (green), 
30Ext(red) was determined by measuring the change in fluorescence of 2nM labeled DNA as a function 
of hparp486 concentration (0.5-6000nM) in solution.  The affinity of hparp486 each DNA is shown in 
Table 3 and is in the range of ~70-300nM.  The Hill coefficients calculated for each fluorescent titration 
were in the range of 0.92-0.99, demonstrating the lack of positive cooperativity in the individual 
interactions (Table 4.3).   B) The ability of each DNA to activate full-length human PARP-1 was tested 
with a commercial assay that monitors the incorporation of biotinylated ADP-ribose onto immobilized 
histones.  The activation induced by 1µM of 30Blunt, 30Nick or 30Ext DNA was normalized to the 
activity stimulated by sheared salmon sperm DNA.  Regardless of the DNA damage model tested, PARP-
1 was ~40 fold more active than in the absence of DNA. 
 
 
Table 4.3.  The affinity of hparp486 for blunt, nicked and 3’-extension DNA.  The percent 
fluorescence quenched, affinity (Kd) and Hill coefficient determined from the interaction of hparp486 
with fluorescently labeled blunt ended, nicked or 3’-extension DNA are listed.  The DNA constructs were 
either labeled in Position A or B, as illustrated in Figure 3B.  Because of its pseudo symmetry, the 
30Blunt construct was only labeled in one location.    
 
DNA Type Fluorescence Quenched Affinity (Kd) Hill Coeff. 
30Blunt 33% 2.82x10-7±4.0x10-8 0.9206 
30Nick (pos. B) 44% 1.46x10-7±2.0x10-8 0.9670 
30Nick (pos. A) 8% ---- ---- 
30Ext (pos. B) 35% 1.30x10-7±1.3x10 -8 0.9904 
30Ext (pos. A) 19% 6.80x10 -8 ±6.0x10-9 0.9802 
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chemiluminescent hPARP-1 assay kit (Trevigen Inc.) to measure hPARP-1 activity in the presence of the 
various 30 base pair DNA fragments tested above. This assay measures the incorporation of biotinylated 
Poly (ADP-ribose) onto histone proteins in a 96-well plate format.  30Ext, 30Nick and 30Blunt DNA 
were each able to stimulate hPARP-1 ~40 fold over the basal activity in the absence of DNA and to the 
same level as sheared salmon sperm DNA (Figure 4.4B).  
 
DNA binding induces conformational changes in hparp486 
We used SAXS to obtain structural information on the various hparp486-DNA complexes.  As a control, 
we measured the scattering curves for 30Ext, 30Blunt and 30Nick DNA individually at 3 and 6 mg/ml.  
While small concentration-dependent differences in radius of gyration (Rg) were noticed, superposition of 
the SAXS scattering profiles and Guinier analysis determined the data are of good quality (Supplemental 
Figure 4.5).  Charge repulsion energies are known to affect DNA monodispersity in solution, and this 
may account for the observed concentration dependent effects [219].  The analysis of the P(r) function 
illustrates that all DNA molecules conform to a double helix in either the A or B DNA form in solution, 
within the resolution of the technique (88-100Å in length).  A comparison of the P(r) functions for all 
datasets obtained for DNA is shown in Supplemental Figure 4.6.  The DAMMIN particle reconstructions 
of each DNA molecule are illustrated in Supplemental Figure 4.7.   
Despite similarities in binding affinities, it is possible that the various DNA damage models bind 
differently to hparp486.  We collected SAXS data on hparp486 in complex with 30Nick, 30Ext or 
30Blunt DNA.  After initial protein and DNA concentrations were determined, each complex was further 
titrated to homogeneity as determined by mobility shift assays.  SAXS data for hparp486 in complex with 
various DNA fragments were initially analyzed the same way as was done for data from hparp486 or 
DNA fragments alone: The dependence of the nature of scattering on concentration was studied by 
comparing scattering profiles (Supplemental Figure 4.8A), the scattering behavior at low angle was 




Figure 4.5.  The distance distribution functions of hparp486-DNA complexes portray a 
conformational change within hparp486 upon binding DNA.  A) The P(r) functions of 30Blunt (dotted 
line), hparp486 (blue) and a 1:1 complex of hparp486-30Blunt complex (green).  Upon binding 30Blunt, 
the profile of hparp486 in complex changes significantly when compared to the normalized profile of 
hparp486 in the absence of DNA.  In particular, interacting with DNA changes the P(r) function from two 
discrete maximum of similar height to a single dominant maximum of 240Å, reflecting an increase in 
Dmax of 90Å over hparp486.  We interpret this to represent a migration from a conformation containing 
two ordered regions connected by an internal flexible linker to an elongated, dynamic complex that does 
not have an internal highly flexible region.  B) The P(r) function of zf-parp (blue), 30Blunt (dotted line) 
and a 1:1 complex of zf-parp-30Blunt.  In contrast to hparp486, the P(r) function of zf-parp is 
characterized by a distinct single maxima, which reflects the lack of a high degree of internal flexibility. 
Upon binding 30Blunt DNA, no evidence of a conformational change is noted and with a maximum 
dimension of 180Å, the complex reflects an increase in size of only 65Å.  C) The SAXS scattering 
profiles of solutions containing 1:1 ratios of hparp486 in complex with 30Blunt, 30Nick or 30Ext DNA 
were analyzed to determine the general shape and size of the complexes (green, blue, orange 
respectively).  The P(r) functions of the complexes illustrate that hparp486 forms complexes of similar 
maximum size with 30Nick and 30Ext DNA (~200Å), but forms a much longer complex with 30Blunt 






representing the data in a Kratky plot (Supplemental Figure 8B) and the pair distance distribution 
functions were determined by indirect Fourier Transform (Figure 4.5). The results show that there is  
minimal concentration dependence for the SAXS data; the Kratky plot is typical for partially flexible 
molecules. 
The SAXS scattering curves for each hparp486-DNA complex are depicted in Supplemental 
Figure 4.8.  The P(r) functions hparp486, 30Blunt and the hparp486-30Blunt complex allowed us to 
qualitatively compare the overall shape of particles in solution and quantitatively compare Rg and Dmax  
values with the relatively rigid DNA fragment (Figure 4.5).  A comparison of the P(r) functions indicates 
a significant change in the particle nature upon binding of hparp486 to 30Blunt DNA.  hparp486 alone 
consists of at least two folded domains (of ~40 and 60 Å in size) connected by a flexible linker.  On the 
other hand, the P(r) function of hparp486-30Blunt DNA is distinct in almost all of its characteristics when 
compared to hparp486 on its own (Figure 4.5A).  This profile has a sharp maximum at ~100Å and a Dmax 
of 240Å (an increase of 90Å over hparp486 on its own).  In contrast to the double maxima of the 
hparp486, the P(r) function of the complex contains a single maximum, which could be reflective of a 
structural change within the protein that occurs upon binding DNA.   
To identify if the changes in the P(r) function were reflective of a conformational change-taking 
place in the Zn3-BRCT region of the protein, we repeated the experiment using the zinc finger region of 
PARP-1 (residues 1-209, referred to as hparp209).  We found hparp209 behaved as a homogenous 
monomer by SEC-MALS (Supplementary Figure 9A), and bound 30blunt DNA as a monomer by 
mobility shift assay (data not shown).  The raw SAXS scattering profile and Kratky plot of hparp209 are 
shown in Supplementary Figures 9B-C.  The P(r) function of hparp209 contains a single discreet 
maximum and a smaller shoulder peak at ~50Å in size (Figure 4.5B).  Particle reconstructions of 
hparp209 clearly depict a flexible terminal region of the protein, but otherwise superimpose well with 
each other (supplementary figure 4.9D).  The hparp209-30Blunt complex maintains the same overall 
profile as hparp209 on its own but only increases in size by 65Å to a Dmax of 180Å (Figure 4.5B).  Thus, 
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in the absence of Zn3-BRCT, hparp209 retains the ability to interact with DNA, but does not retain the 
characteristic change in shape that we identified in hparp486.   
 Inspection of the P(r) function allows us to compare the complex formed between 
hparp486, 30Ext, 30Nick DNA and 30Blunt (Figure 4.5C).   We determined a similar Dmax for the 
30Nick and 30Blunt complexes, but note some differences in the profile of the P(r) function for each 
complex.   We found that both particles have a Dmax of ~190-210Å and exhibit an overall elongated shape.  
Similarly, both complexes have a broad peak in the P(r) plot with a maximum at ~80-100Å in size. At 
approximately 190-210Å in Dmax, these complexes are ~20% shorter than the sum of Dmax obtained for 




The specific molecular mechanisms that lead to PARP-1 enzymatic activation in the presence of 
DNA damage have yet to be identified.  Our understanding of the enzymatic complexity of PARP-1 relies 
not only on the structure and function of individual domains, but requires knowledge of the inter-domain 
communications that regulate the enzyme.  Here we propose that PARP-1 zf-parp domains communicate 
the presence of DNA-damage by inducing a conformational change that leads to activation of the PARP-
1.  Additionally, we have established many basic features of DNA recognition by PARP-1 that were 
previously unknown, for example length requirements, affinity, stoichiometry, and the mode of 
interaction.        
Notably, our SAXS data have provided the first low-resolution structure of the N-terminal half of 
PARP-1 (Figure 4.2).  The most striking feature of this model is interior structural flexibility, (likely in 
the form of hinges connecting two structured domains or sets of domains), illustrated by the double 
maxima in the hparp486 P(r) function.  The region of interior flexibility is ~55Å from either the C or N-
terminus of hparp486.  After comparing the particle reconstruction, tertiary model and the dimensions of 
the individual PARP-1 domains, we propose two models for the sequences, which might constitute the 
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hinge region.  The first would be a region immediately following the second zinc finger domain (residues 
~208-220).  The distance across the zinc-binding face of the first two zinc finger domains is ~25Å, and 
when including a small linker region between the domains the total distance between the N-terminus of 
zinc finger 1 to the C-terminus of zinc finger 2 is ~50-60Å.  An alternative model places the hinge region 
between residues 370-385.  This region is ~55Å away from the BRCT domain C-terminus in the 
hparp486 SASREF model.  Interestingly, either model supports the notion that the zinc ribbon domain 
functions to relay the DNA damage signal from the zf-PARP region to the enzymatic domain.  Moreover, 
both models are supported by the P(r) function of hparp209, which does not contain this interior flexible 
region.   
 We found that PARP-1 has similar affinities for the three DNA damage forms tested.  This may 
be a result of PARP-1 having evolved as a general sensor of DNA ends and not as a specialized ‘nick’ 
sensor.  The ~3 fold reduced affinity of PARP-1 for blunt ended DNA may be due to the increased 
rigidity of this DNA fragment, as two zf-PARP containing enzymes have been shown favor large DNA 
distortions [61, 220].   
 The SAXS data of the PARP-1-DNA complexes depict an overall elongated, asymmetric 
structure.  In line with previous results[221], the Dmax of the PARP-1-DNA complexes suggest significant 
contacts are made between the protein and double stranded DNA in the three models that were tested.  
The asymmetric form of binding with which PARP-1 associates to the region surrounding the DNA 
damage is reminiscent of the DNA damage recognition of HU-like proteins within bacteria [222, 223].  
Recently, HU-like proteins have been shown to associate with cruciforms, nicks and other high affinity 
DNA targets of PARP-1 [222, 223].  This asymmetric association to regions of DNA damage may 
represent a conserved mechanism that exposes the lesion while protecting the surrounding undamaged 
region.   
Two recent structural studies of the PARP-1 zinc-ribbon domain have revealed that this domain is 
required for DNA-mediated activation of PARP-1 by either catalyzing dimerization of the full-length 
protein or inducing a conformational change[47, 48].  In light of our SAXS data and in the absence of any  
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Figure 6.  A model for the interactions of hparp486 with damaged DNA. The overall shape and Dmax 
of hparp486 (A), zf-parp (B), 30Blunt DNA (C) and their complexes (D and E) have been experimentally 
determined by SAXS.  The Dmax of 180Å (a 65Å increase) and asymmetric shape of the zf-parp-30Blunt 
complex is consistent with a single parp zinc finger interacting the blunt end (D).  The hparp486-30Blunt 
complex is also elongated (E), but increases in size by 90Å (to 240Å).  To account for both the change in 
profile of the P(r) function (Fig. 5 A, C) and greater Dmax,we model this with a conformational change 
that occurs in the Zn3-BRCT region of the protein.  In contrast, when interacting with nicked DNA (F) or 
a 3’ extension region (G), hparp486 forms a more compact complex but a conformational change still 
needs to be taken into account to reach a Dmax of ~200Å.  We propose that ultimately the conformational 
change that occurs during binding of DNA leads to activation of the PARP-1 enzymatic domain. 
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data suggestive of DNA-mediated dimerization, we support the notion that a DNA-mediated 
conformational change in the region surrounding zinc-ribbon domain leads to PARP-1 activation.  We 
propose that the conformational change that occurs upon DNA association is communicated across the 
hinge region, and ultimately leads to activation of the PARP-1 enzymatic domain.  We have summarized 
an interpretation of our findings in Figure 4.6.  The model is drawn to scale to reflect total maximum 
dimension of individual hparp486 domains, DNA, and the hparp486-DNA complexes.  We propose that 
hparp486 interacts with DNA containing overhangs or nicks through an increased area of contact 
compared to its interaction with blunt end DNA in interactions that lead to the decreased Dmax for these 
complexes.  Taking into account the single maximum revealed from the SAXS data, we have modeled 
this complex as an extended form of hparp486 bound to the area surrounding the DNA damage forming 
an elongated and asymmetric complex.  In conclusion, we believe it is unlikely that PARP-1 is activated 
by DNA-dependent dimerization, but instead propose a conformational change upon interaction with 
damaged DNA results in its activation.   
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Supplementary Figure 1. parp486 SAXS raw data represented by Guinier, Porod and Kratky 
analysis. A) Superposition of raw parp486 SAXS data at 3, 6 and 9 mg/ml concentrations depicts 
minimal concentration dependent scattering effects. B) Guinier analysis of the low scattering angles 
depicts minimal aggregation. The residuals are illustrated in the lower portion of the graph. C) Kratky 
analysis of the data illustrates a folded, yet flexible particle. D) Porod graph of parp486 SAXS data 











Supplementary Figure 2. Superposition of ab initio SAXS models of hparp486. The side (left) and top 
(right) views of five of the thirty averaged models that were used to create the final hparp486 particle 
reconstruction are shown. Each model is represented in a unique color. While the models do differ in 
certain areas, the overall shape of the particle remains similar. These models fit the SAXS scattering 











Supplementary Figure 3: EMSA of hparp486 interacting with a 53 base pair blunt ended DNA. 
Top: EtBr stain; bottom: Coomassie stain. The longer DNA fragment allows hparp486 to interact with 
DNA in either monomer or dimer form at hparp486:DNA ratios between 0.5-1.75. As the ratio of 
hparp486 increases, the dimer form becomes more prevalent. The longer DNA differs from the shorter 
















Supplementary Figure 4. Superposition of the SEC-MALS elution profiles of solutions containing either 
2:1 molar ratios of hparp486-DNA complexes (peak 1), free hparp486 (peak 2) or free DNA (peak 3). In 
all cases peak 1 contains a 1:1 mixture of hparp486-DNA as well as free hparp486. This is noted by the 
decreasing molecular weight in the peak’s shallow decent at increased volumes, as well as the significant 












Supplementary Figure 5. Hill plots derived from the interactions of hparp486 with 30blunt, 30nick 
and 30ext DNA (A, B and C-D, respectively). In all cases, the slope of the line is less than 1(Table 3). 
The Hill coefficient is displayed in the upper left hand corner of each plot. Because the Hill coefficient is 





Supplementary Figure 4.6. Analysis of 30Blunt, 30nick and 30ext DNA SAXS data by Kratky, 
Guinier and P(r). A) Superposition of raw SAXS data for 30blunt, 30nick an 30ext DNA. B) 
Superposition of Kratky plots for each DNA illustrate that the 30nick and 30ext DNA do have some long 
range interactions. C1-C3) Guinier analysis similarly depict intermolecular interactions within the 30nick 
(C2) and 30ext’ (C3) DNA samples. Blunt ended DNA (C1) remains homogeneous. The residuals are 
illustrated in the lower portion of each graph D) Superposed distance distribution functions of all DNAs. 
The data had 2-5 initial points truncated to remove the poor scattering at low angles. The resulting P(r) 
function portrays that all DNAs are between 88-100Å in the maximum dimension. This result is in 









Supplementary Figure 7. Ab initio models of 30ext, 30nick and 30blunt DNA samples. The models 
were calculated from the average of ten DAMMIN ab initio models. The DNA models are all between 



















Supplementary Figure 4.8. Analysis of SAXS data for parp486 in complex with blunt, nicked and 
6n3’ DNA. A) Raw SAXS scattering for each protein-DNA complex. B) Kratky analysis of the 
complexes reveals an overall similar profile. C1-C3) Guinier analysis of each complex reveals that the 














Supplementary Figure 4.9. Analysis of Purified hparp209. A) Top: SECMALS elution profile of 
purified hparp209 illustrates that the protein is a homogeneous monomer of with a molar mass of 22.5 
kDa. Bottom: SDS-PAGE analysis of hparp209 from fractions of the SEC-MALS column reveal a 
singleband at approximately 23 kDa. 1 and 2 µl of the final concentrated protein fractions that were used 
for SAXS analysis are shown in the bottom right of panel A. B) SAXS scattering profiles of hparp209 
(black) and the hparp209-30Blunt complex. C) Kratky analysis of hparp209 (black) and hparp209-
30Blunt (red) complexes reveals that in both cases the particles have an overall ordered profile, albeit 
with some disorder at the higher scattering angles in the case of hparp209. D) Superposition of five ab 
initio particle reconstructions of hparp209 that fit the P(r) function (Fig. 4.5) with a chi square of 1.1 or 















 The experiments discussed in this chapter are meant to provide a better understanding of how 
PARP-1 interacts with DNA-damage.  We have extended the work presented in Chapter 3 by 
incorporating similar studies to the functional full-length enzyme.  Advanced small-angle neutron 
scattering experiments were performed and analyzed with the help of Dr. Susan Krueger and Dr. Joseph 
Curtis of the National Institute of Standards and Technology Center for Neutron Research (NCNR).  The 
joint PARP-1 project served as a model system to develop methods to analyze flexible proteins, protein-
protein and protein-nucleic acid complexes.  These experiments would not have been possible without the 
initial interest of Dr. Wayne Lilyestrom and the willingness of Dr. Karolin Luger to allow me to work 
independently to maintain the collaboration and to travel to make critical measurements at both the 
NCNR and the synchrotron SAXS-beamlines at the Advance Light Source (ALS) and Syncrotron Source 
Radiation Laboratories (SSRL). 
Summary: 
 
Scientific evidence in the fields of DNA repair and aging link the protection of the genome to 
longevity.  One protein in particular, Poly(ADP-ribose) Polymerase-1 (PARP-1), has been extensively 
linked to DNA damage repair.  PARP-1 is a DNA damage sensor on its own and is a component of the 
Base Excision Repair (BER) pathway machinery. DNA damaging events like ionizing radiation or 
oxidative stress stimulate PARP-1 into action.  Upon stimulus, the chromatin-associated PARP-1 
catalyzes the addition of polymers of ADP-ribose (pADPr) by modifying its substrate NAD+ and 
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covalently linking it to itself and other chromatin associated proteins.  It is known that PARP-1 binds 
damaged DNA at its N-terminus.  It is not understood how that DNA-binding event conveys the message 
that is crucial in activating the C-terminal catalytic domain. We have used a combination of biochemical 
and biophysical studies to probe the stoichiometry and enzyme efficiency for key types of DNA damage 
models. Small Angle Neutron, X-ray and Light Scattering experiments were used in a hybrid approach 
with molecular modeling to reveal structures of the full-length PARP-1 protein, in its entirety, and its 
complexes with DNA for the first time.  The data discussed here support a model in which the binding of 
damaged DNA conveys a conformational change that is structurally responsible for the activation of the 




The enzyme, Poly(ADP-ribose) Polymerase 1 is the founding member of the PARP superfamily.  
PARP-1 is highly conserved in eukaryotic organism and it is thought to be the major producer of 
Poly(ADP-ribose) PAR. PARP-1 is an abundant nuclear protein also known to be involved in 
transcriptional regulation as well as global regulation of chromatin structure. PARP-1 is crucial for many 
functions in the cell and its enzymatic activity has been linked to longevity in mammals. Increased 
enzymatic activity has been correlated positively with lifespan differences amongst various mammals that 
were tested [90].  PARP-1 catalyzes PAR, a post-translational modification with emerging importance, 
onto itself and other ‘Chromatin Associated Proteins’ (ChAPs) [112].  When the cell is in a non-stressed 
state PARP-1 is thought to bind and help condense chromatin, much like H1.  However, many of the 
structural and functional details for the interaction of PARP-1 with chromatin are unknown.  Binding 
damaged DNA stimulates the catalytic activity of PARP-1 [68].  Following initiation, PARP-1 modifies 
itself in its automodification domain (residues 374-525) [103]. The modification PARP-1 passes on to 
itself and other acceptor proteins is a glutamic acid or lysine linked ADP-ribose moiety, which is 
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synthesized from its substrate NAD+ molecule.  PARP-1 modifies proteins by the addition of multiple 
ADP-ribose units to make PAR. The discovery of pADPr as a product of NAD+ catalysis suggests the 
modification is dependent on a changing nuclear environment [106].  Following the discovery of PARP-
1, many other ADP-ribosylating enzymes were discovered all of which share a sequence homology with 
the C-terminal catalytic domain.  Homology to this domain is seen in lower eukaryotes and relegates 
proteins to the PARP superfamily [23].   However, not all PARP family members reside in the nucleus or 
share the same activity [224, 225].  Nuclear PARP proteins appear to be highly expressed and PARP-1 
has been shown to be the most abundantly expressed of all the ADP-ribosylating family members [123].  
Additionally, PARP-1 proteins from different mammalian species exhibit differences in specific activity.  
This specific activity difference is thought to be a result of variability in primary sequences, which allows 
for differing levels of automodification.  The level of automodification is thought to be one of many 
factors that correlate with lifespan differences among species [87].  
PARP-1 itself is a multi-domain protein that contains several domains in addition to its catalytic 
domain [124].  The N-terminal region of PARP-1 is the DNA binding domain (DBD), it includes two 
tandem zinc finger motifs.  Adjacent to the DBD resides a third zinc-binding motif, Zn3, this domain has 
no known DNA binding activity.  Connected to the Zn3 domain by a sizable linker is the BRCT (BRCA1 
C-terminus homology) domain.  The BRCT domain is connected to the C-terminal catalytic domain by an 
uncharacterized region of secondary structure known as the WGR domain (Figure 5.1).  Several 
structures of individual domains have been deposited in the Protein Data Bank (PDB) (Figure 5.1) but 
with its flexible linkers between domains, PARP-1 itself should be expected to be flexible (from fold 
index, a web-based secondary structure prediction algorithms [226]). The full-length protein is difficult to 
produce in large quantities in bacteria. One published protocol on bacteria produced PARP-1 discusses a 
D214A mutant construct that shows a marked decrease in the specific activity of the mutant enzyme 
[227].  It is thought that the reduction of PARP-1 activity allows for an increase in bacterial production. 
The difficulty that bacteria have in producing large quantities of PARP-1 may be due to the large size  
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Figure 5.1, The human PARP1 protein contains six known domains. A.) The two N-terminal zinc 
fingers (Zn1, Zn2) are responsible for binding damaged DNA in a process that activates the C-terminal 
catalytic domain. Once activated, PARP-1 targets its automodification region, WGR and BRCT domains, 
and links long chains of ADP-ribose moieties to surface exposed glutamate and aspartate residues. B.) 
PARP-1 was incubated at ratios of trypsin (from left to right roughly 1:100. 1:200, 1:300, 1:400, 1:500 
and 1:600) trypsin:PARP for 1hr at room temperature.  The reaction was quenched by adding SDS-
protein loading buffer spiked with 0.1M PMSF. PARP-1 is primarily cleaved in half.  According to N-
terminal sequencing, the trypsin cut site is located in the linker region between the BRCT and WGR 
domains. N-terminal sequencing of the two most concentrated bands, 52 and 56 kDa, shows that the most 
sensitive site for proteolysis under the conditions used are within the linker region between the BRCT and 
WGR domains. C.) An SDS-PAGE of 3 PARP-1 constructs, from left to right, the His6-chimera protein 
Parp-1-486, the full-length enzyme containing all 1014 amino acids and the His6-chimera protein 
Parp487-1014. These proteins are estimated to be 98% pure. The amino acids that comprise the different 






(1014 amino acids), its multi-domain structure or possibly toxicity.  Bacteria do not have a protective 
barrier around the cellular DNA, like a nuclear membrane, therefore it is possible that PARP-1 binds 
bacterial DNA freely.  Because PARP-1 becomes enzymatically activated in the presence of DNA it has 
the potential to deplete cellular NAD+ and ATP stores (indirectly) while modifying itself and other 
proteins with linear and branched chains of ADP-ribose [228].  Bacteria would likely respond to the 
unregulated hPARP-1 activity by degrading the protein during expression trials (data not shown).  To 
overcome the limitations of bacterial expression of PARP-1 many researchers have resorted to baculoviral 
expression systems in Sf9 insect cells [87, 93, 140]. Without understanding how the many domains of 
PARP-1 interact, its molecular function and the regulation of its activity remain elusive. Understanding of 
activity is important, for example over-activation of PARP-1 results in necrotic cell death in some 
instances and survival from cancer in other instances [229].  Thus, the use of PARP-1 competitive 
inhibitors holds promise during treatment of certain cancer [230].  
Many of the individual PARP-1 domain structures deposited in the Protein Data Bank (PDB) do 
not provide adequate information to understand the overall structure and function; for this understanding 
the entire (functional) protein is needed.  Several of the domains PARP-1 domains in the PDB have little 
in terms of associated discussions or functional characterization.  The biological importance for the 
individual domains is most likely realized only in the context of the full-length enzyme.  As of late, 
structures of the DNA-binding region and the adjacent domain, Zn1-Zn2 and Zn3 (Figure 5.1), 
respectively, have been published [36, 48]. Important clues to how the Zn1 and Zn2 domains bind DNA 
have just been revealed. It appears that Zn1 and Zn2 share functional similarities with HMG Zn-fingers 
and hydrophobic interactions between key amino acids and DNA bases mediate their binding function 
(ref). The structural information and the biochemical characterization of the Zn3 domain suggest its 
functionality is crucial in the communication of the DNA binding event at the N-terminus to the 
enzymatic activity at the C-terminus [47, 48].  It is thought that the Zn3 domain can respond to DNA 
binding at the adjacent Zn1-Zn2-comprised DBD and pass the signal downstream toward the catalytic 
domain by conformational change [36, 48].  Lilyestrom et al. were able to directly show a DNA-induced 
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conformational change for a fragment of the human PARP-1 protein, suggesting a possible structural 
basis for the communication between binding and catalytic domains [231].  Recently, a crystal structure 
of 4 of the 6 PARP-1 domains in complex with DNA was published, and the manner in which they bound 
DNA was suggestive, to the authors, that a conformational change occurs upon binding DNA [49].  
Here we describe the conformational change of the full-length PARP-1 enzyme when bound to 
small oligonucleotide DNA damage models.  We find that PARP-1 is a mono-disperse monomer in 
solution and it binds DNA in a 1:1 stoichiometry.  Small Angle X-ray and Neutron Scattering, contrast 
variation and global fitting techniques were combined to gain structural insights on several PARP-1 
protein constructs and their complexes with DNA.  Furthermore, with the crystallography and NMR 
structural data now available to us [35, 36, 49], we have been able to directly test published atomistic 
constraints on how PARP-1 interacts with DNA in solution scattering data. Importantly, our studies 
focused on the intact protein alone and in complex with DNA-damage models similar to those used in the 
crystallography studies. The structures of the protein and protein-DNA complexes were further evaluated 
in a modern molecular dynamics program suite, SASSIE [232].  Course-grained Molecular Dynamics 
allows us to propose the first ever ensemble description of structures present in solution in our studies of 
the enzymatically functional full-length, human PARP-1. 
 
Materials and Methods: 
Cloning, expression and purification of Parp1-486 and Parp487-1014: DNA encoding 
roughly the first (1-486) and second halves (487-1014) of human PARP-1 was cloned into the 
PET28a vector system (Novagen).  The proteins were expressed (via IPTG induction) in E. coli 
BL21 (DE3) (Novagen) for 6 hours at 25°C.  Cell pellets were resuspended in 25 mM Tris 
pH=7.5, 250 mM NaCl buffer and frozen until use.  The protein was bound to a Nickel-NTA fast 
flow column (Qiagen) and washed with 3 volumes of resuspension buffer (same buffer as above) 
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prior to being eluted at 300 mM imidazole.  Following this, Parp1-486 or Parp487-1014 were 
further purified by S200 size exclusion and HiTrap SP anion exchange columns (GE Healthcare).  
To ensure quality control, the purity and homogeneity of the proteins were analyzed by gel 
filtration, Coomassie-stained SDS-PAGE and static and multi-angle light scattering (Wyatt 
Dawn Heleos II instrument, ASTRA Software Version 3.2.12).  
Expression and purification of full-length PARP-1: Baculovirus with an integrated gene 
encoding the sequence for human PARP-1 (V762A) was used to make viral plaques in T-flask-
bound Sf9 cells.  Here on referred to as Parp1-1014.  The virus was diluted in TNM-FH media 
containing 10% fetal bovine serum (FBS) with a final multiplicity of infection (MOI) of ~106.  
Plaques were harvested using sterile technique and used in 7-9-day amplifications in a volume of 
150mls with a density of 1.0x106 cells/mL.  The amplified virus was then used as a 100x stock 
for large-volume protein expressions.  Spinner flasks containing 1.0-1.5x106 cells/ml grown in 
50% ExCell 420® and 50% ExCell Titerhigh® (Sigma-Aldrich) were infected for a period of no 
longer than 72 hours at 27°C.  At the time of infection 5 µM ZnSO4 and 4% FBS were added to 
aid in expression levels.  Cells were harvested by a 20 minute spin at 1100xg.  Cells were 
sonicated on ice in the presence of Roche Complete EDTA-Free protease inhibitor tablets.  The 
supernatant was cleared by an 18-kRPM spin for 20 minutes.  Protamine sulfate was added at 
1.0mg/ml and the supernatant cleared by 18-kRPM spin for 20 minutes.  Lysates were diluted 
and loaded onto a 5 ml Cation Exchange column.  The purest fractions were pooled and run on a 
5 ml HiTrap Heparin column.  Pure fractions were pooled, concentrated and run on a S200 size 
exclusion column. 
Catalytic Reactions:  Michaelis-Menten enzyme kinetics were set up according to Beneke et al. 
[93].  The reactions contained 0.5 nM PARP-1 and 0.75 nM DNA and brought to a final volume 
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of 30 µL (before NAD+ addition) of 10 mM MgCl, 50 mM Tris pH=8. In summary, enzymatic 
reactions were set up in technical triplicates at 30°C for 30 seconds. Post-reaction, the resulting 
PAR was cleaved by trichloroacetate and bound to a charged membrane (Zeta-probe® BioRad 
Inc.) through a dot-blot apparatus.  The membrane was then blocked and probed with an anti-
PAR monoclonal antibody. Next, blots were incubated with Atto647-linked goat anti-mouse 
secondary antibody and imaged on a Typhoon (GE Healthcare, Life Sciences) fluorescence 
imager with an excitation wavelength of 488nm and emission wavelength >610nm.  Dot-blots 
were analyzed by ImageQuant 5® and the resulting data analyzed using the Michaelis-Menten 
mode of Prism® (GraphPad Prism). 
Limited Proteolysis:  Purified Parp1-1014 was dialyzed into digestion buffer, (25mM Tris 
pH=7.0, 100mM NaCl, 5% glycerol).  Parp1-1014 was incubated at ratios of trypsin (Sigma-
Aldrich) (from left to right roughly 1:100. 1:200, 1:300, 1:400, 1:500 and 1:600, Figure 5.1B) 
trypsin:PARP for 1hr at room temperature.  Reactions containing bovine thrombin (Sigma-
Aldrich) were performed in an analogous way, except Parp1-1014 was incubated with a varying 
number of units of protease rather than molar ratios. For DNA titrations, a value of 0.5 units of 
thrombin was added to each reaction.  A 14-17mer DNA (a 3bp 3’-overhang DNA) was titrated 
into reactions and incubated for 30 minutes prior to adding thrombin enzyme.  Adding SDS-
protein loading buffer spiked with 0.1M PMSF quenched the reactions.  Samples were run on 
SDS-PAGE and imaged or transferred to PVDF membrane (Millipore) and sent for N-terminal 
protein sequencing (using the Pick ‘n PostTM service offered by ALPHALYSE). 
Light Scattering Measurements:  Samples of either human Parp1-1014, Parp1-486 or their 
DNA complexes, each at a concentration of 2mg/ml, were loaded onto an AKTA purifier HPLC 
system.  The SEC-MALS running buffer was as follows in 75 mM Tris pH 8.0, 300 mM NaCl 
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and 1.0 mM TCEP Samples were characterized over a SHODEX-803 (Shodex) or a Superdex 
200 10/30 (GE healthcare) size exclusion column at a flow rate of 0.3-0.5 mLs /minute prior to 
flowing into an inline Dawn Heleos II (Wyatt Technologies) multi-angle light scattering 
instrument followed by a OPTILAB rEX refractive index detector (Wyatt Technologies).  To 
obtain hydrodynamic information like the Stoke’s radius (Rs) of the molecules, gel filtration 
standards were used to calibrate the columns (BioRad).  A dn/dc value of 0.185, 0.170, and 0.180 
were used to determine the concentration of Parp1-486, DNA and the Parp1-486-DNA complex, 
respectively.  Data analysis was carried out with Astra Software version 5.3.4.  Reported masses 
are the mass averaged molecular masses.   
Analytical ultracentrifugation: Samples were dialyzed extensively against 25 mM Tris pH 8.0, 
200 mM NaCl and 1mM TCEP prior to sedimentation.  All experiments were performed in a 
Beckman XL-I using the absorbance optical system and a 4-hole, AN60-Ti rotor.  Sedimentation 
velocity (SV) was performed in a 1.2 cm, 2-sector EPON centerpiece, while sedimentation 
equilibrium (EQ) was performed in a 1.2 cm, 6-sector centerpiece.  For SV, 400 µl of a 0.7 
Abs280nm of full-length PARP-1, Parp1-486 and Parp487-1014 were sedimented at 50,000 rpm 
for 4 hours at 20°C, with a radial step size of 0.002cm in the continuous scanning mode.  A total 
of 60 scans were analyzed using the Demeler and van Holde method [233] to yield the diffusion-
corrected, integral distribution of S over the boundary [G(s)] within Ultrascan (version 9.4).  
Fitting of the hydrodynamic properties and molecular mass model was performed within 
Ultrascan as well.  
DNA oligomer preparations:  The oligomer sequences for the 21ext primer were 5’-
ATCAGATAGCATCTGTGCGGCCGCTTAGGGTTAGGG-3’ for the overhang strand and 5’-
CCCTAAGCGGCCGCACAGATGCTATCTGAT-3’ for the shorter strand.  Adding or deleting 
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nucleotides from the 3’-region for the sequences shown above generated additional DNA 
constructs.  Oligonucleotide sequences were ordered from Integrated DNA Technologies IDT® 
DNA (USA). The different oligonucleotide models with either 3’-overhangs or the double-
stranded DNA blunt-ended models were created by annealing equimolar amounts of paired 
primers.  To anneal DNAs, the oligomer were mixed and placed in an Eppendorf® tube, that was 
inserted in a 1 liter boiling water bath for 5 minutes, then allowed to cool to room temperature 
over night.  Care was taken to avoid light exposure of labeled oligomers.  The homogeneity of 
annealed DNA was tested by analyzing samples on 20% TBE-PAGE stained with ethidium 
bromide. 
Mobility-shift assays: Protein-DNA complexes were assayed for homogeneity and 
stoichiometry by analyzing their mobility on 0.7% native agarose gels stained with Coomassie 
and ethidium bromide to visualize protein and DNA respectively.  Low EEO agarose was 
purchased from Fisher.  Native agarose gels were run at 4°C in 25mM Tris pH. 8.0, 20mM 
glycine, at 60 volts for 60 minutes.  
Small Angle X-ray Scattering: SAXS data for the human PARP-1 constructs, DNA constructs and their 
complexes were measured at the SIBYLS beamline (12.3.1) at the ALS using a Mar CCD area detector 
(165 mm diameter). A 15µl sample was placed in a 1 mm thick chamber with two windows of 25 µm 
mica. The detector to sample distance was 1.5 m. A dual double-crystal monochromator was used to 
select an energy of 10 keV (λ = 1.298 Å) to optimize the signals corresponding to larger protein 
complexes. The curves were measured at concentrations of human PARP-1 proteins at 4mg/ml, 2mg/ml, 
and 1mg/ml; DNA samples at 6mg/ml and 3mg/ml; and human PARP-DNA complex samples equal to 
3mg/ml, 2mg/ml and 1mg/ml. Data images were subjected to circular integration, normalization, and 
subtraction of sample and buffer image files.  
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All datasets collected were nearly free of concentration-dependent effects, except for the DNA 
samples with overhangs, which did reveal some evidence of concentration-dependent effects, 
and had the initial 2-5 data points removed.  For DNA, the data sets at lower concentrations were 
processed for shape determination. The Rg for each particle was approximated using PRIMUS 
[165] to evaluate the Guinier equation and GNOM [166] to evaluate the P(r) function. The value 
of the maximum diameter of the particle, Dmax, was determined empirically by examining the 
quality of the fit to the experimental data for a range of Dmax values. 
Ab initio particle reconstructions were built by the program DAMMIN [167].  This software 
represents the protein as an assembly of dummy atoms inside a search volume defined by a 
sphere of the diameter Dmax.  Starting from a random model, DAMMIN employs simulated 
annealing to build a model that will fit the experimental data and also fulfills stringent local 
protein-like conditions, such as chain connectivity and particle compactness.  For each final 
model, thirty independent DAMMIN reconstructions were aligned and averaged with the 
programs DAMAVER and SUPCOMB to reduce the likelihood that the models represent local 
minima [234].    The most typical averaged model was filtered to an appropriate volume with the 
program DAMFILT (ab initio models are shown and further discussed in Chapter 3). 
Small Angle Neutron Scattering (SANS): Similar to the SAXS sample preparation, 
concentrated Parp1-1014 and Parp1-486 proteins (~4mg/ml) and DNAs (~20mg/ml) were dialyzed in 0, 
20, 70, 80 and100% D2O complex buffer (300mM NaCl, 50mM Tris pH=8).  Protein-DNA complexes 
were formed after determining the proper ratio on gel shifts.  Once large-scale complexes were formed, 
they were checked for monodispersity in SEC-MALS. To determine any D2O dependent effects, 
complexes were monitored by SEC-MALS in the 100% D2O buffer.  Aside from losses attributed to 
sticking to dialysis membranes, no increase in the visible aggregation, apparent as a small peak in the 
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void volume of the S200, was present.  When losses due to sticking became too great the addition of 5 
mM L-arginine alleviated the sticking.  Both the buffer and samples were degassed prior to being loaded 
into 1.0 mm or 2.0 mm lollipop CD cuvets.  The cuvets were then placed in the beamline at the NCNR’s 
NG-3 30 meter SANS instrument [235].  Samples and their dialysis-reference buffers were measured with 
the detector at three different distances 1.5 meters, 4.5 meters and 15 meters (the specific distances used 
were for data collection at the high-, middle- and low-q ranges, respectively) [235].   
SANS experiments often require the incorporation of multiple data sets for the same sample in 
buffers containing different D2O percentages.  The purpose of varying the concentration of D2O in the 
buffer is to exploit a key difference in the properties of how X-rays and neutrons interact with matter.  
Neutrons interact with the nuclei of matter rather than the electrons, which interact with X-rays. 
Exogenous neutrons, like those in a SANS beamline, demonstrate an significant sensitivity to atomic 
isotopes and it is this physical property we harness in contrast variation experiments where we use heavy 
water (the stable isotope deuterium is substituted for hydrogen).  Additional benefits for using SANS are 
that measurements made at different detector distances can be added together so the scattering from 
different length-scales can be evaluated simultaneously.  For instance, measurements made at the 13 
meter detector distance will yield information on the largest length-scale, measurements taken at 4.5 
meters yield the medium length-scale information while the 1.3 meter SANS and the SAXS data will 
have the most information on the smallest length-scales (the high-angle data of SAXS is of greater 
intensity than for that seen in SANS). The ability to incorporate and simultaneously evaluate many 
parameters makes SANS a very powerful global fitting method.  Certain experimental snags or 
inconsistencies, often due to poor determination of protein concentrations, and intermolecular interactions 
caused by high concentrations and or D2O effects [236], can be evaluated in the context of other methods 
and the most logical interpretation of the data can be determined.   
The contrast series we used in our global fits were of samples that were dialyzed into buffers 
containing 0%, 20%, 70%, 100% D2O for the full-length enzyme and an additional contrast point, a 
sample with 80% D2O in the buffer, for the Parp1-486 construct.  The 0% D2O data was used to evaluate 
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the protein in the SAXS-like H2O condition.  The other D2O percentages were used in order to exploit the 
differences neutron-sensitive molecular properties of the DNA and protein.  The atomic composition of 
DNA and protein differ considerably, and so too does the ability of neutrons to scatter off of those 
macromolecules. The differences are quantifiable and depending on the molecules’ atomic composition, 
there will be a certain scattering length density (SLD) for which neutrons interact.  Since the neutron was 
discovered many scientists have worked out these SLD values for most if the elements and they can be 
found on internationally accepted tables.  For DNA, the SLD is roughly the same as a solution containing 
70% D2O and 30% H2O. When a protein-DNA complex is measured in a SANS experiment, using a 70% 
D2O buffer, the DNA in that mixture will have the same SLD as the buffer in which it is contained, this is 
known as the DNA’s match point.  When DNA is ‘matched’ the scattering signal that results is from the 
protein alone.  In the 20% D2O condition, the DNA has a greater signal than the protein, similar to the 
increased signal from the more electron dense DNA in a SAXS measurement.  Since the method depends 
on global fitting, to solve the contrast variation equation for a system containing two components, one 
needs to have contrast data at several different SLDs to satisfy the cross-terms of the equation (see Glatter 
and Kratky [237]).  Likewise, the SAXS data for all of protein and protein-DNA complexes was used as 
additional contrast data since the scattering length density (SLD) for the molecules are different for X-
rays.  
 SANS measurements for an empty cell and an empty beam were made at all detector distances 
and the scattering profiles were put on an absolute scale by relation to the neutron flux of the beam.  
Buffer measurements for all detector distances were also collected and the scattering signal was 
subtracted from that of the sample.  Data reduction was performed according to NCNR protocol using 
IgorPro (Wavemetrics) NCNR SANS data reduction module macros [238]. 
 
Molecular modeling: Using X-ray crystal and NMR structural information, we incorporated the 
known structures of each of the domains of PARP-1 into a starting model that contained atomic 
coordinates for these domains, a crucial beginning step for molecular modeling (pdb files used 2DMJ, 
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2CS2, 2RIQ, 2COK, 2CR9 and 2PAW).  About ~10% of the protein remained unaccounted for and was 
assumed to consist of disordered loops, so those amino acids were built with the aid of the program 
Modeller [239].  The atomistic-DNA model, based off the 21-27mer 3’-overhang sequence, was 
generated in the “make_na” webserver (http://structure.usc.edu/make-na/server.html).  For DNA-bound 
PARP models, the 21-27mer 3’-overhang DNA was first aligned to the Zn2-DNA (pdb 3ODC) structure,  
then the Zn1 (pdb 3OD8) region was built with the DNA-penetrating loop intercalated upstream from the 
Zn2 binding region as proposed in the manuscript describing the PARP-1 Zn-fingers binding to DNA [36] 
(Supplementary Figure 5.2). 
Starting structures of the proteins and their complexes were energy minimized to determine any 
improper constraints in the molecular models using the program NAMD [240].  As a means to better 
understand how the molecules behave in solution, we used a coarse-grained, Monte-Carlo based, 
molecular dynamics program, SASSIE [232].  Atomistic models were centered and aligned around their 
centers of mass.  The starting models were run through the dihedral generator program where the 
reference PDB-file was linked to a DCD-file containing the atomic coordinates for the entire ensemble.  
All atoms were kept rigid except for user designated regions of disorder defined by amino acid 
corresponding to their position in the protein sequence, (linker region 1 = 1-5aa, linker region 2 = 91-
112aa, linker 3 = 202-224aa, linker region 4 = 350-387aa, linker region 5 = 487-528aa and linker region 6 
= 640-664aa). For practical purposes, the second linker region for all protein-DNA complexes was held 
rigid within the dihedral generator program. The dihedral program generated up to 104 structures by 
randomly varying sets of dihedral angles for amino acids within the user-defined flexible linker regions.  
As the structures were created they were energy minimized using NAMD and the CHARMM-22 force 
field to ensure steric clashes or overlaps did not occur. Generated atomistic structures were then run 
through the CRYSON program [[241, 242].  In CRYSON each generated structures was processed and 
theoretical scattering curves calculated.  SAXS and SANS data for the Parp1-486, Parp1-1014 and their 
DNA complexes were interpolated so that all of their scattering profiles were matched in data points and 
extrapolated to I(0). Finally, the generated models were run through a filtering program that sorts 
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structures according to the fit of each scattering profile to the actual data, and values of Rg and χ2 fits to 
SAXS or SANS data. The vacuum electrostatics for Parp1-1014 were calculated using the APBS program 




Successful purification of large quantities of PARP-1 is only achievable by eukaryotic expression 
methods 
 
Much structural information is available on the individual domains of Poly(ADP-ribose) 
Polymerase 1 (PARP-1).  Very little information on how the individual domains of PARP-1 interact is 
known.  Efforts to produce large quantities of full-length human PARP-1 in bacterial expression systems 
proved very difficult. We have come to rely upon the baculoviral system for the production of large 
quantities (~5.0 mg/L) of the full-length PARP-1 enzyme.    
 After large-scale purifications of PARP-1 were achievable we began to biophysically characterize 
the enzyme.  We found it was a monodisperse monomer in low and high concentration solution studies, 
analytical ultracentrifugation (AUC) and size exclusion chromatography-coupled multi-angle light 
scattering (SEC-MALS) (Figure 5.2).   Interestingly, past publications have described the PARP-1 
protein as behaving like a homo-dimer [244].  Because of discrepancies between past publications and our 
experimental findings we wanted to verify that PARP-1 was fully functional and properly folded.  We 
assayed the activity in both PARP’s ability to bind DNA and synthesize poly(ADP-ribose) moieties.  We 
found that Sf9-produced PARP-1 binds and shifts several different types of DNA oligonucleotides in   
electrophoretic mobility shift assays (EMSA) (Figure 5.3A).  Consistent with published data PARP-1 
only synthesizes Poly(ADP-ribose) (PAR or pADPr) effectively when both NAD+ and DNA are present 




Figure 5.2.  Solution studies of PARP-1 indicate it is a monodisperse monomer. A.) and B.) graphs 
from analytical ultracentrifugation (AUC) sedimentation velocity experiment indicate that the 
sedimentation coefficient for the full-length protein is 4.4, a reasonable value for an elongated 113-kDa 
protein. B.) Sedimentation coefficients of two halves of PARP-1, Parp1-486 and Parp487-1014.  C.) The 
size-exclusion-coupled multi-angle light scattering (SEC-MALS) of full-length PARP-1 and Parp1-486 
indicate molar masses of 111 and 57 kDa, respectively. D.) Results from SEC-MALS experiments of full-




Table 5.1. The hydrodynamic properties of the Parp1-1014, Parp1-486 and Parp487-1014.  Listed 
are various hydrodynamic properties derived from the different solution studies of the PARP1 proteins.   
Stokes radii were obtained by using protein standards of known size and molecular mass within the size-
exclusion column attached to the multi-angle light scattering system.  Svedberg (S20,w) values were 
obtained for uncomplexed proteins by AUC. For protein-DNA complexes, small amounts of free DNA 
made sedimentation velocity experiments difficult.  Instead, SEC-MALS was used for these protein-DNA 
complexes.  A method to approximate the molar mass for molecules in solution was used and the 










Limited proteolysis of full-length PARP-1 reveals two stable fragments 
 
Next, we determined if PARP-1 was properly folded by limited proteolysis.  We expected that a slow, 
controlled proteolysis treatment would yield the 6 distinct and fully folded domains that have been 
described structurally.  If the protein was improperly folded, we expected to see extreme sensitivity to 
protease.   Limited proteolysis by trypsin instead yielded two main proteolytic fragments with apparent 
masses equal to 56 and 52-kDa in size, respectively (Figure 5.1B).  The result suggests that the protein is 
properly folded since only a few of the ~150 predicted trypsin cut sites are actually accessible.  
Further analysis of the proteolysis experiment, mass spec analysis (MALDI-TOF) and N-terminal 
sequencing, revealed that the faster moving SDS-PAGE band has a molecular weight of ~56.8-kDa and 
contains the WGR and catalytic domains as seen by western-blot using a monoclonal antibody raised 
against that domain (data not shown). The larger species with the apparent 56-kDa size turned out to be 
similar to the Parp1-486 fragment, containing the Zn1, Zn2, Zn3 and BRCT domains, characterized 
previously by Lilyestrom et al. [231].  
The limited proteolysis experiments proved promising for crystallization studies since the 
experiments yielded two considerably stable fragments.  Bacterial expression constructs were successful 
at producing both the Parp1-486 and the Parp487-1014 fragments at relatively high concentration (6 and 
18 mg/L respectively).  Although extensive crystallization screens were tried, the two protein fragments 
did not crystallize.  The extensive biophysical characterization of Parp1-486 in Lilyestrom et al., 
described a well-behaved fragment with functional DNA binding activity [231].  Additionally, the 
Parp487-1014 fragment is well behaved in solution studies (Figure 5.2B and 5.2D) but its catalytic  
activity was not detectable in enzymatic activity experiments (data not shown).  The undetectable level of 
activity of Parp487-1014 was is not a surprise since the enzymatic activity of the catalytic domain, 
Parp662-1011, was previously described as being 500-fold less than the full-length PARP-1 [43].  Our 





Figure 5.3.  PARP-1 is fully functional in the presence of small oligonucleotide DNA-damage model 
substrates.  A.) Electrophoretic mobility shift assays (EMSA) for both PARP-1-1014 and PARP-1-486 
indicating binding and shifting of the 21-27mer 3’-overhang DNA. The upper images in A.) and B.) are 
ethidium bromide stained gels of the PARP-1-1014 (left) and PARP-1-486 (right) titrations to a fixed 
amount of DNA.  Below, in the same order, are the Coomassie-stained versions of the same gels. Judging 
from migration of the complexes into the gel, it is apparent that the Parp1-1014-DNA complex is less 
mobile within the native agarose, compared to the Parp1-486-DNA complex. C.) Left is the 8% 
acrylamide SDS-PAGE gel of a Michaelis-Menten reaction for Parp1-1014.  Right is a complementary 
western-blot analysis run side-by-side under the same running conditions as the Coomassie stained gel. 
The blot was probed with anti-PAR monoclonal antibody followed by goat anti-mouse secondary 
antibody, conjugated with an Atto647 fluorophore.  Parp1-1014 automodifies itself upon the recognition 
and binding of DNA, the 21-27mer 3’-overhang DNA damage model.  With increasing NAD+ 
concentration, an increase in higher molecular weight PAR is seen in the gel and western blot (NAD+ 
increases from left to right in a concentration range of 10µM to 300µM). 
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of roughly the same molecular mass, 56.5-kDa and 56.8-kDa respectively, the Parp1-486 is more 
elongated by AUC and size exclusion chromatography (Table 5.1). 
 
Structural studies of PARP-1 indicate the full-length protein is more compact than truncation 
mutants. 
 
The intrinsic flexibility and regions of disorder in the full-length PARP-1 guided our 
structural studies toward solution-based methods.  We began using Small Angle X-ray Scattering 
(SAXS) experiments to gain low-resolution structural insights.  Initial SAXS studies on the 
Parp1-486 and Parp1-209, published in Lilyestrom et al. described the longer larger fragment as 
being elongated and flexible while the Parp1-209, containing the Zn1 and Zn2 DNA binding 
domains (DBD), was is more rigid and more condensed in nature [231].  In addition, we wanted 
to understand how the flexibility of the Parp1-486 and Parp487-1014 fragments compared to the 
flexibility of the full-length enzyme.  Pure (~98% by SDS and SECMALS) full-length PARP-1, 
Parp1-486 and Parp487-1014 proteins were evaluated for monodispersity by SEC-MALS.  All 
three proteins eluted as monodisperse monomers and none showed any real tendency to 
aggregate (Figures 5.2 and 5.4).   
SAXS experiments were set up using three concentrations of each protein (usually 4, 2 
and 1 mg/ml).  Data were then scaled and merged to detect concentration dependent effects like 
intermolecular attractions (the curves will drastically increase as they approach the Y-axis 
asymptote) or repulsion (the curves will have a sudden drop in signal as the q-values approach 
zero) (data not shown).  All of the PARP-1 proteins seemed to have only slight intermolecular 
attraction, by Guinier analysis, in the highest concentration range so, only the lower  
 144 
 
Figure 5.4. Size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) 
of full-length PARP-1 and PARP1-486 and their complexes with 21-27 bp overhang DNA.  A.) The 
PARP-1 and PARP1-486 are highly pure, monodisperse monomers in solution with experimental 
molecular masses of 111 kDa and 56 kDa, respectively.  The experimental masses for the complexes with 
DNA are 127 kDa and 72 kDa.  The mass for DNA is 14.7kDa.  Aliquots from these same samples were 
used for all SAXS experiments discussed here. B.) The elution profiles of the PARP1-1014 and the 
PARP1-1014-DNA complex used for SANS experiments.  The molecular weight was measured as 
111kDa while the left-hand shoulder on the peak represents  200 kDa, the mass consistent with a homo-
dimer of Parp1-1014 (~2% of total sample volume).  While the Parp1-1014-DNA complex had a mass of 
~129 kDa the dimer shoulder remained present and increased to approximately 6% of the sample volume 
loaded. To prevent sticking of PARP to the membrane, L-arginine was incorporated in the dialysis and 
size-exclusion buffers.  The L-arginine increased the efficiency of dialysis, however, low levels of 





Figure 5.5. Small Angle X-Ray Scattering (SAXS) profiles of PARP-1 and the 21-27mer 3’-Overhang 
DNA. A.) The scattering profiles from top to bottom: PARP1-1014-DNA Complex, PARP1-1014, PARP1-
486-DNA Complex, PARP1-486, PARP487-1014 and the 21-27mer 3’-overhang DNA.  The data look clean 
and remain robust until a q-value of ~0.3 the data become too noisy beyond that q-range.   None of the samples 
showed any sign of radiation damage or concentration dependent effects, like intermolecular attractions or 




Table 5.2.  Results from Size-Exclusion-Coupled Multi-Angle Light (SEC-MALS) and Small Angle 
X-ray Scattering (SAXS) experiments.  The calculated molar masses of the PARP1 proteins and their 
complexes with DNA match, with great certainty, the measured values obtained in SEC-MALS 
experiments. Dmax values for each species were approximated from P(r) distribution analysis using 
PRIMUS.  For Parp1-486 the values closely match those in Lilyestrom et. Al (see Chapter 4). *Only 





concentrations were used for further analysis (data not shown).  Further analysis on the scattering curves 
was performed to determine the degree of protein folding the using a Kratky plot and a Pair Distribution 
Fourier transform was performed and the results plotted as a P(r)-plot in order to independently determine 
the Rg.  This method serves as an alternative method to derive the Rg-value and it can be achieved 
without having to rely on the Guinier region, a region very sensitive to aggregation (Figure 5.6).  Porod 
plot analysis was then performed and the volume under the curve calculated for each protein (q4•I(q) vs 
q).  From the volume calculations the average molecular mass of the molecules could be calculated and 
all were very close to their theoretical molecular masses (Table 5.5).   The scattering curves were then 
used to calculate ab initio molecular envelopes (ab initio envelopes are described and shown in Chapter 
3) and key values like the average radius of gyration (Rg) and the maximum dimension (Dmax) of the 
particle (Tables 5.3 and Table 5.4 and Figure 5.6A and 5.6B).  Both separate halves of the PARP-1 had 
very similar Rg values while full-length PARP-1 was expectedly larger.  A small contribution to the Rg-
values for both the Parp1-486 and Parp487-1014 no doubt comes from the 16 N-terminal amino acid 
residues that remain on the proteins as a cloning artifact from the introduction of a His6-affinity tag 
(previous studies suggest the two proteins are very sensitive to proteolysis and the removal of the affinity 
tag was deemed too risky).  As an additional evaluation of the elongated nature of the proteins the ratio of 
the Rg/Rs–values were calculated according to the work of Tande and Wagner (Table 5.1) [245].  Taken 
together, the data suggest that the full-length and the two protein halves considerably deviate from the 
shape of a sphere.  The possibility exists that an elongation of the Parp1-486 and Parp487-1014 protein 
fragments may be due to the loss of key domain interactions that are abrogated when the protein is 
cleaved.   
Since we have access to both Parp1-486 and Parp487-1014 constructs, we tried to determine if 
those domains, now on separate protein fragments, can interact in trans to form an active full-length 
protein.  We set up complexes at concentrations in the µM range but were unable to form a complex, as 
seen by size exclusion chromatography, SEC-MALS and AUC (Supplementary figure 5.1).  We  
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Figure 5.6 Small Angle X-ray Scattering (SAXS) data analysis.  A.) and B.) the pair distribution (P(r)) 
plots of Parp1-1014 and Parp1-486, respectively.  The blue curve represents the P(r) distribution of the 
protein alone and the red represents the P(r) distribution for the protein-DNA complex. The overall shape 
and the distribution of interacting species are very different for both proteins when they are in complex 
with DNA.  Additionally, the maximum dimension (Dmax) for both molecules increases by ~60Å and 
~50Å for PARP1-1014 and PARP1-486, respectively in complex with DNA.  To determine the best Dmax 
value, several approximations were made before finding the one that had the best fit to the data.  A good 
fit was in part verified by producing Rg-values close to those calculated from the Guinier analysis.  The 
hashed lines in both A.) and B.) represent the P(r) plots for the molecules in ~100% D2O buffer.  C.) and 
D.) the Kratky analysis for Parp1-1014 and its complex with DNA and Parp1-486 and its complex with 
DNA, respectively.  From the Kratky plots it is evident that there is a plateau in the high-q region 
(q=0.25).  The bell-shaped region signifies that the molecule is well behaved and mostly folded and the 
plateau region can give information on the degree of flexibility.  Because roughly 10% of the protein is 
comprised of flexible linkers, the protein behaves like it has some regions of disorder (a globular protein 
would have a plateau that approaches the x-axis).   When either protein is in complex with DNA the shape 
of the curves change considerably and both have a similar increase in the height of the plateau region.  




determined the ability of Parp1-486, alone and in the presence of DNA, to activate the enzymatic function 
of Parp487-1014.  In those experiments, Parp1-486 was not able to activate Parp487-1014 in trans (data 
no shown).  Interestingly, the previously mentioned cut-site for trypsin is located in the linker region 
between those domains.  It seems that without the covalent linkage between the BRCT and WGR 
domains, the ability of those domains to interact is lost. It is possible that one such linker region, the one 
located between the BRCT and WGR domains, is integral in relaying the DNA binding event at the N-
terminus to the catalytic domain at the C-terminus.  The very same linker region was recently shown to 
contain the three lysine amino acids that serve as critical automodification targets [42].  
Automodification, in the form of large chains of negatively charged ADP-ribose, might serve to disrupt 
potential domain-domain interactions that might be contributing to the more condensed nature of the 
Parp1-1014 as compared to the more elongated Parp1-486 or Parp487-1014.  
 
Small oligonucleotide DNA damage models activate PARP-1 
 
 In Lilyestrom et al. we determined reported that 30-base pair (bp) blunt-ended, nicked and 
overhang DNAs were able to stimulate the full-length enzymatic activity ~40-fold more than that of the 
enzyme in the absence of DNA [231].  This was is an interesting important result because most past 
previous experiments relied on sheared salmon sperm DNA, most likely a mixture of all kinds of DNA-
damage substrates, to activate the enzyme.  To better understand the enzymatic parameters of PARP-1 in 
the presence of different DNA damage models, we performed Michaelis-Menten kinetics assays and 
compared the relative enzymatic activity levels to the relative binding affinities of PARP-1 to multiple 
DNA damage models (see Chapter 2). 
 To answer the question whether the activation of PARP-1 leads to an intramolecular modification 
or an intermolecular modification (self modification vs. modification of a neighboring molecule) we 
performed a DNA titration assay using the 30mer nicked DNA.  Our hypothesis was that PARP-1 acts as 
an intramolecular modifying enzyme. If indeed the reaction is intramolecular, the reaction rate will 
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depend only on the DNA concentration, and vice versa. If DNA is limiting within a reaction then the 
number of DNA-activated enzyme molecules should also be limiting.  Under such limiting conditions, a 
molecule that modifies its neighbor should display nearly the same level of activity regardless of DNA 
concentration (as long as the DNA concentration is greater than its dissociation constant) because the 
modification substrate is in great excess, lots of free enzyme.  If however, the reaction occurs by the 
enzyme modifying certain residues on its own side-chains, or that a DNA-induced conformational 
change, then limiting the DNA concentration within the reaction might result in far less activity.  The 
result of the titration experiment indicated that up until a certain concentration of DNA is reached, a ratio 
of 0.2:1 DNA:PARP-1, the enzymatic activity level is far reduced (Figure 5.7).  When DNA is limiting 
(only a given number of molecules can become active-enzymes) and both the substrate (PARP-1) and its 
enzymatic cofactor (NAD+) are in excess, the reaction does not reach the maximum capacity for those 
conditions.  When DNA rises to a certain concentration, the maximum capacity of the enzyme reaches a 
plateau that remains stable even when excess DNA is present (Figure 5.7C and 5.D).  These results are 
interesting and might serve as a model for the design of future enzymatic studies.  Perhaps using 
advanced enzymatic techniques and equipment like a stopped-flow mixing apparatus, some of the key 
properties of the complicated PARP-1 enzymatic parameters can be elucidated.   
 For the remaining studies discussed here only two of the most stable DNA-damage models were 
assayed in order to determine differences in enzymatic efficiency: a double-stranded blunt-ended DNA 
and a double-stranded DNA substrate with a 3’-Overhang (data for the 21mer blunt DNA is not shown). 
Catalytic reactions where PARP-1 itself served as the modification target were set up with a series of 
reactions containing increasing [NAD+] and molar excess of DNA.  The level of automodification present 
for each reaction was visualized using an 8% acrylamide PAGE-gel followed by a western-blot analysis 
while probing with an anti-PAR monoclonal antibody (Figure 5.3).  The enzymatic activity levels were 
quantitated as described in Chapter 2.  Although we saw little difference in the level of activation between 
DNA damage models, a direct comparison of the enzymatic efficiency between DNA damage substrates 
has translational importance.  Understanding the enzymatic functions PARP-1 in the presence of different  
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Figure 5.7.  The PARP1 enzymatic activity occurs through an intramolecular mode of 
automodification.  A.) An 8%-acrylamide SDS-PAGE gel showing an enzymatic reaction where all 
reaction components except DNA were kept constant.  From left to right, an increase in automodified-
PARP1 is visible in the high molecular weight smearing, which occurs simultaneously with the 
disappearance of the 113kDa PARP1-1014 band.  B.)  A western-blot analysis of an identically loaded 
gel.  The blot was first probed with anti-PAR monoclonal antibody followed by goat anti-mouse 
secondary conjugated with an Atto647 fluorophore.  C.) Dot-blot with Zeta-probe bound PAR.  The PAR 
was cleaved by addition of 20% TCA and 5% of the total reaction was bound to the membrane.  The blot 
was probed in a procedure similar to the western-blot. The red box denotes the standard curve where a 
dilution series of known concentration of commercially available PAR was bound to the membrane.  The 
standard curve was used to quantitate the PAR concentrations in the experimental conditions.  The white 
box represents a control in the form of a Michaelis-Menten reaction of a 30mer nicked DNA (the [NAD+] 
ranged from 0-300µM).  D.)  A plot of PAR formed in 30 seconds as a function of different DNA ratios 
used in the reactions.  The average Vmax, of 42.97±4.52 pmol PAR/30sec was calculated from the best-fit 
line (grey).  A plateau in the activity is reached when the PARP:DNA ration is greater than or equal to 
0.2:1.0.  Below a certain level of complex formation, the enzyme appears to be minimally activated.  
Perhaps it is not until a threshold of DNA is reached that enough enzyme can be activated to produce a 
detectable level of automodification. A DNA binding induced conformational change may be required for 
an efficient activation of the protein. 
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DNA-damage models is important because specific types of chemotherapeutics are known to cause 
specific types of DNA damage.  We continued our structural studies of PARP-1 with the two different 
DNA-damage models in order to rule out the possibility that one particular damage type could induce 
more of a conformational change on the enzyme than another damage type (i.e. a double-strand break site 
vs. a site with a 3’-overhang). 
 
Structural studies of the complexes between PARP-1 and blunt and 3’-overhang DNA damage 
models. 
 
 Extensive biophysical characterization resulted in our model that suggests Parp1-486 has the 
ability to undergo a conformational change in the presence of DNA in Lilyestrom et al. [231].  It was 
from this work that we hypothesized that the DNA binding-induced conformational change might be even 
more significant in the context of the full-length protein, the relevant and functional enzyme.  Such a 
conformational change may be required for the efficient activation of the C-terminal catalytic domain 
upon DNA-binding at the N-terminus a distance spanning a distance of up to several hundred amino acid 
residues and, prior to this study, an unknown angstrom length. 
 Understanding the conformational change in the PARP-1 protein upon DNA binding became 
paramount.  As a means to reduce any possible contribution the DNA might have on particle length, 
shorter DNA-damage models were designed (i.e. 21mer blunt vs the 30mer blunt used in past studies).  
As mentioned before, our studies required the most stable DNA damage models possible.  To achieve 
stability we stuck to the simplest DNA damage models, an overhang and a blunt DNA (the nicked DNA 
consisted of annealing 3 single stranded DNAs, two of which had very low melting points and its use 
would risk introducing more heterogeneity into any system studied).  The 3’-overhang and blunt models 
consisted of a 21-27mer 6 bp 3’-extension and a 21mer double stranded DNA (dsDNA), respectively. 
 The major proteins of interest in the current study are Parp1-1014 and Parp1-486, which were 








Figure 5.8.  Limited proteolysis of PARP-1 in the  absence and presence of DNA. 
A.) Full-length PARP-1 (Parp1-1014) was exposed to limiting concentrations of thrombin protease.  The 
resulting pattern of digestion was distinctly different than the pattern seen in the presence of trypsin 
protease (see Figure 1).  B.) The 0.5 unit concentration of thrombin in A.) was used in a limited 
proteolysis experiment where DNA was titrated at different concentrations in different reactions.  Rather 
than protecting the protein from digestion the DNA increased the sensitivity of Parp1-1014 to proteolysis.  
Additionally, having DNA present caused a different digestion pattern, indicating a conformational 
change in the PARP-1 structure as seen by a different digestion pattern in the presence of DNA. An 
identical gel to that seen in B.) was run simultaneously and transferred to PVDF membrane.  The two 
major bands in the gels were excised and sent for N-terminal sequencing. N-terminal sequencing 










shift DNA in EMSA experiments.  However, DNA complexes with the full-length protein have a 
noticeably different mobility within the gel and might represent a greater degree of elongation than that of 
the Parp1-486-DNA complex (Figure 5.3).  Large-scale complexes were set up according to gel shift 
ratios and analyzed by SEC-MALS.  Both proteins formed one-to-one complexes equally well with both 
DNA models.  Monodisperse complexes were then used in SAXS experiments at three different 
concentrations (3mg/ml, 2mg/ml and 1mg/ml).  Again, SAXS scattering profiles for the three different 
concentrations were scaled and overlaid to determine any concentration dependent effects.  Only at the 
highest concentrations did the complexes with full-length PARP-1, and to a lesser degree Parp1-486, 
show signs of intermolecular attractions (see Tables 5.3 and 5.4).  
Once the SAXS data were analyzed it became obvious that both full-length and Parp1-486 
underwent large, DNA-induced conformational changes (Tables 5.2 and 5.3).  The values obtained for 
Parp1-486, these findings are consistent with the published work of Lilyestrom et al. (see Chapter 3), 
even though the DNA-damage models used in this study are considerably smaller [231].  Analysis of the 
complexes by the methods of Kratky, Porod and Guinier were performed.   From these methods, we saw 
that the complexes were well behaved and did not show a tendency to aggregate and the Porod volumes 
correspond with expected molecular masses (Kratky plots and Porod volumes are shown in Figure 5.6B 
and Table 5.5, respectively).  We also saw that the complexes underwent a conformational change as 
seen by P(r) analysis and drastic changes in Rg and Dmax were observed compared to the protein alone 
(Figure 5.6A and Table 5.3). 
 
Small Angle Neutron Scattering (SANS) studies indicate proteins undergo elongation in the 
presence of DNA. 
 
Macromolecules exposed to X-ray radiation have scattering intensities that are proportional to 
their electron density.  In the case of protein-DNA complexes the electron density for the two different 
macromolecules is quite different and the contribution of each in a complex can be determined by sucrose 
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gradient work.  A superior method is the application of small angle neutron scattering (SANS).  Neutrons 
interact with atomic nuclei rather than with electrons.  Neutrons exhibit a high degree of sensitivity 
toward isotopes, especially when hydrogen atoms are substituted for deuterium because of the difference 
in their scattering length densities (SLDs).  
 Contrast variation and SANS experiments in general require large quantities of material and are 
very time-intensive.  Due to a relatively low intensity beam and the weak interactions with matter,  
experiments can span several days. The goal of an experiment is to form concentrated (4-6 mg/mL with 
several mLs of sample needed), monodisperse complexes in various concentrations of D2O.  Often times, 
D2O can cause intermolecular interactions that are often exacerbated with increasing concentration of the 
protein or protein-DNA complex.  These interactions are well-known [236] but not well understood. 
Concentrated Parp1-1014 and Parp1-486 protein fragments (~4mg/ml) and DNAs (~20mg/ml) were 
dialyzed in ~100% D2O complex buffer (300mM NaCl, 50mM Tris pH=8).  To determine any D2O 
dependent effects on the molecular state, complexes were monitored by SEC-MALS in the same D2O 
buffer.  Occasionally only slight aggregation was apparent in the void volume peak on the chromatograms 
(data not shown).  Protein-DNA complexes in ~100% D2O were formed for Parp1-486 at 3.0 mg/ml, 
2.0mg/ml and 1.0mg/ml and full-length PARP-1 at 2.0mg/ml.  Complexes for the 21mer blunt DNA were 
assembled for Parp1-486 at 3.0, 2.0 and 1.0mg/ml and Parp1-1014 at 2.0mg/ml.  SAXS data were 
collected, scaled and superimposed to determine D2O-dependent effects.  Only slight D2O dependent 
effects were seen in the lowest scattering angles with the highest concentrated samples (Table 5.3 and 
Table 5.4 for the Parp1-486 and Parp1-1014, respectively). 
SANS analysis of Parp1-486 and the DNA-Parp1-486 complexes 
 
SANS experiments were prepared as before with the Parp1-486 protein and its complex with the 










Figure 5.9.  SANS contrast variation data on Parp1-486 protein and its complex with the 
21-27bp overhang DNA.  A.) The scattering profiles of Parp1-486 alone.  Only two major 
contrasts were chosen for Parp1-486, the 0% D2O condition and the 85% D2O condition. B.) 
The full contrast series of Parp1-486 in complex with DNA (0%, 20%, 70%, 85% and 100% 
D2O). C.) A table containing Rg values obtained in the full contrast series of Parp1-486 in 
complex with an overhang DNA damage model (0%, 20%, 70%, 85% and 100% D2O). The 
column containing the “relative signal” is meant to signify the changing contribution of signal 




Table 5.3. Molecular parameters derived from Small Angle Neutron and X-ray Scattering for 
Parp1-486 and its complexes with 21-27 bp overhang DNA.  The entire data calculated for the 
contrast-variation series of Parp1-486 and its DNA complexes. The data for Parp1-486 are slightly better 
than for the full-length because the truncated protein is more monodisperse.  The Parp1-486 datasets are 









within the SANS measurements time restraints.  Concentrated Parp1-486 protein (~6.0 mg/ml) and 21-
27mer DNA (~20.0 mg/ml) were dialyzed in ~100% D2O complex buffer (300 mM NaCl, 50 mM Tris 
pH=8).  Dialysis of the protein alone resulted in ~40 loss of the initial material due to sticking to the 
dialysis membrane (loss detected by absorbance readings at 280nm before and after dialysis).  Because 
sticking is a form of aggregation, extra precautions to prevent aggregation during SANS data collection 
were necessarily applied.  It is known that small molecule additives, or excipients, can increase solubility 
of properly folded proteins and stabilize unfolded proteins [246].  Addition of L-arginine at a 5 mM 
concentration was sufficient to prevent sticking/aggregation of both Parp1-1014 and Parp1-486 in 
dialysis, when D2O was present.  SEC-MALS experiments showed that the complexes were stable and 
behaved nearly identically to conditions with and without L-arginine (same elution times and peak widths 
as seen in Figure 5.4).  However, having L-arginine present during the process of concentrating the 
protein to ~6mg/ml caused the Parp1-1014 protein to undergo a slight self-association in the form of a 
dimeric species (a 2-6% fraction of a 200kDa species from SEC-MALS).  The self-association seen most 
likely was an interaction mediated by two potential surface exposed cysteine side-chains (likely, the very 
same cysteines used for maleimide-linkage of fluorophore, Chapter 2).  Alternatively, the dimerization 
could result from promiscuity of any number of the Zinc-coordinating cysteine residues found in Zn1-
Zn3.  Disulfide bonds that disrupt the coordination of zinc, when reversed might render the participants 
unfolded, and more likely to aggregate, since it is unlikely the Zn would return to its properly bound state 
even after the cysteines were reduced.    Regardless, the unfortunate appearance of a dimeric species was 
especially noticeable as a left-hand shoulder in the elution peak of the Parp1-1014 and its DNA-complex 
(Figure 5.4B).  Past experiments have shown that a reversal of a dimer in SDS-PAGE could be easily 
achieved through the addition of reducing agent however, depending on the cysteine involved, reducing 
the disulfide linkages may not resuscitate the structure of a domain if the loss of Zn-coordination resulted 
in a loss of the Zn-atom in that domain (data not shown).  We therefore added TCEP (tris(2-
carboxyethyl)phosphine) to a final concentration of 5mM, a concentration in nearly 1000-fold excess of 
the protein.  We performed the experiment in the presence of TCEP for the duration of three days. 
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SANS measurements for the Parp1-486 and its complex with the 21-27mer 3’-overhang DNA 
were performed in 0%, 20%, 70%, 85% and 100% D2O at concentrations between 3.1 and 1.3mg/ml 
(SANS parameters for the Parp1-486 and its complex with DNA are tabulated in Table 5.3).  The SANS 
profiles for the complete contrast series are overlaid in for the Parp1-486 protein and the Parp1-486:DNA 
complex in Figure 5.9A and Figure 5.9B, respectively.  Overall the SANS results matched the SAXS 
results in terms of Rg changes in the presence of DNA (Table 5.3). Most telling was the result of the 
complex in 70% D2O contrast variation condition.  For Parp1-486 in the 70% D2O condition, the match 
point of the DNA, indicates the Rg of protein alone was about 20 Å greater than the protein at the same 
condition without DNA bound. Rg values for the proteins and the protein-DNA complexes in the different 
D2O conditions are represented in (Table 5.3). 
 
SANS analysis of Parp1-1014 and its DNA complexes 
 
The Parp1-1014 and the Parp1-1014:DNA complex contrast series includes a the following D2O 
percentages; 0%, 20%, 70% and 100%. The resulting SANS scattering profiles for the contrast series for 
the Parp1-1014 and the Parp1-104:DNA complexes are presented (Figure 5.10A and Figure 5.10B, 
respectively). From Table 5, some of the I(0)-values for the different contrast conditions were higher than 
expected (especially as the percentage of D2O increased above 20%), but the alternate method of 
determining molecular mass, in addition to the molecular masses obtained in SEC-MALS seems to 
strengthen the data (Table 5.2 and Table 5.5). Along with the Rg values determined from the low-q 
region of the scattering profiles of the molecules, a second parameter can be extracted from the same 
region, the intensity values at the a scattering angle of zero, I(0).  I(0)-values can be obtained by 
extrapolation and are used to calculate the molecular mass of a molecule (reference).  Traditionally, the 
molar mass value is one of the strongest controls for well-behaved systems in small angle scattering 
studies [247].  From Table 5.3 and Table 5.4 the I(0)-calculations of many of the samples had very high 











Figure 5.10.  SANS contrast variation data on the Parp1-1014 protein and its complex with the 21-
27bp overhang DNA.  A.) The scattering profiles of the Parp1-1014 alone. At conditions of 0% D2O, 20% 
and 70% D2O the full-length enzyme was reasonably “well-behaved” and the Rg-values were very close to 
those seen by SAXS. The highest concentrations of D2O were problematic, in terms of aggregation, but the 
tendency to aggregate seemed to be somewhat dependent on the protein concentration as well. The 
scattering profiles were very similar to those seen in SAXS. B.) The contrast series of Parp1-1014 in 
complex with DNA (0%, 20%, 70%, and 90% D2O). C.) As in Figure 9 this table contains the crucial 
parameters obtained in the contrast series of Parp1-1014 in complex with an overhang DNA damage model 
(0%, 20%, 70% and 90% D2O). The column containing the “relative signal” signifies the changing 







Table 5.4. Molecular parameters derived from Small Angle Neutron and X-ray Scattering for full-
length PARP-1 and its complexes with 21-27 bp overhang DNA.  The measured I(0) value was used 
for calculating molar mass of the complex (reference). Under unfavorable experimental conditions, the 
measured molar mass will be larger than predicted.  High D2O conditions may contribute to protein 
aggregation because D2O is known to reduce the solubility of protein (reference). Thus, low percentage 
D2O solutions should provide more reliable information. An alternative method to calculate molar mass 
of molecules in SAS is shown in Table 5.  As an aside, the Parp1-1014-DNA complex in 70% D2O was 
well behaved on multiple occasions.  The calculated and measured values for the protein-DNA complex 













large proportion of the samples that have larger than expected I(0)-values.  Heterogeneity in the system 
(like a small proportion of dimeric PARP-1 from Figure 5.4B), slight differences between the sample 
buffer (used for buffer signal subtraction) and addition of oligonucleotides, and poor determination of 
initial protein concentrations can lead to sample irregularities [247].  Additionally, prior to incorporating 
the use of L-arginine into the sample buffer, a large amount of what appeared to be protein remained 
bound to the walls of the SANS sample cuvets.  The apparent sticking seemed to be alleviated in future 
experiments when L-arginine was present but the phenomenon may contribute to the I(0)-derived molar 
mass inconsistencies. 
Upon close inspection of the Parp1-1014 and the Parp1-486 data tables (Table 5.3 and 5.4) it is apparent 
that overall, the lower concentration samples behave better than the higher concentration samples (i.e. less 
polydispersity manifesting itself as error in the Guinier region, the region where Rg values are calculated).  
The trade-off to having lower concentration samples is really evident in that those samples have lower 
data intensity and worse signal-to-noise ratios.  To achieve the best SANS data for the full-length PARP-
1-DNA complexes, in the lower concentrations (~1.0mg/ml), especially at the critical DNA match point 
condition of 70% D2O, these samples were measured in the SANS instrument for extended periods to 
increase signal to reduce noise in the data set. Because there was a large uncertainty in the form of large 
error bars and the loss of a well defined plateau region in the low-q, the SANS data of Parp1-1014 in the 
higher percentages of D2O, ≥70%, was not used due to the tendency to aggregate in the experimental 
concentrations that were used (noticeably larger Rg-values and associated errors).  Interestingly, SAXS 
data collected in 100% D2O did not display the same trend.  
SANS studies on the complexes of the full-length PARP-1 with the 21-27mer overhang DNA 
reveal a large positive change in Rg, from 54 to 80 Å compared to the un-complexed Parp1-1014 (Table 
5.4).  The I(0)-value for the Parp1-1014 in complex with the 21-27mer 3’-overhang DNA at that 70% 




Table 5.5. Porod volume calculations for the SAS profiles of the PARP-1 proteins and PARP1-DNA 
complexes. Porod volumes were calculated from the Porod region of the various scattering profiles 
according to Fisher et. al. The method approximates the molar mass of the samples by assuming an 
average density of 1.37g/cm3.  For the DNA-protein complexes the density will not match precisely, 
however, assuming that the complex is in a 1:1 ratio the DNA would only comprise roughly 11% of the 
mass.  The molecular masses calculated from the Porod volumes are close to the values expected for the 
samples.  Porod volumes might be a reasonable alternative to using the I(0)-calculations since the very 
low-q regions of many of the samples might contain scattering signal from the contaminating oligomeric 
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value of 131 kDa, a value that is corroborated using the Porod volume to calculate molecular mass (Table 
5.5).  Of note, a ~4kDa increase in molecular mass for the Parp1-1014:DNA complex should be expected 
as a result of Hydrogen/Deuterium exchange in the higher percentages of D2O, hence the 131 kDa 
expected molecular mass for the 70% D2O condition (larger than the theoretical mw of 127.8kDa in H2O).  
Additionally, the Rg-measurement indicates that the protein at the DNA match point is itself 20Å larger 
than the protein in the unbound form.  That result is indicative of a scenario in which the DNA in the 
complex is not contributing much to the length of the complex.  Moreover, the Rg-value for the protein in 
the 20% D2O condition, the condition where the DNA signal is stronger than the protein signal, is not 
greatly different than the 70% D2O condition.  Furthermore, the Rg-values of the proteins and the protein-
DNA complexes obtained by SAXS are in close agreement with the SANS data.  Additional evidence of a 
conformational change is available in the change in Stokes’ radii (Rs) for the protein-DNA complexes 
since the elution profiles were compared with column calibration standards, and Stokes’ radii calculated 
for each.  Furthermore, the change in Stokes’s radii, or elution volume, also reflects a molecular mass that 
is appropriate for a 1:1 PARP:DNA complex as seen in SEC-MALS data (as seen in Figure 5.4 and 
tabulated in Tables 5.1 and 5.2).  
 
Parp1-1014 is more susceptible to protease digestion upon binding DNA. 
 
 In order to confirm that indeed PARP1 undergoes a conformational change upon binding DNA, 
another limited proteolysis experiment was performed.  A careful search for alternative proteases revealed 
that another serine protease family member, thrombin, is expected to cleave PARP1 in just one site 
(residue 496, prediction with the aid of http://web.expasy.org/peptide_cutter/).   
As a means to prevent DNA from occluding any possible protease cut-sites, a smaller 14-17mer 
3bp 3’-overhang DNA was used.  Because PARP1 is thought to protect ~14bp of DNA (7bp for each of 
the Zn-fingers in the N-terminal DNA binding region), a DNA of approximately 14bp should be 
sufficient to reproduce the conformational change but not too large to prevent the protease from reaching 
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any potential cut-sites near the vicinity of the DNA.  To prevent any possible molecular crowding events 
that might enhance protease activity DNA was titrated into reactions on a fractional basis. After digesting 
the Parp1-1014 protein with increasing units of thrombin, an optimal value of 0.5 units was chosen for 
DNA titration experiments (Figure 5.8A).  Next, Parp1-1014 was incubated with increasing amounts of 
DNA for 30 minutes prior to adding thrombin.  From those thrombin digestions it became obvious that 
Parp1-1014 was indeed more sensitive to protease digestion with DNA present (Figure 5.8B).  
Additionally, when DNA was present the digestion patterns appeared markedly different than when it was 
absent.  These results suggest that DNA imparts a change on the protein and may in fact indicate that 
PARP1 maintains a more open structure in the presence of DNA. 
 
Ensemble atomistic models reveal the probable regions of PARP-1 that are responsible for the 
increased length seen when it complexes with DNA damage models. 
 
 Small angle scattering data collected on biological macromolecules can yield low-resolution 
structural information.  Scattering data are usually displayed as a plot of I(q) vs. q, where I is the intensity 
vs. q the momentum transfer (Figure 5.5).  It is often taken for granted that 3-D structural information, 
albeit low-resolution, can be calculated from such a curve.  Ab initio envelopes can be calculated using 
spherical harmonics but these envelopes do little to help one envision how certain structural regions are 
positioned in solution (see Chapters 3 and 4).  To better understand the low-resolution structure of a 
multi-domain protein, the positions of structural features like the positions of individual domains can be 
modeled and these models judged by comparison of calculated SAXS profiles to experimental data.  To 
gain structural insights on how a molecule behaves in solution, small angle scattering data can be used in 
conjunction with high-resolution crystallography or NMR data.  Since so much structural information is 
known for PARP1, it is a great candidate for molecular dynamics simulations. Many computer programs 
have been designed to help build and refine atomistic models.  Since solution studies are low-resolution in 
nature, at best only a family of models that fit the experimental data can be obtained.  Atomistic modeling 
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programs generate large numbers of possible structures (up to 105), known as ensembles.  Ensembles are 
thought to represent the shape heterogeneity of the molecules in question by comparing results to the low-
resolution SAS data, which is representative of the bulk average scattering profile of the solution The 
most effective programs allow for a comparison of modeled data to experimental data, so one can 
evaluate the goodness-of-fit for the model ([232, 248]).  Some programs generate theoretical scattering 
profiles for just such comparisons to experimental data.  One such program suite, SASSIE has recently 
been developed to model structures of intrinsically disordered proteins and their protein or nucleic acid 
complexes [232].   
The combined structural data from X-ray crystallographic and NMR studies allowed us to create 
atomistic models for Parp1-486, Parp487-1014 and Parp1-1014 (see methods).  Starting structures for the 
proteins alone were in great agreement with the data since the predicted scattering profiles for the proteins 
had Χ2-values ~1 (data not shown).  The full-length PARP-1 model was further explored to determine if 
adding DNA on the very edge of the N-terminus would result in a ~30 Å increase in Rg.  Models for three 
such DNA positions are depicted in Supplementary Figure 5.3.  The results show that even if DNA was 
bound on the very N-terminal end of the protein, a highly unlikely position considering that the Zn2 
domain has a higher affinity for DNA than does the Zn1 domain, the Rg-values for the simulated model 
are far less than what is seen experimentally (Table 5.6).   As a means to investigate likely domain-
domain interaction regions, the surface electrostatics of one of the full-length PARP-1 atomistic structures 
were investigated using a modified version of the Poisson-Boltzman equation [243].  No obvious charged 
patches or regions where domains might interact were immediately apparent (Supplementary Figure 
5.4).  Once the starting structures were built and energy minimized we began our hybrid Monte Carlo-
Molecular Dynamics simulations in the SASSIE program.  In SASSIE, each of the starting structures 
were centered and aligned and theoretical scattering profiles were calculated.  Next, the boundaries of the 
known domains were defined so that only the linker regions were allowed to vary in the structure-
generating program.  The linker boundaries of PARP-1 used in the modeling were between the following 
pairs of amino acids; linker 1 91-112, linker2 202-224, linker3 350-387, linker4 487-528, linker5 640-664 
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also, the first 5 N-terminal amino acids were allowed to rotate.  For our experiments, sets of dihedral 
angles (φ,ψ) for each of the amino acids in each of the linkers were allowed to rotate a maximum of 30° 
per round. Every round of MMC calculations resulted in a generated structure that was evaluated 
energetically by the confines defined by the most current molecular dynamics techniques [232].  The 
spectra from the large ensembles of structures were then filtered according to closeness of fit to 
experimental scattering profiles. 
 Multiple runs that generated ensembles of 104 structures were performed for each of the 
molecules studied by SAS.  A theoretical scattering profile was then generated for each of the different 
confirmations of the protein or protein-DNA complex.  Approximate Rg-values for the ensemble were 
then plotted against structure number as a means to see the breadth of conformational space each MD run 
covered (Parp1-486, Parp1-1014, Parp1-486-DNA complex, and the Parp1-1014-DNA complex; Figure 
5.11A, Figure 5.12A, Figure 5.13A and Figure 5.14A, respectively).  The structures were then filtered 
for goodness of fit to experimental scattering profile for each molecule and the χ2-value for the best-fit 
structures were plotted against Rg (Figure 5.11-14B and Figures 5.11-14C).  From Figure 5.11 and 
Figure 5.12 it is obvious that both the Parp1-1014 and the Parp1-486 molecules are very flexible and that 
many possible structures fit the data with relatively low χ2-values.  Also, noticeable is that the structures 
with the very small and the very large Rg-values also have the highest χ2-values.  The same is true for the 
Parp1-486-DNA complex and the Parp1-1014-DNA complex as seen in Figure 5.13 and Figure 5.14, 
respectively. 
 To better understand the importance of the ensembles and the solution studies themselves, we 
incorporated the use of density maps as a means to visualize the extreme flexibility of the molecules.  
Because the ensembles are atomistic in nature, and are saved in coordinate file format, we can plot the 
relative position of a given domain or domains for the entire ensemble of 104 structures.  To further refine 
our ensembles, we decided to plot density maps of the best-fit structures, which included the structures 
with the lowest χ2-values.  For the DNA complexes the χ2-values typically ranged from 12 to 1.5.  For 
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best results, we concatenated the structures from 3-4 separate runs of 104 structures resulting in an 
analysis of effectively 30-40,000 structures.  The best-fit structures for the proteins alone had low χ2-
values that ranged from ~3 to 0.5.  For the isodensity plots for both Parp1-486 and Parp1-1014 we 
centered and aligned the ensemble around the Zn3-domain (Figures 5.15 and 5.16, respectively).  For the 
DNA-bound forms of Parp1-486 and Parp1-1014, the iso-density plots were aligned on the Zn1-Zn2 
(DNA binding domain) (Figures 5.17 and 5.18, respectively).  From Figure 5.19 one can visualize just 
how flexible, in terms of the density of the ensembles, and the differences for the Parp1-486 are easily 
compared to the full-length enzyme.   
 When all the structures are aligned on the Zn3, both proteins share a common feature the position 
of the Zn1 and to a lesser extent Zn2 are very dynamic as opposed to the BRCT domain.  From the 
density plots one can see how the Zn1-Zn2 domains appear to be continuously scanning and might 
explain why the domains are so effective in their ability to find and bind multiple DNA structures. For the 
structures of the proteins in complex with 3’-overhang DNA, the density maps of the complexes were 
centered and aligned on the Zn1-Zn2 DNA-bound region.  From the density maps of the complexes one 
can visualize the increase in the extended nature of the proteins once bound to their DNA substrate.  The 
image brings to mind a beads-on-a-string example where the string tethers the bead and only allows a 
given domain a certain reach depending on its mass and the length of the linker tether. As with the 
proteins alone, a direct comparison of the ensemble coverage of the proteins in complex with DNA can be 
seen in Figure 5.19. When one compares all four density plots for the Parp1-1014, Parp1-1014:DNA 
complex, the Parp1-486 and the Parp1-486:DNA complex it becomes very obvious that the ensemble of 
the truncation construct has a severely diminished maximum distance. 
 Finally, the atomistic models of the best-fit structures for each run can be examined individually 
or can be compared to the resulting structures from different runs (Figure 5.20A).  Figure 20A depicts the 
resulting best-fit structures from three separate SASSIE runs of the full-length PARP1-DNA complex in 
the critical 70% D2O condition.  Overall, the structures have very similar χ2-values, size dimensions, 
general shapes and overall very elongated, open appearances. When measurements of the approximate 
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Figure 5.11.  Ensembles of possible PARP1-486 conformations present in SAS profiles.   A.) Using 
the Configuration Generator module within the program SASSIE, 104 possible structures were generated 
by randomly varying ϕ and φ angles within the linker regions that reside between ordered domains.  In 
black + symbols represent all the configurations that were generated.  The green circles represent the 
accepted structures that were energetically favorable and lacked overlap as confirmed by NAMD 
minimization using the CHARMM-22 force field. Small Angle Scattering (SAS) profiles were generated 
for all of the accepted structures using the program CRYSON.  From this plot one can see the range of 
Rg-values possible for the different conformations.  B.) The scattering profiles for the accepted structures 
were then filtered according to the fit to experimental SANS data.  The plot is of the profiles of the best 
and worst structures to the PARP1-486 SANS data in 0% D2O (blue, red and green, respectively).  C.) A 











Figure 5.11.  Ensembles of possible PARP1-486 conformations present in SAS profiles.   A.) Using 
the Configuration Generator module within the program SASSIE, 104 possible structures were generated 
by randomly varying ϕ and φ angles within the linker regions that reside between ordered domains.  In 
black + symbols represent all the configurations that were generated.  The green circles represent the 
accepted structures that were energetically favorable and lacked overlap as confirmed by NAMD 
minimization using the CHARMM-22 force field. Small Angle Scattering (SAS) profiles were generated 
for all of the accepted structures using the program CRYSON.  From this plot one can see the range of 
Rg-values possible for the different conformations.  B.) The scattering profiles for the accepted structures 
were then filtered according to the fit to experimental SANS data.  The plot is of the profiles of the best 
and worst structures to the PARP1-486 SANS data in 0% D2O (blue, red and green, respectively).  C.) A 





Figure 5.12. Ensembles of possible Parp1-1014 protein conformations present in SAS profiles.   
Using the same procedure as in Figure 11, models were generated for PARP1-1014, filtered and selected 
(A), fit to experimental data (B) and c2 values plotted (C). The worst χ2-values are for the structures with 
the extreme Rg-values.  It is clear that a large number of structures fit the data quite reasonably when 













Figure 5.13. Ensembles of possible PARP1-486-DNA complex conformations present in SAS 
profiles.  A) Structures were created and filtered as described in Figure 11.  B.) The scattering profiles for 
the accepted structures were then filtered according to the fit to experimental SANS data.  The plot is of 
the profiles of the best and worst structures to the Parp1-486-DNA complex SANS data in 70% D2O 
(blue, red and green, respectively).  The best-fit structure had a χ2=3.4, which is acceptable. C.) A plot of 
the χ2-values vs. the optimal Rg-value for each of the best-fit structures.  The worst χ2-values are for the 
structures with the extreme Rg-values.  It is clear that a large number of structures fit the data reasonably, 
however, the greatest density of structures are confined to the Rg-values near 60Å (very close to the Rg-












Figure 5.14. Ensembles of possible Parp1-1014-DNA complex conformations present in SAS 
profiles. A) Structure were generated and filtered as described in Figure 11. B.) The scattering profiles 
for the accepted structures were then filtered according to the fit to experimental SANS data.  The plot is 
of the profiles of the best and worst structures to the Parp1-1014-DNA complex SANS data in 70% D2O 
(blue, red and green, respectively).  The best-fit structure had a χ2=1.66 (and without the low-q data the 
χ2=1.33). C.) A plot of the χ2-values vs. the optimal Rg-value for each of the best-fit structures.  The 
worst χ2-values are for the structures with the extreme Rg-values.  It is clear that a large number of 
structures fit the data reasonably, however, the greatest density of structures are confined to the Rg-values 

















Figure 5.15.  Iso-density plots of Parp1-486.  The ensemble of accepted structures from several 
SASSIE, 3 or 4x104, runs were combined and filtered against experimental data.  As a means to better 
visualize the breadth of domain coverage, all of the structures were centered and aligned around the Zn-3 
domain. The top cartoon in the figure is a schematic representation of the domain organization of Parp1-
486.  Under each domain are three different views of the density plot for each domain.  The globular 











Figure 5.16.  Iso-density plots of Parp1-1014.  The ensemble of accepted structures from several 
SASSIE, 3 or 4x104, runs were combined and filtered against experimental data.  As a means to better 
visualize the breadth of distances that each domain can cover, all of the structures were centered and 
aligned around the Zn-3 domain. The top cartoon in the figure is a schematic representation of the domain 
organization of Parp1-1014. Just as in the cartoon the domains are colored in a gradient of blue to red and 
the colors correspond to N to C terminal, respectively.  Under each domain are three different views of 
the density plot for each domain.  The globular nature of each region signifies the area that a particular 










Figure 5.17.  Iso-density plots of the Parp1-486-DNA complex.  The ensemble of accepted structures 
from several SASSIE, 3 or 4x104, runs were combined and filtered against experimental data.  As a means 
to better visualize the breadth of distances that each domain can cover, all of the structures were centered 
and aligned around the Zn1-Zn2 DNA binding region. The top cartoon in the figure is a schematic 
representation of the domain organization of Parp1-486. Just as in the cartoon the domains are colored in 
a gradient of blue to red and the colors correspond to N to C terminal, respectively.  Under each domain 
are three different views of the density plot for each domain.  The globular nature of each region signifies 











Figure 5.18.  Iso-density plots of the Parp1-1014-DNA complex.  The ensemble of accepted structures 
from several SASSIE, 3 or 4x104, runs were combined and filtered against experimental data.  As a means 
to better visualize the distances that each domain can cover, all of the structures were centered and 
aligned around the Zn1-Zn2 DNA binding region. The top cartoon in the figure is a schematic 
representation of the domain organization of Parp1-1014. Just as in the cartoon the domains are colored in 
a gradient of blue to red and the colors correspond to N to C terminal, respectively.  Under each domain 
are three different views of the density plot for each domain (front, side and top).  The globular nature of 






maximum distance (Dmax) are made in the final structure of the Parp1-1014 or its complex with DNA, the 
resulting values are very close to the Dmax values predicted in the pair distribution plots, P(r), for those 
molecules (Figure 5.20B and Figure 5.20C, respectively).   For instance the apparent Dmax for the Parp1-
1014 protein is 183.24Å and for the 21-27mer 3’-overhang DNA:Parp1-1014 complex the apparent Dmax 
was 234Å as compared to the GNOM values of 187Å and 240Å, respectively.  Not surprisingly, the 
linker region containing the thrombin cut-site and separately defined sites of automodification exists as a 
slightly condensed loop-structure in the Parp1-1014 structure while the same region is fully exposed in 
one of the best-fit structures of the protein in complex with DNA.  Comparing the linker region within the 
best-fit model Parp1-1014 alone and the model of the protein-DNA complex reveals a large increase in 




 PARP-1 recognizes DNA damage in the cell through its N-terminal DNA binding region, which 
consists of the Zn1 and Zn2 domains.  The recognition of damaged DNA is crucial for the maintenance of 
the genome [85, 86].  Once PARP-1 finds DNA damage in the form of double stranded breaks, 3’-
extensions and nicked regions (referred to in this manuscript as blunt, overhang and nicked damage 
models) it conveys a signal to the C-terminal catalytic domain, which in turn activates the enzymatic 
function.  The signal that allows for the catalytic domain’s activation is not known but was thought to 
emanate from the hinge-like Zn3 domain [35, 36, 231, 249].  Recently our group described an N-terminal 
fragment of PARP-1 that was able to undergo a conformational change upon binding DNA damage 
models.  We described an elongation of the Parp1-486 protein in complex with DNA by using SAXS.  In 
this work we attempted to extend the previous study by incorporating Small Angle Neutron Scattering 
combined with contrast variation and atomistic modeling coupled with low-grain molecular dynamics.  







Figure 5.19. A comparison of the different iso-density plots of Parp1-486, Parp1-1014, Parp1-486-
DNA complex and the Parp1-1014-DNA complex.  As a means to better visualize the differences that 
each protein or protein-DNA complex can cover, the density plots have been aligned and overlaid. The 
best-fit density plots for each species gives information on the possible distances the domains can travel 
within a given protein or protein:DNA complex. When DNA is present in the form of a complex, the 
density plots grow in volume.  The corresponding volume increase when DNA is present and correlates 
with the increase in Rg-values for the ensembles.  As might be expected, the PARP1 proteins have a great 
deal of flexibility but the greatest density of structures within the χ2 vs Rg plots of Figures 11-14 reside in 
the Rg-range defined by the SAS data.  The density plots are a good representation of the intrinsic 
flexibility of the proteins.  Even in the absence of DNA the proteins have the potential to expand as much 
as their linker regions allow, just as they can when DNA is present however, in the absence of DNA, the 
PARP1-1014 and Parp1-486 are significantly more compact.  Filtering the structures against the data 


































Figure 5.20.  The best-fit atomistic structures of the full-length PARP1 enzyme and its DNA 
complex. A.) The best-fit structures of the Parp1-1014 in a complex with the 21-27mer 3’-overhang DNA 
damage model (head on and rotated 90°).  From left to right, the best-fit structures for SASSIE run 5, run 
6 and run 7.  Two #2-values for each of the structures are listed and #2-values improve further is the low-q 
data collected at the 13-meter detector distance is not included when filtering the ensemble against the 
experimental data collected in 70% D2O, the DNA match point. The structures are colored in a gradient 
from blue to red from the N- to C-terminus, respectively.  B.) Measurements of the approximate 
maximum dimension (Dmax) for the best-fit Parp1-1014 structure.  Distance 1= 160.83Å and Distance 
2=183.24Å..  C.) Measurements of the approximate maximum dimension for the Parp1-1014-DNA 
complex.  Distances 1-4 correspond to 197, 204, 234 and 211, respectively.  From B.) Distance 2 and 
from C.) Distance 3 are the apparent Dmax-values for the Parp1-1014 and Parp1-1014-DNA complex, 
respectively.   D.) A close-up view of the linker region that resides between the BRCT and WGR domains 
in the best-fit Parp1-1014 atomistic model.  The red sticks comprise the thrombin proteolytic site and are 
the amino acids proline and arginine.  The magenta sticks represent the lysine residues that serve as the 
major automodification targets (Altmeyer et. al., 2009).  The blue and red spheres are the N-terminal and 
C-terminal ends of the linker region, respectively.  When comparing the linker region in E.), the best-fit 
atomistic model for the Parp1-1014-DNA complex, the linker region is considerably expanded in the 




full-length PARP-1.  The structural information we have obtained is relevant to the DNA repair field 
because our studies included the full-length PARP-1 in complex with DNA-damage substrates and these 
complexes were enzymatically active.  We have described the DNA-binding induced conformational 
rearrangements of the full-length enzyme.   
Our solution-based studies incorporate several robust methods including small angle x-ray 
scattering, small angle neutron scattering, size-exclusion chromatography coupled multi-angle light 
scattering and ensemble structural modeling techniques.  The melding of these methods allows for the 
dynamic description of important yet elusive flexible proteins like PARP-1.  When combined with the 
information discussed in the second chapter of this thesis we have contributed to the PARP1 field by 
increasing understanding of this protein and its complexes with DNA not only structurally, but by 
describing its specificity, affinity and enzymatic efficiency in the presence of certain DNA damage 
models.   
 Initial SAXS-derived ab initio envelopes of the two halves of PARP-1 described very elongated 
particles (depicted in Chapters 3 and 4).  It came as a surprise to see the full-length PARP-1 envelope was 
smaller than the sum of the halves.  This result indicates that the full-length protein is more compact or 
the linker regions are not as elongated as they are in the separate halves.  To further study the possibility 
that key domain interactions are disrupted when the protein is studied in fragments, we modeled the 
domains within the ab initio envelope by using an atomistic ensemble search method.  Overall, the low-
grain molecular dynamics describe a tendency for the flexible linkers to expand and contract and for the 
domains to reorganize themselves in manner that resembles breathing.  However, the best-fit structures 
for the Parp1-1014 or Parp1-486 are somewhat compact and resemble the shape and dimensions of the ab 
initio models of Chapter 3.   Interestingly, when the protein is in complex with DNA the molecule is 
increasingly elongated.  Additionally, the models derived from molecular dynamics correspond with the 
physical parameters that were directly obtained in the various solution studies.  The major changes that 
can be visualized are the extended nature of the linker regions between domains.   One linker resides in 
the region between the BRCT and WGR domains (amino acids 487-528), and contains the most sensitive 
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trypsin cut-site.  We attempted to recapitulate the binding of BRCT and WGR domains but no complexes 
between Parp1-486 and Parp487-1014 were stable in solution studies (Supplementary Figure 5.1).  
Additionally, the enzymatic function of the enzyme could not be induced even when the critical cofactors 
(DNA, Mg2+, NAD+) and the two separate halves of the protein were present.  This result suggests that a 
conformational change within the intact enzyme is crucial for the activation of the catalytic subunit.    
Examining the electrostatics of the protein do not reveal any obvious regions that might serve as unique 
charged-patch interfaces upon binding DNA (Supplementary Figure 5.4).  Perhaps the WGR and BRCT 
domains do not actually share a stable interface but rather are held in place by one or more specific 
conformations of the linker domain between them.  It is probable that the linker will not perform its 
intended function, whether it is to relay a signal or serve as a modification target, when not covalently 
attached to the two flanking domains, as in the full-length protein.  In terms of the enzymatic function a 
recent study by Altmeyer et al. using mass spec analysis, elegantly described the major sites of 
automodification.  In that study, the major targets for ADP-ribosylation reside in the very same linker 
region and specifically include lysine residues K498, K521 and K524 [42].  In our best-fit models of the 
Parp1-1014 protein alone compared to the DNA bound state, the linker region between the BRCT and the 
WGR domain expands significantly and the distance between the two domains grows from 40.5Å to 77Å 
(Figure 5.20D and E).  Perhaps the non-DNA bound state the sites of automodification remain semi-
protected as a form of autoregulation.  In such a scenario, the residues would remain slightly buried until 
the enzyme senses damaged DNA.  Upon binding DNA damage, the enzyme would undergo a 
conformational change and in so doing, the primary target sites for enzymatic attack would then become 
exposed.  Our results describing an increased sensitivity to proteolytic cleavage to residues 494 and 495 
in the presence of DNA supports the previous hypothesis.  The automodification of critical amino acid 
targets on the PARP1 protein are a critical step for activating the DNA-damage response of the cell.  
Regulating the formation the poly(ADP-ribose) polymers might serve as a pathway checkpoint as well.  
For it is known that the ADP-ribose polymers serve as a signaling mechanism and a binding platform for 
base excision repair pathway components like XRCC1 and DNA-ligase III [67].  Additionally, from 
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Chapter 2, the FRET studies of the automodified PARP1 indicate that once activated and modified the 
protein retains its ability to bind DNA.  This newly described ability might serve to anchor the protein to 
the sites of damage until repair pathway members like Ku70/80 could arrive and protect the ends.   
 From SAS we found that both Parp1-486 and the full-length PARP-1 undergo large 
conformational changes when they form complexes with DNA.  The cause for the elongation appears to 
be a binding-induced conformational change that starts at the DBD (amino acids 1-202) but how that 
event travels through rest of the protein remains unclear however, there is some evidence that the signal 
can be mediated through the in trans addition of Zn3 .  The conformational change described here appears 
to be due to stretching in the linker regions between domains.  Both Parp1-1014 and Parp1-486 undergo 
an ~20Å change in Rg and grow in maximum dimension by ~50Å and ~60 Å, respectively.  The major 
support for this claim comes from the SANS contrast variation experiments.  The Rg values for the 
PARP:DNA complexes in the 70% D2O condition, the DNA match point, are very close to the Rg-values 
obtained in 0% D2O and in the SAXS measurements, the conditions where DNA is the dominant 
scatterer.  This Additionally, while building the DNA into the starting models for the complexes, the 
DNA was moved around to different positions in order to recreate the increase in Rg values.  Even when 
the DNA was moved to the very edge of the N-terminus of our full-length PARP-1 starting structure, an 
unlikely DNA interface with Zn1, its length could not account for the large differences between the 
protein and the protein-DNA complexes (Supplementary Figure 5.3).  
  Recently, the mechanism for how the Zn-finger domains bind DNA became more clearly defined 
in the form of separate crystal structures of Zn1-DNA and Zn2-DNA complexes [36].  Following that 
publication was one that describes the types of crystallographic interactions between several of the PARP-
1 domains and a small oligonucleotide DNA .  The crystal structure describes the DNA interactions 
between the first Zn-finger, Zn1 and the WGR domain, a domain about which little functional knowledge 
existed.  It appears that the Zn3-domain contributes to the interaction by bridging other domain contacts.  
The authors of the recent structure paper feel that the domain-contacts seen in the crystal structure 
describe the DNA-induced mechanism of how PARP-1 becomes activated when it binds its allosteric 
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regulator.  However, the construct the authors used in that study were missing a large portion of the 
protein, including the Zn2 domain, the Zn-finger with the greatest affinity for DNA, and the domain that 
critically mediates contacts between PARP-1 and its XRCC1-complex partners, the BRCT domain.  
When comparing the calculated scattering profile for the recent PARP-DNA structure PDB file, the Rg-
values were 40 Å and 43Å for the protein and the protein-DNA, respectively.  Even when the missing 
domains were added back to the structure the scattering profiles nor the associated Rg-values did not 
approach our solution scattering Rg-values for the full-length enzyme alone let alone the PARP-1-DNA 
complex.  Regardless of the differences in their results, we have incorporated the various models of DNA-
binding in the form of the molecular interactions seen in high-resolution crystal and NMR structures [35, 
36, 49] into our modeling as a way to validate and improve our starting structures. 
The solution studies described here sheds light on how the entire PARP-1 protein changes when it 
interacts with DNA.  Our studies have focused on how a DNA similar in length to the one used in the 
crytallization study affects the conformation of the full-length, active human PARP-1 enzyme.  This study 
is the first to describe how the full-length enzyme behaves in solution as a monomer or in complex with a 
DNA substrate. Our low-resolution studies have described what may be a crucial conformational 
rearrangement necessary for enzymatic activation.  
The DNA-induced conformational change of PARP1 described here might serve as a topic of 
study for future well-designed studies that couple the conformational rearrangement with enzyme 
kinetics.  From such studies it might be possible to better describe the mechanism of activation.  
Understanding just how the conformational change affects the enzyme at smaller time scales or how those 
changes influence the actual critical steps of enzymatic functionality will have direct pharmacological 
value.  Case-in-point, different chemotherapeutics can cause different types of DNA damage and many 









Supplementary Figure 5.1.  Solution studies of the interaction of the PARP1-486 and PARP487-1014 
protein fragments.  A.) Gel filtration experiments on the two halves of PARP-1 incubated at high µM 
concentrations indicate two components. B.) Analytical ultracentrifugation (AUC) sedimentation velocity 
experiments indicate an average sedimentation coefficient for the “complex” compared to the proteins 
alone. C.) Size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) 
experiments on the proposed complex of PARP1-486 and PARP487-1014.  The molecular mass of the elution 














Supplementary Figure 5.2.  Atomistic model building for the PARP1:21-27mer 3’-overhang DNA.  
A.)  The best-fit model for PARP1 was built using the program Modeller (25) as described in the methods 
section.  The PARP1-1014 was then adapted by removing the N-terminal Zn1 domain from the PDB file.  
The Zn2-DNA structure (pdb 3ODC) was then used to align the Parp98-1014 structure (colored blue to 
red with a respective N-C terminal gradient) to ensure the proper DNA interface.  Next, the PDB of the 
21-27mer 3’-overhang was aligned with the DNA used for crystallization.  The Zn1 domain (red ribbon) 
was then inserted into the major groove of the DNA approximately 14bps upstream of the Zn2 binding 
site (it is know from DNAase protection that the PARP1-1014 has a ~14bp footprint [9].  The binding 
position is very similar to the position proposed in the crystallographic work by Langelier et. al. [18].  
Next, the Modeller program was used to re-attach the linker region to the C-terminus of the Zn1-domain.  
Finally, the entire structure was validated and energy minimized using NAMD and the CHARMM-22 
force field.  B.) The finished, energy minimized structure for the PARP1-DNA complex (the DNA has 









Supplementary Figure 5.3.  Simulations suggest that placing DNA at the end of the protein cannot 
reproduce the large change in Rg seen in the experiments of the 21-27bp overhang DNA-PARP1-
1014 complex.  A.) Using the best-fit model of PARP1-1014 (χ2~1.0) we tried to recreate the large Rg-
change seen in the SANS/SAXS data of the PARP1-1014-DNA complex by placing the DNA as close to 
the end of the protein as possible.  The different models created for this experiment have a different 
colored DNA molecule.  The DNA molecules for each model have a different register, relative to each 
other. B.) Predicted scattering profiles for each of the models with the different DNA-registers (described 
as frames).  At most, the DNA gives a ~13 Å increase in Rg (when DNA is bound to the far edge of the 
protein, a position unlikely to interact with DNA). C.) Table of the Rg values derived from the simulated 
scattering profiles for the models of different DNA register.  No matter the register of DNA used in the 
simulation, the Rg-value does not come close to the real values seen in the experimental data.  The crystal 
structures and binding affinities of Langelier et. al., suggest that Zn2 has the highest affinity for DNA and 
that the major interface DNA-protein interface occurs at the intercalating loop (colored red and denoted 
by an orange arrow)[18].  The contrast variation data suggests that even when the DNA signal is 
negligible, the Rg of the protein in the PARP-DNA complex is ~20Å larger than the protein alone under 
the same condition.  Taken together, the Rg-values from the different contrast conditions point to a large 









Supplementary Figure 5.4.  The calculated vacuum electrostatic potential for the PARP1-1014 
surface residues.  The program APBS uses the Poisson-Boltzmann equation to calculate the surface 
electrostatic potentials for macromolecules [32]. The APBS program can be used in conjunction with the 
Virtual Molecular Dynamics (VMD) program.  The electrostatics were colored red to blue to represent 
basic and acidic amino acid side chains, respectively. The range of charges plotted was from -30 to 30 
kT/e.  The protein is predominantly basic in nature and has a predicted pI of ~10.  A.) and B.) are 
different representative images that are rotated 90° relative to one another.  Overall, the charges appear to 
be homogeneously spread around the surface with no particularly obvious cluster of negative or positive 
residues with the exception of the Zn1 and Zn2 residues.  The basic clusters on the DNA-binding region 

















The experiments herein represent our efforts to characterize PARP-1, thereby contributing to a 
better basis for how this important protein functions in key biological processes.  We focused primarily 
on determining how PARP-1 functions in the presence of its two major substrates, DNA damage and 
nucleosomes.  The second and fourth chapters relate the relative enzymatic, stoichiometric and 
thermodynamic parameters of PARP-1 in the presence of these two substrates.  We have shown that 
PARP-1 is a monomer in solution, and it remains so even in complex with its DNA-damage or chromatin 
substrates.  Additionally, PARP-1 as an intact protein has a higher binding affinity for both DNA-damage 
and chromatin substrates.  These findings imply that the N-terminal DNA-binding region may interact 
with DNA more effectively if its other domains are present, a conclusion consistent with the most recent 
crystallographic studies of a nearly full-length PARP-1 in complex with a DNA-damage substrate [49]. 
 The work presented in the third, fourth and fifth chapters represent our attempts to 
provide structural information on the full-length enzyme both alone and in the presence of its DNA-
damage substrates.   Our experiments are the first to extensively describe the hydrodynamic properties of 
monodisperse solutions of PARP-1 and PARP-DNA complexes.  We have incorporated the independently 
obtained structural information for the individual domains of PARP-1 and used them to better describe 
the average solution structure of the full-length enzyme.  We have done so by combining atomistic 
models, molecular dynamics and small-angle scattering techniques to assign experimental constraints and 
strengthen the otherwise low-resolution structural information. We find that PARP-1 is indeed extremely 
flexible and can occupy a vast configuration space where the radii of gyration (Rgs) can reside between 
45 and 140 Å yet, the best-fit configurations are ~60 Å.  This finding suggests that, although capable of 
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extending to lengths where the Rg-values are 140 Å, the protein prefers to reside in a somewhat 
constrained conformational space.  Additionally, from the solution and structural studies we have shown 
that PARP-1 undergoes a conformational rearrangement in the presence of DNA damage models, a 
finding that was independently corroborated recently [49]. 
 It is our hope that these studies offer the field a better understanding of how PARP-1 behaves in 
solution and a basis to design other pertinent experiments.  Additionally, the technical and experimental 
advances we have made will facilitate future efforts to obtain valuable solution information on large, 


























 The body of research presented in this thesis represents my efforts to contribute to the 
understanding of how PARP-1 performs within several key biochemical systems.  As is the case with 
many studies of complex systems, successful interpretation of the biological problem requires that one 
first ask the correct questions and then assemble or synthesize the right tools in order to answer those 
questions. The experiments described here were designed to answer specific questions related to the 
biological functions of PARP-1.  Along the way certain avenues for future experiments have opened up.  
The following section of this thesis is dedicated to the design of a key experiment I believe will contribute 
to the understanding of just how PARP-1 binds the nucleosome.  The experimental design is not unique, 
in fact it is very similar to an experiment that helped researchers define a low-resolution description of the 
nucleosome that was later verified by the crystal structure.  The method of choice for study of the 
nucleosome-PARP-1 interaction would be Small-Angle Neutron Scattering (SANS) in combination with 
contrast variation.  Given the flexibility of PARP-1, and its inherent protease sensitivity, and the need to 
bind nucleosomal linker DNA to form a proper complex with chromatin, the likelihood that 
crystallization of the PARP-nucleosome complex will readily occur is quite low.  Instead, SANS analysis 
in conjunction with isotopic substitution (ie contrast variation), of either the histone components or the 
PARP-1 protein fragments chosen for that study, combined with modern molecular dynamics modeling 
techniques will help to determine elucidate the binding mode of the PARP-1 to the mononucleosome.  
The resulting structural information obtained will help to elucidate how PARP-1 binds both nucleosome 





The enzyme Poly (ADP-Ribose) polymerase-1 (PARP1) is the most abundant member of the 
PARP-superfamily of proteins[123]. PARP1 performs key roles in two major cellular processes, 
regulation of chromatin architecture[109, 250] and the sensing of DNA damage[23]. PARP1 binds to 
nucleosomes and poly (ADP-ribosylates) histones and chromatin-associated proteins to expose specific 
DNA sequences to the cellular machinery involved in gene transcription and/or DNA damage repair. In 
vitro studies have thus far reported that (a) in the absence of DNA damage, PARP1 is closely associated 
with silent chromatin and is enzymatically inactive. (b) Upon sensing DNA damage, the enzymatic 
activity of PARP1 increases dramatically. One key question is how PARP1 is activated upon sensing 
DNA damage, and how it interacts with chromatin.  
We hypothesized that the orientation and overall structure of PARP1 when in complex with 
damaged DNA is different from that of an undamaged chromatin substrate and that this accounts for the 
activation of the PARP1 enzymatic domain upon interaction with damaged DNA. Here we propose to use 
SANS to determine the mechanism of binding of PARP1 to the base unit of chromatin, the mono- 
nucleosome. It is our hope that these data will lead to an increased understanding of how PARP1 




 Human PARP-1 is a modular protein organized into at least 6 domains [211] (Figure 7.1). Its 
affinity for DNA is regulated by two unique zinc-finger motifs (residues 1-209; referred to as zf-PARP, 
Figure 7.1, which are sufficient to target the entire protein to damaged DNA and nucleosomes [124, 251]. 
Recent publications have focused on a different mode of DNA binding, the PARP1-dependent chromatin  
binding and subsequent higher-order chromatin compaction [123, 124]. In vitro evidence suggests that the 
zf-PARP fragment can bind to nucleosomes but is inefficient in compacting chromatin when compared to 
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the full-length protein [124]. It is thought that the C-terminal enzymatic domain of PARP1 with no known 
DNA-binding ability may contribute to chromatin compaction but is can do so unless it is covalently 
attached to the N-terminal zf-PARP domain. Since the enzymatic domain is required for compaction of 
chromatin a specific orientation for PARP1 binding may be required and should be investigated further.  
 We have already characterized several PARP1 constructs (the full-length included) ([231], 
unpublished data). Although no multi-domain structures of PARP1 are known, the structure of over 90% 
of human PARP1 has been defined within six individual domains that have been deposited in the protein 
databank (PDBID: 2JVN,2DMJ,2CR9,2CS2,2COK,3IID Figure 7.1B). Much structural information is 
available for the nucleosome (NCP) including many high-resolution crystal structures (PDBID: 1AIO 
Figure 7.1C). Our group has begun to study nucleosomes with additional DNA length because it has been 
shown that PARP1 binds more than the minimum 146 bp needed to form the nucleosome core particle 
(NCP)[123]. Light scattering and SAXS data shows that full-length PARP1 forms a 1:1 complex with 
a206 bp nucleosome (Figure 7.2A). Using the known domain structures along with molecular dynamic 
simulations and ensemble optimized methods we have reconstructed detailed structures of the PARP1 
enzyme and 206 bp nucleosome from our data (Figure 7.1B). Preliminary studies of how PARP1 binds 
the “undamaged” model, the nucleosome, are currently underway but require SANS experiments to allow 
us to distinguish protein from DNA.  
 In order to maximize our opportunity to collect the high quality SANS data of our protein-DNA 
complexes, we have established a collaboration with Dr. Susan Krueger, at NIST Center for Neutron 
research. Using the sequence information for PARP1 and a 206 bp nucleosome, we have designed 
appropriate SANS D2O contrast protocols (described below) that will allow us to determine protein and 
DNA components within nucleosomes and PARP1-nucleosome complexes. We anticipate the need for 3 
to 5 milligrams of protein per SANS measurement, an amount well within our production capabilities. 
To date, we have begun testing the solubility of our PARP1 constructs in increasing amounts of 





Figure 7.1: Starting models for the study of human PARP1-nucleosme complex 
formation. A.) The human PARP1 protein contains six known domains. The two N-terminal zinc fingers 
(Zn1, Zn2) are responsible for binding damaged DNA in a process that activates the C-terminal catalytic 
domain. B.) A Model of the tertiary structure of full-length Human PARP1. The Ab initio calculated 
envelop of full-length PARP1 is illustrated in grey, while the tertiary structure of the protein is 
represented in a red-blue gradient (N-C terminus) The tertiary structure of PARP1 was generated by rigid-
body fitting of individual domains using the SASREF program building linker regions between domains 
and refining the structure by energy minimization and position restrained refinement, (Initial atomistic 
PARP-1 model was generated by Wayne Lilyestrom PhD and it is not to scale with the nucleosome) C.) 
A model of a 206 bp nucleosome based on the nucleosome crystal structure, 1AIO. Green bases contained 
within red phosphate backbones designate the linker DNA not required for formation of the nucleosome 











analysis. Finally we have recently received rapid access SAXS time at SSRL beamline BL4-2 in and we 
have collected data of protein-DNA complexes in both H2O and D2O. Light scattering and SAXS data 
suggest differences in scattering profiles are likely due to conformational changes of the PARP1-
nucleosome complex and not aggregation (Figure 7.2B). In conclusion, SANS analysis of PARP1-
nucleosome complexes will provide key information on how PARP1 functions in the presence of 
chromatin and possibly lead to a better understanding of how PARP1 functions when bound to its other 




We would ask for three days of beamtime to perform a complete contrast variation series of experiments 
on the nucleosome and the PARP1-nucleosome complex.  The 206 bp nucleosome will allow us to 
determining the trajectory of the linker DNA (currently unknown). The PARP1-nucleosome complex will 
allow the determination of the structure of a the PARP1 protein in the complex (for comparison to our 
previously obtained SAXS data). We plan to measure the complex under buffer conditions with 0%, 15%, 
~40%, ~65%, 85% and 100% D2O. Thus, 3 measurements will be made under each contrast condition: 
206 bp nucleosome, PARP1-nucleosome complex and buffer background.  Thus, 3 measurements will be 
made under each contrast condition: 206 bp nucleosome, PARP1-nucleosome complex and buffer 
background. The same buffer background measurement will be used for both complexes at a given 
contrast condition. The scattering from the PARP1-nucleosome sample may be strong enough to measure 
in 30-40% D2O buffer to obtain data as close to the protein match point as possible. At least two 
instrument configurations will be needed in order to cover a q-range large enough to encompass the range 
of Rg values expected as a function of contrast. While the Rg values of the nucleosome alone are 






Figure 7.2. Biophysical studies of the PARP1-nucleosome complex. A.) Size exclusion 
chromatography coupled multi-angle light scattering (SEC-MALS) experiments of PARP1, 206 bp 
nucleosome and the 1:1 PARP-nucleosome complex (110KDa, 230KDa and 340KDa, respectively). 
Titration experiments show PARP1 prefers to form a 1:1 complex with nucleosomes even though two 
free DNA ends, known PARP1 recognition sites, are present (see Chapter 2 for more details). B.) Small 








complex, (>85A). The protein concentration will be approximately 4 mg/ml in the two samples. A lower 
concentration will be used for the higher-D2O contrast conditions, if necessary. In Dr. Krueger’s 
experience, it will take three days of beamtime to perform these two simultaneous contrast variation series 
of measurements. 
SANS data will be analyzed initially using the standard Guinier analysis to determine Rg and 
I(0). These parameters will also be determined using standard P(r) analysis. We will plot sqrt(I(0)) vs 
%D2O in order to verify the match point of the complexes. We will also perform a Stuhrmann analysis to 
determine Rg for the protein and DNA components in the complex as well as the separation of the centers 
of masses of the two components. Software to perform these analyses exists at the NCNR. We will also 
use the web-based MULCH software[252] to perform these analyses and to calculate the separate 
intensities for the protein and DNA in the complexes. Atomistic structure models of the separate 
components and the entire complex will be determined using the SASSIE suite of software developed at 
the NCNR for the modeling of flexible proteins in solution, using the starting structures described in 
Figure 6.1. SASSIE uses a combination of Monte Carlo and molecular dynamics approaches to find a 
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Structural characterization of H3K56Q nucleosomes and nucleosomal arrays 
 
Appendix Overview 
 This section of this manuscript represents an auxillary study for in which I was involved.  I 
contributed to this work by performing Molecular Replacement on the Histone H3 K56E containing 
nucleosome.  The problems and issues pertaining to the treatment and interpretation of x-ray diffraction 
data served as a fantastic learning platform for this author.  Additionally, I was able to gain experience 
with powerful structural biology software and gain computer skills that will benefit me for the rest of his 
life.  Without this training opportunity the author would have found completing the structural portions of 
chapters 4 and 5 impossible.   Additionally, it was I who dealt primarily with the Protein Data Bank 
(PDB) representatives for the deposition of the coordinate files, electron density maps and all other 
associated information pertaining to the crystal structures of histone H3 K56E and histone H3 K56Q 




The posttranslational modification of histones is a key mechanism for the modulation of DNA 
accessibility.  Acetylated lysine 56 in histone H3 is associated with nucleosome assembly during 
replication and DNA repair, and is thus likely to predominate in regions of chromatin containing 
nucleosome free regions.  Here we show by x-ray crystallography that mutation of H3 lysine 56 to 
glutamine (to mimic acetylation) or glutamate (to cause a charge reversal) has no detectable effects on the 
structure of the nucleosome.  At the level of higher order chromatin structure, the K to Q substitution has 
no effect on the folding of model nucleosomal arrays in cis, regardless of the degree of nucleosome 
density.  In contrast, defects in array-array interactions in trans (‘oligomerization’) are selectively 
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observed for mutant H3 lysine 56 arrays that contain nucleosome free regions.  Our data suggests that 
H3K56 acetylation is one of the molecular mechanisms employed to keep chromatin with nucleosome 




Nucleosomes, the basic building blocks of chromatin, are formed by coiling 147 base pairs of 
DNA around a protein core that consists of two copies each of histones H2A, H2B, H3 and H4 [253].  
Hundreds of thousands of nucleosomes arrayed on chromosomal DNA undergo hierarchical condensation 
steps to achieve the degree of compaction that is necessary to fit the entire eukaryotic genome into the 
confines of the nucleus [254]. Properties that regulate the degree of compaction of nucleosomes and 
chromatin (e.g., histone saturation levels, histone variants, and post-translational modifications) will 
either locally or globally affect DNA accessibility to permit access to the genome.   
Posttranslational modifications of histones have emerged as a key mechanism to regulate 
important biological processes such as transcription, DNA repair, and replication (reviewed for example 
in [255, 256]).  Numerous side chains in the histone tails, and an increasing number of amino acids in the 
structured regions of the histones, are the targets of tightly regulated and highly specific activities that add 
or remove chemical modifications to specific locations in chromatin in response to biological cues 
(reviewed in [255, 257, 258]).  Modern techniques identify new post-translational modifications at a rapid 
rate; however, our understanding of the mechanisms by which the chemical modification of selected 
histone residues affects chromatin biology has lagged behind. In many cases, specifically modified 
histone tails in turn recruit specific activities required for the required task (e.g. DNA repair, transcription, 
etc.; [259]).  Recent structural work has confirmed the notion that the structure of the nucleosome itself is 
not greatly affected by histone modifications [260]. However, modification of certain residues has 
pronounced effects on the ability of nucleosomal array to fold and compact into higher order structures of 
increasing complexity [260-262].  
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Recently, the acetylation of H3K56 has received much attention due to its implied biological 
roles in transcription, DNA repair, and in maintaining genomic stability [263-266].  The modification is 
added onto non-nucleosomal H3 by the HAT Rtt109 (in yeast) or p300 (in metazoans) and is 
subsequently incorporated into nucleosomes.  H3K56ac is a marker for newly synthesized histones during 
replication ([267] and references therein), and is also implicated in creating a favorable chromatin 
environment for DNA repair [268, 269].  Additionally, it plays a role in chromatin disassembly during 
transcriptional activation [263, 264].  Because of the location of this residue in the structured region of H3 
near the DNA at its entry- and exit point [253] it has been speculated that acetylation may destabilize the 
nucleosome sufficiently to account for some of the observed biological effects [270].   
A recent exciting technical development now allows genetic encoding of N(epsilon)-acetyllysine 
into recombinant proteins in specific positions [271]. This has enabled a first analysis of nucleosomes and 
nucleosomal arrays reconstituted with histone H3 specifically acetylated at K56 [272].  These studies 
showed that H3K56ac does not affect salt-dependent nucleosome stability, but that moderately increased 
‘breathing’ of the DNA ends can be observed in H3K56ac nucleosomes.   It was further shown that there 
is no effect of this modification on the salt-dependent compaction of saturated nucleosomal arrays with 
and without linker histone H5.   However, a long saturated array of nucleosomes with linker histone does 
not mimic the natural chromatin configurations in which H3K56ac is found (see above). Due to the 
preponderance of H3K56ac in regions of active transcription and near sites of replication- and repair-
coupled DNA assembly, this modification should also be studied in the context of subsaturated chromatin 
depleted of nucleosomes and linker histone, i.e., nucleosomal arrays containing nucleosome-free regions.     
Here we present two crystal structures of nucleosomes in which H3K56 has been substituted with 
either glutamine to mimic acetylation, or with glutamic acid to introduce a charge reversal at this location.  
Our data indicate that the structure of the nucleosome remains unaffected by these changes.  We also 
analyze the folding and oligomerization properties of subsaturated and saturated nucleosomal arrays 
bearing K56Q and find that this substitution negatively affects the ability of the arrays to oligomerize 
when they are subsaturated and contain nucleosome-free “gaps” in the arrays.  No effects of K56Q were 
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observed at the level of local array folding. Our data suggests that the acetylation of H3K56 results in a 
more globally open and accessible chromatin structure in regions of the genome depleted of nucleosomes.   
 
Materials and Methods 
 
Proteins and DNA 
  Histone expression and purification was performed as described previously [143]. The 147 bp 
palindromic α-sat DNA was purified as described [143].  The 208-12 5S rDNA repeat used to prepare 
model nucleosomal arrays was purified following published procedures [273, 274].   
 
Reconstitution of nucleosomes and nucleosomal arrays 
Nucleosomes were reconstituted onto palindromic 146 bp DNA fragment derived from α-satellite 
DNA as previously described [143, 253].  Briefly, equal molar ratios of histone octamers containing 
H3K56Q or H3K56E were mixed with 147 bp α-sat DNA  in TE buffer (10mM Tris-HCl, 0.25 mM 
EDTA, pH 7.5) containing 2.0 M KCl2. and dialyzed using salt gradient dialysis into TE buffer (0 M 
KCl2).  Nucleosomes were heat shifted at 37o for 1 hour to uniformly position the octamer on the 147 bp 
DNA template.  The nucleosomes were purified from excess DNA and unbound protein using a Prep Cell 
Model 491 purification system (Bio-Rad) and analyzed by native – PAGE [143].   
Nucleosomal arrays were reconstituted onto 208-12-5S rDNA as described [275].  Briefly, 
equimolar ratios of histone octamers containing H2A, H2B, H4 and H3 or H3K56Q were mixed with the 
208-12 DNA template in TE buffer (10 mM Tris-HCl, 0.25 mM EDTA, pH 7.8) containing 2.0 M NaCl2, 
followed by step-wise salt gradient dialysis to low salt TEN buffer (2.5 mM NaCl2-TE) [275, 276].  
 
Nucleosome crystallization  
Nucleosomes containing H3K56Q and H3K56E were crystallized by using salting in vapor 
diffusion at nucleosome concentrations ranging from 8-10 mg/ml and solution conditions of 36 mM KCl, 
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40 mM MnCl2, 5 mM K-cacodylate and 36 mM KCl, 42 mM MnCl2, 5 mM K-cacodylate.  The crystals 
were soaked in 24% 2-methyl, 2,4-pentanediol (MPD), 5% trehalose, 40.0 mM KCl, 37.0 mM MnCl2 5.0 
mM K-Cacodylate, pH 6.0 [253].  X-ray data was collected at the Advanced Light Source (beam line 
4.2.2). The data was processed with Denzo and Scalepack.  PDB entry 1KX5 was used as a search model 
for molecular replacement. Molecular replacement and further refinement was done with CNS [277].  
Coot was used for model building [278]. 
 
Analytical ultracentrifugation 
 Sedimentation velocity studies were carried out using a Beckman XL-A analytical 
ultracentrifuge using absorbance optics.  Samples were mixed to a final A260 of 0.6 - 0.8 and equilibrated 
at 200 C. for one hour prior to sedimentation.  Nucleosomal arrays were sedimented at 18-25,000 rpm 
with radial increments of 0.001cm.  V-bar and ρ were calculated using Ultrascan v9.4 for windows.  
 
Folding and oligomerization of nucleosomal arrays 
To assay folding, nucleosomal arrays were diluted with TEN buffer to a final concentration of 2.0 
mM MgCl2 and a final A260 of 0.6 – 0.8 and subjected to sedimentation velocity.  Boundaries was 
analyzed using the improved method of van Holde and Weischet [233] to obtain the integral distribution 
of sedimentation coefficients, G(s), using UltraScan v9.4 for windows.  The average sedimentation 
coefficient (smid) was defined as the sedimentation coefficient at the boundary midpoint (boundary 
fraction = 0.5). 
To assay oligomerization, differential centrifugation was used as previously described [279, 280].  
Briefly, nucleosome arrays were diluted to an A260 = 1.2 with TEN buffer.  Arrays were mixed with 
MgCl2-TEN buffer, incubated for five minutes at room temperature and then centrifuged in a bench-top 
microfuge at 13,000 RPM (~16,000 x g) for 5 min.  The A260 of the supernatant was then determined in 
a Beckman DU 800 Spectrophotometer.  Data were expressed as a percentage of the total sample that 
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remained in the supernatant as a function of MgCl2. The Mg50 is defined as the MgCl2 concentration at 




The crystal structures of nucleosomes containing H3K56Q and H3K56E.  
We used site directed mutagenesis of H3 to mimic acetylation (H3K56Q), and to introduce a 
more extreme disturbance at this site by changing the charge from positive to negative (H3K56E). 
Recombinant H3 containing H356Q or H3K56E were assembled into histone octamers together with 
recombinant H2A, H2B, and H4.  Mono-nucleosomes were reconstituted onto palindromic α-sat DNA 
[253]. Both mutant nucleosomes were indistinguishable from wild type unmodified nucleosomes based 
on heat-shifted mobility changes in EMSA assays (Figure A.1A, B).  
 We determined the crystal structure of nucleosomes reconstituted with H3K56Q and 
H3K56E to a resolution of 3.8 and 3.2 Å respectively, using molecular replacement.  Table A.2.1 
summarizes data collection and refinement statistics for both datasets.   H3K56 is located near the entry 
and exit point of nucleosomal DNA (Figure A.2A, B).  The N epsilon group of H3K56 has a distance of 
~ 4 Å to the nearest phosphate group in nucleosomal DNA (Figure A.2C).  The mutation of H3K56 to Q 
or E had no  
effect on the overall structure of the nucleosome, as revealed by rmsds of < 0.5 when comparing either 
structure to the wild type nucleosome.  The H356E side chain is clearly visible in the electron density 
generated in omit maps (Figure A.2C).  The acidic side chain rotates away from the DNA and towards 
the solvent.  The density for H3-56Q is not visible due to the relatively low resolution of this structure. 
However, the main conformation of the main chain of the histone and the C β atom of H356Q is not 
altered compared to the wild type structures.  
Importantly, DNA conformation was also unchanged in both particles compared to wild type 






Figure A.1. Nucleosomes reconstituted with H3K56Q and K56E. A) Mutation of H3K56 to Q or E 
results in reduced electrophoretic mobility on triton-urea gels. 4 µg of refolded histone octamers 
containing mutations to histone H3K56Q (lane 1), H3K56Q with WT H3 (lane 2), WT (lane 3) and 
H3K56E (lane 4) were loaded and electrophoresed on an AU-PAGE gel stained with coomassie blue. ( ) 
indicates wild type H3 and ( ) indicates H3K56Q and H3K56E mobility. B) Reconstituted nucleosomes 
containing H3- K56 mutations have a similar ability to heat shift. Nucleosomes containing H3 K56Q 
(lanes 1 and 2), WT H3 (lane 3 and 4) and H3 K56E (lane 5 and 6) reconstituted with 147 bp %-Sat DNA. 
Nucleosomes were heat shifted (+) for 1 hour at 370C (lanes 2, 4 and 6). Samples were separated on a 5 
% native polyacrylamide gel and stained with ethidium bromide (top) and Imperial Protein Stain (Pierce) 












1    2     3     4 
H4 
 -      +     -    +     -    +    X 




















Page 13 of 18 
 
Table 1: data collection and refinement statistics for nucleosomes reconstituted with H3K56Q and 
H3K56E.  
   
Data Collection K56Q K56E 
Space Group P212121 P212121 
Cell dimensions    
a, b, c (Å)  109.54, 105.56, 180.65 109.51, 105.67, 180.56 
,, 90, 90, 90 90, 90, 90 
Resolution (Å) 20 (3.78) 20 (3.2) 
Rsym or Rmerge  0.109 (0.358) 0.055 (0.342) 
I/I 6.0 (4.3) 19.53 (3.9) 
Completeness % 100 (100) 81(73.6) 
Redundancy  7.23 (7.41) 2.2(2.0) 
   
Refinement   
Resolution (Å) 3.78 3.2 
Observations 308,860 (26,559) 372,562 (35,641) 
Rwork/Rfree 0.2684/0.3146 0.2845/0.2926 
No. Atoms   
   Protein 6012 5831 
    DNA 5980 5980 
B-factors   
    Protein 87.5 50.1 
     DNA 147 109.6   
R.m.s. deviations   
Protein bond lengths 0.013 0.013 
 DNA bond lengths  0.005 0.005 
Protein bond angle 1.711 1.642 




backbone is too long for a hydrogen bond, and since there is plenty of space for the mutated amino acid to 
avoid charge-charge interference. Because the side chain is free to rotate, it is unlikely to cause charge- 
charge repulsion with the DNA. It has been previously observed that the acetylation of H3K56 results in 
increased breathing of DNA ends [272].  Crystal packing stabilizes the DNA in a ‘closed’ conformation 
[281], and thus our results are entirely consistent with this observation.    
 
H3K56Q affects oligomerization of nucleosomal arrays that are depleted of nucleosomes. 
 
In vitro chromatin condensation consists of two reversible salt-dependent structural transitions: 
folding (mediated by short-range nucleosome – nucleosome interactions within one nucleosomal array) 
and oligomerization (mediated by inter-array interactions) [254, 260, 261]. To investigate the effect of 
H3K56 modification on higher order chromatin structure, we assembled model nucleosomal arrays from 
208-12 DNA and histone octamers containing the acetylation mimic, H3K56Q. The condensation 
behavior of wild type and mutant nucleosomal arrays via inter-array interactions was then determined as a 
function of MgCl2 concentration.  Because the acetylation of H3K56 is predominantly associated with 
chromatin assembly and nucleosome-free genomic regions, we wanted to test the effect of H3K56Q on 
the condensation properties of not only saturated templates, but subsaturated templates containing 
nucleosome-free repeats [276]. 
The oligomerization curves for nucleosomal arrays that had an average ~11 bound histone 
octamers per 208-12 DNA template are shown in Figure A.3A, black symbols. The degree of saturation 
was determined by sedimentation velocity in TEN buffer (smidpoint = 25-26.5 S; data not shown) as 
described [275, 276].  Under these conditions, the MgCl2 concentration at which the sample was 50% 
oligomerized (Mg50) of H3K56Q arrays was indistinguishable from wild type arrays.  However, when 
the oligomerization experiment was repeated with subsaturated nucleosomal arrays containing an average 
of only ~8 histone octamers/template (smidpoint = 21-22 S; data not shown), the oligomerization curve 




Figure A.2: Structural analysis of nucleosomes reconstituted with H3K56E. A) Location of H3K56 in 
the nucleosome. H3 is shown in blue, H4 in green, H2A in yellow, and H2B in red. H3K56 is indicated in 
magenta. The nucleosome is viewed down the superhelical axis. B) as A), but rotated around the y-axis by 
about 75 degrees. C) Detailed view of the structure of a nucleosome with H3K56E, superimposed onto 
the wild type structure. Distances between the side chains and DNA are indicated. Electron density (2Fo-






summary of the oligomerization data obtained over a wide range of saturation levels is shown in Figure 
A.3B.  
Data are plotted as Mg50 against the number of nucleosomes as determined by sedimentation 
coefficient in TEN. The data points are fit with a linear regression to demonstrate the overall trend, even 
though the distribution of points for H3K56Q is suggestive of nonlinear behavior.  The results showed 
two clear trends. First, the Mg50 of the wild type arrays increased linearly as the extent of saturation 
decreased, consistent with previous results [282]. Second H3K56Q had a major effect on oligomerization 
of highly to moderately subsaturated arrays. Of note, the effect of K56Q on oligomerization was greater 
than the effect of the loss of histone octamers per se. These data demonstrate that the H3K56Q mutation 
is able to significantly disrupt cooperative, inter-array interactions when the arrays contain nucleosome-
free regions.  
 
Folding of nucleosomal arrays is unaffected by the H3K56Q mutation.  
 
We next examined the salt-dependent folding of wild type and H3K56Q nucleosomal arrays as a 
function of array saturation. Folding is assayed increases in the sedimentation coefficient at lower salt 
concentrations than cause oligomerization.  S-values were identical for wild type and H3K56Q arrays in  
low salt TEN at all levels of saturation. Samples were exposed to 1.75 mM MgCl2 to induce folding and 
subjected to sedimentation velocity in the analytical ultracentrifuge. Data were analyzed to obtain the  
integral distribution of sedimentation coefficients across the boundaries [233]. Figure 4A shows the data 
obtained for saturated arrays. Both the wild type and H3K56Q arrays folded robustly as indicated by the 
right-shifted sedimentation coefficient distributions that ranged as high as 55S [254]. Importantly, the 
wild type and H3K56Q profiles were essentially identical, indicating no effect of this modification on 
folding under these conditions. A graph of smidpoint against the number of nucleosomes per template 




Figure A.3: H3K56Q disrupts intermolecular oligomerization of subsaturated nucleosomal arrays. 
A) Intermolecular oligomerization assay. Nucleosomal arrays were incubated with varying concentrations 
of MgCl2, followed by centrifugation. The fraction of array remaining in the supernatant is plotted as a 
function of MgCl2 concentration. Samples of the following saturation levels, indicated by SmidTE were 
analyzed: black circles, filled: wild type, 26.5S; black circles, open: wild type 20.8S; red triangles, filled: 
H3K56, 25.2S; red triangles, open: H3K56Q, 22S. B) Effect of nucleosomal array saturation on 
intermolecular oligomerization. Nucleosomal arrays were reconstituted at various ratios of histone 
octamer to 208 bp 5S DNA repeats. Arrays were analyzed by sedimentation velocity analysis in TE buffer 
to determine their degree of saturation (SmidTE). MgCl2 concentration required for half of the arrays to 
remain in the supernatant is plotted as a function of SmidTE. Black circles, wild type; red triangles,  
H3K56Q. Lines represent a linear regression through the data points. 
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Posttranslational modifications of histones have the potential to alter chromatin structure at many levels. 
Modification or amino acid substitutions of the histone tails (e.g. [260, 261, 283] or introduction of 
histone variants to alter the nucleosome surface (e.g. [284, 285]) can change higher order chromatin 
folding and oligomerization.  Post-translational modifications of histones can also have moderate effects 
on accessibility and DNA conformation in a mono-nucleosome [286-289], and may alter the ability of 
histones to engage in histone-histone and histone-DNA interactions, with potential effects on nucleosome 
stability as was recently observed for the acetylation of H3K56  [272].  It is therefore important to 
characterize the effect of each histone post-translational modification at multiple structural levels and in 
different contexts.   
The vast majority of histone modifications are located in the flexible histone tails, with little if 
any potential to impact the structure of the nucleosome per se.  However, an increasing number of 
posttranslational modifications are being identified in the structured region of the histones, with several 
on side chains near the DNA.  Thus far three from the latter category have been characterized 
biophysically and structurally. The dimethylation of H3K79 has no effect on either the structure 
nucleosomes or the condensation of nucleosomal arrays [260]; the acetylation of H3K115 and H3K122 
increases the rate of thermal repositioning [290], with no implications for the structure (M.L. 
Dechassaand K.L., unpublished); and the acetylation of H3K56 results in subtle changes in the exposure 
rate of DNA ends in mononucleosomes [272]. 
H3K56Q mimics constitutive acetylation in that it causes reduced superhelicity of plasmid 
chromatin isolated from yeast cells and more rapid nuclease digestion of cellular chromatin [268, 291] 
and thus represents a good model for structural studies of H3K56Ac.  We find that the substitution of  
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Figure A.4. H3K56Q does not affect intramolecular folding of nucleosomal arrays. A) Sedimentation 
velocity analysis of 208-12 nucleosomal arrays in TE (10mM Tris-HCl (pH7.4) and 0.25mM EDTA) or 
TE with 1.75mM MgCl2. Integrated sedimentation coefficient distributions of nucleosomal arrays were 
determined by sedimention velocity and van Holde-Weischet analysis. S20,w is the sedimentation 
coefficient corrected to water at 20 °C. Black circles: wild type arrays in TE; open circles: wild type 
arrays in MgCl2. Red triangles: H3K56Q arrays in TE; open triangles, H3K56Q arrays in MgCl2. B) 
Intramolecular folding of nucleosomal arrays at varying levels of nucleosome occupancy. Black circles: 
wild type arrays, red triangles: H3K56Q arrays. Nucleosomal arrays were reconstituted at various ratios 
of histone octamer to 208 bp 5S DNA repeats. Arrays were analyzed by a sedimentation velocity analysis 
in either TE or TE + 1.75 mM MgCl2 buffers. The SmidTE and SMgmid are defined as the sedimentation 
coefficients at the boundary fraction = 0.5 in TE and TE with 1.75mM MgCl2, respectively. Lines 
represent a linear regression through the data points. 
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H3K56 with either Q or E (resulting in an acetylation mimic or charge reversal, respectively), results in 
no discernable structural changes either in the histone octamer or in the path of the DNA.   
Since the canonical crystal packing of nucleosome entails base stacking of the DNA as it enters 
and exits the nucleosome [281], the crystal lattice selects for nucleosomes in which the DNA is in close 
contact with the histone octamer; and thus subtle differences in DNA dynamics, as demonstrated by 
Neumann and colleagues [272] cannot be detected through x-ray crystallography.       
Lysine 56 acetylation is an abundant modification of newly synthesized histone H3 molecules 
that are incorporated during S phase and during DNA damage repair [292].  Our finding that the 
acetylation-mimic H3K56Q affects the oligomerization of nucleosomal arrays only in the context of 
subsaturated arrays containing nucleosome-free regions is consistent with this important role.  The 
oligomerization of nucleosomal arrays reflects long-range interactions between nucleosomes that are 
distinct from the short-range interactions responsible for array folding [254].  The independence of the 
two condensation transitions is reinforced by our result that the same K56Q mutation that disrupts 
oligomerization of subsaturated nucleosomal arrays has no effect on array folding, irrespective of their 
saturation level.   
At this point one can only speculate on the physical basis for the effect observed with 
subsaturated arrays.  It seems likely that our results are related to the increased site exposure of 
nucleosomal DNA observed by Neumann and colleagues in H3K56Ac nucleosomal arrays [19]. We 
speculate that site exposure may be more pronounced in arrays with multiple long nucleosome free 
regions, which serves to free up more linker DNA in the subsaturated arrays. This subsequently would 
require more MgCl2 to induce oligomerization, as we have observed.   It is also possible that H3K56 
constitutes a surface area of the nucleosome that interacts with the histone tails during oligomerization, 
but not folding, and that H3K56Ac is more effective at disrupting such an interaction if there are large 
gaps in the array.  Clearly, further experiments are required to dissect the molecular basis for the unique 
behavior of subsaturated arrays during oligomerization.  
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Our findings have several important ramifications for genomic regions harboring nucleosomes 
with acetylated H3K56. The presence of genomic chromatin containing nucleosome free regions is 
linkedto processes involving increased DNA accessibility, such as transcription, repair, and replication 
[263-266, 268, 269]. As discussed above, H3K56Ac tends to be associated with the nucleosomes in and 
around nucleosome free regions. The surprising observation that oligomerization of nucleosomal arrays 
containing nucleosome free regions is selectively affected by the K56Q mutation, with H3K56Q 
destabilizing inter-array interactions in vitro, strongly suggests that H3K56 acetylation is one of the 
mechanisms employed to keep chromatin with nucleosome free regions accessible at the higher order 
level. Both our data with H3K56Q, and those obtained previously with H3K56Ac [272], indicate that this 
modification does not function at the level of local chromatin fiber folding. However, we note that folding 
is intrinsically inhibited by nucleosome free regions [273, 274]. Furthermore, the destabilization of (H3-
H4)2 tetramer-DNA interactions by H3K56Ac (A. J. Andrews and K.L., unpublished) may also facilitate 
nucleosome eviction events at RNAPII promoters, subsequent to the removal of the H2A-H2B dimer by 
ATP-dependent nucleosome remodeling enzymes or histone chaperones [293, 294]. Regardless of the 
mechanism(s) involved, identification of a modification that specifically targets chromatin with 
nucleosome free regions is novel.  Our data are consistent with a model in which the tertiary interactions 
of subsaturated nucleosomal arrays are regulated by acetylation of H3 K56, and disruption of such 
interactions by H3 K56Ac has a significant impact on DNA repair, transcription, and the stability of 
stalled replication forks. 
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